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Abstract 
 
This thesis is divided into two parts. The first part describes the production of a small 
stereodiverse library of 2-substituted piperidines. Novel chiral titanium alkylidene reagents ii 
alkylidenated resin-bound esters i to give acid-labile resin-bound enol ethers iii. These were 
cleaved to give amino ketones iv. The switch in the nature of the resin from acid-stable to 
acid-labile is key to the purity of the amino ketones iv, as during cleavage only the acid-
sensitive enol ethers iii are cleaved, leaving the unreacted esters i on the resin. The amino 
ketones iv were cyclized using TMSCl to give cyclic iminium salts v. Diastereoselective 
reduction of the iminium salts v with NaBH(OAc)3 gave piperidines vi which, after cleavage 
of  the  chiral  protecting  group,  gave  the  desired  enantiomerically-enriched,  2-substituted 
piperidines vii.  
 
O
O R
N
H
TiCp2
Ph
N
H
Ph
O R
N
H2
Ph
R
O
TFA-DCM (4:96)
ii
i iii
iv
O
O CF3
N
H2
R
Pd/C, H2, HCl
vii
N R
Ph
N R
Ph
v
vi
TMSCl
NaBH(OAc)3
Cl
 
 
The piperidines vii were produced in good overall yield, high purity, and good to 
excellent stereochemical purity. By switching the enantiomer of the phenylethylamine chiral 
protecting group used, either enantiomer of the desired piperidine could be produced at will.  
The second part of the thesis describes a solution-phase route to 2,6-syn substituted 
piperidin-4-ones xii inspired by the Petasis-Ferrier rearrangement. Imino esters x derived 
from β-amino acids viii were methylenated using the Petasis reagent, dimethyltitanocene, to 
give imino enol ethers xi containing nucleophilic and electrophilic functionality in the same  
3
molecule. The mild microwave conditions used for the methylenation gave the enol ethers xi 
in minutes. Potentially, the reaction takes advantage of selective heating of the polar Petasis 
reagent in a  non polar solvent  system so that the rate determining decomposition of the 
Petasis reagent is accelerated without affecting any sensitive substrate. Acidic conditions 
activated the imine and induced cyclization to give the desired 2,6-syn piperidin-4-ones xii in 
good yield and excellent diastereoselectivity. A small library of piperidinones was produced 
to demonstrate the method. 
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BT  benzothiazole 
oC  degrees centigrade 
CDA  chiral derivatizing agent 
CI  chemical ionization 
conc.  concentrated 
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DOS  diversity-orientated synthesis 
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DMF  dimethylformamide 
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dr  diastereomeric ratio  
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ε’  dielectric constant 
ε”  dielectric loss 
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EI  electron impact 
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er  enantiomeric ratio 
EtOAc  ethyl acetate 
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GC  gas chromatography 
h  hour 
HMDS  hexamethyldisilazane 
HMPA  hexamethylphosphoramide 
HPLC  high performance liquid chromatography 
HWE  Horner-Wadsworth-Emmons 
Hz    Hertz 
IR  infrared 
LDA  lithium diisopropylamide 
m   multiplet 
MAOS  microwave-assisted organic synthesis 
mp  melting point 
min  minutes 
MOM  methoxymethyl 
MS  molecular sieves 
NMR  nuclear magnetic resonance 
NOE  nuclear Overhauser effect 
Nu  nucleophile 
PCC  pyridinium chlorochromate 
pg  protecting group 
Ph  phenyl 
PhH  benzene 
PhMe  toluene 
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PSI  pounds per square inch 
Py  pyridine 
q  quartet  
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quin.  quintet 
QUINAP  1-(2-diphenylphosphino-1-naphthyl)isoquinoline 
RCM  ring closing metathesis 
RT  room temperature 
s  singlet 
SASRIN  super acid sensitive resin 
SPS  solid-phase synthesis 
t   triplet 
tanδ   loss factor  
TBS  tert-butyldimethylsilyl 
TES  triethylsilyl 
Tf  triflate 
TFA  trifluoroacetic acid 
THF  tetrahydrofuran 
TIPS  triisopropylsilyl 
TMEDA  N, N, N’, N’-tetramethylethyldiamine 
TMS  trimethylsilyl 
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Chapter 1 
Solid-Phase Chemistry 
 
1.1 Background 
 
First  introduced  as  a  method  to  streamline  peptide  synthesis  by  the  late,  great 
Merrifield
1, solid phase chemistry has grown to become a versatile and powerful method to 
make a wide variety of molecules. An insoluble solid support is functionalized with a linker 
that  connects  it  to  the  substrate. Effectively,  this means that the substrate  can  easily be 
separated from the reaction mixture by simple separation of the liquid and solid phases. A 
large excess of reagent can therefore be used to drive the reactions to completion and all 
unused, excess reagent can be removed by filtration and washing. Furthermore, the solid-
supported  substrates  can  be  contained  within  porous  reactors,  allowing  several  different 
substrates, each contained in a different reactor, to be treated in one reaction vessel. This 
batch synthesis strategy means that many different products can be produced at one time in 
the same flask. Importantly, for industry and drug discovery, the easy workup/purification 
also allows solid-phase synthesis (SPS) to be easily automated. Adaptability to automation 
combined  with  batch  synthesis  means  that  libraries  of  thousands  of  compounds  can  be 
produced very quickly.  
 
1.2 Diversity-Orientated Synthesis
2 
 
  Diversity-orientated synthesis (DOS) involves the production of libraries of small, 
diverse compounds via automation and, typically, SPS. Small molecules have proven to be 
potent  in  many  different  areas,  especially  as  drugs,  and  as  tools  in  the  investigation  of 
biological pathways.
3 In particular, the ability to tune a compound’s activity by modifying 
structural attributes means that small molecule probes provide unparalleled versatility in the 
unravelling of nature’s complex workings. 
  Access to large and diverse small molecule libraries  is of paramount importance. 
Sometimes,  existing  knowledge  of  biological systems  being targeted or investigated  can 
direct  the  synthetic  strategies,  allowing  for  structure-based  rational  design.  However, 
existing information is not always available, and even when it is, only a broad guideline is 
provided. Thus, even structure-based rational design must take into account a diverse and 
large volume of chemical space. Furthermore, to investigate fully a region of chemical space, 
the compounds produced must be stereodiverse. It is not enough just to construct different  
10
scaffolds. The investigation must be deeper and take into account the different stereoisomers 
of each scaffold. A typical library inspired by DOS will contain thousands of compounds 
ideally, each existing in a unique region of chemical and stereochemical space.  
  DOS should not be carried out in a blind way. By incorporating information from 
known  biologically  potent  compounds  a  DOS  can  be  directed.  Successful  drugs  and 
biology’s collection of natural products populate a list of privileged structures.
4 These small 
but  powerful  molecules  allow  the  chemist  to  build  a  library  by  decorating  a  proven 
foundation. Building on previous success by incorporating privileged structures allows the 
library to not only be large and diverse, but also significant. 
  The purity of each and every tested member in a DOS-inspired library must be high. 
Biological screening is sensitive and confidence that only one compound is being tested is 
necessary  to  be  sure  of  the  origin  of  observed  effects.  DOS  requires  huge  numbers  of 
compounds, and SPS provides a means to access these large numbers. Unfortunately, solid-
supported intermediates cannot be purified. Thus, the reactions used in a DOS should be 
robust, proceeding with maximum efficiency, providing high yields and greater than 90% 
purity.  Due  to  the  stereospecificity  of  biological  systems,  stereochemical  purity  is  an 
essential consideration in the planning of a DOS. The targets should be one enantiomer. 
  A  variety  of  beautiful  work  has  been  accomplished  in  the  production  of  DOS-
inspired libraries. By using the adaptability of SPS to automation, a library of 45,140 drug-
like  aromatic  nitrogen-containing  heterocycles,  such  as  purines  and  pyrimidines,  was 
produced
5  by  Schultz  and  co-workers,  who  then  screened  the  library  for  the  ability  to 
influence stem cell differentiation.
6 One member in the library, purmorphamine 1, was able 
to induce differentiation of mouse mesenchymal stem cells into osteoblasts, an action called 
osteogenesis.  Other  members  of  the  library  also  induced  various  effects  on  stem  cells, 
including neurogenesis, cardiomyogenesis, and dedifferentiation. Importantly, the DOS was 
not guided by any biological information. However, by creating a huge library, including 
multiple privileged structures, and covering a large volume of chemical space, Schultz and 
co-workers were able to discover potent small molecule stem cell differentiators. 
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Taking  advantage  of the  ability  of SPS  to  produce  vast  numbers of  compounds, 
Schreiber  et al. produced  a 4,320 member  library  of  dihydropyrans using a  Diels-Alder 
cycloaddition.
7  Careful  reaction  planning  and  an  excellent  chiral  catalyst  ensured  that 
enantiomeric excess of the final products was high, 80 to 96 % ee. Furthermore, by using 
both  enantiomers  of  the  catalyst,  both  enantiomers  of  the  product  could  be  formed 
separately, thus making the route stereodiverse. Purity of the final dihydropyrans that came 
off resin was excellent (≥ 95% pure in >75% of cases). Biological screening of the library 
found  that  one  member,  haptamide  B  2,  showed  excellent  activity  in  affecting  the 
transcription factor Hap3 in vivo.
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  SPS  and  DOS  are  great  partners  in  the  discovery  of  new  biologically  active 
compounds. Only with the special characteristics of SPS, particularly the adaptability to 
automation,  can  effective  DOS  be  achieved.  By  taking  into  consideration  diversity, 
stereodiversity, the region of chemical space to be investigated, and by carefully planning 
chemically  robust  solid-phase  routes,  DOS  will  continue  to  produce  important  drug 
candidates and reveal information about biological systems. 
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1.3 Linkers 
 
  DOS is perhaps the greatest test of an SPS. DOS requires a variety of reactions to be 
compatible with potentially thousands of substrates. This means the substrate as a whole, 
including the solid support, must tolerate all reaction conditions used to transform specific 
moieties within it. The reactions, substrates and resin must be carefully chosen. The vast 
majority of the mass of a solid support used for SPS is typically polystyrene; however, the 
most important part of the solid support is the linker that “links” the substrate to the support. 
Different linkers have different effects on the eventual outcome of the reaction. Of particular 
importance are the loading conditions, the ability of the linker to tolerate a variety of reaction 
conditions,  the  cleavage  conditions,  and  the  “trace”  that  the  linker  leaves  behind  at  the 
former point of attachment in the cleaved product. The linker-dependant loading conditions 
should allow for a wide variety of different substrates to be linked to the resin, and as with 
all solid-phase transformations, loading must be high yielding. Once the substrate is on resin 
the linker must be inert to all proposed transformations and all proposed reactants. Cleavage 
conditions  rely  on  the  chemical  properties  of  the  linker.  These  properties  must  allow 
cleavage to occur in high yield and under conditions that do not damage the product being 
released from resin. Finally, the trace of the point of attachment to resin should ideally be a 
desired functionality of the cleaved product. When taking into account the large numbers of 
compounds and reactants used in DOS, the ability of the linker to be transformed without 
affecting the substrate and vice versa is of particular concern. Thus the choice of linker is 
key to minimizing the negative effects, and possibly even gaining profit from SPS. There are 
a variety of linkers reported in the literature,
9 and the choice of which linker to use is as 
crucial  to  the  success  of  the  synthesis  as  any  of  the  conditions  chosen  for  chemical 
transformation.  
 
1.4 Acid-Labile Linkers 
   
Several popular acid-labile linkers are ester-derived. The sensitivity of the linker is 
determined by the stability of the cation formed after cleavage in relation to the stability of 
the protonated ester, Scheme 1.1.  
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When the cation is very unstable, as with Merrifield linker 3, HF is required for 
cleavage. Few compounds are left unaffected by HF so linkers based on more electron-rich 
benzylic esters are often used to facilitate cleavage, and allow for a more diverse array of 
target molecules. Wang linker 4, and the SASRIN linker 5, are cleaved by 50% TFA in 
DCM, and 1-3% TFA in DCM respectively, Scheme 1.2. By using volatile acids such as 
TFA and HF, excess acid can be removed by simple evaporation to give the cleaved product 
with minimum workup.  
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While ester linkers are the most commonly used, amide-derived supports such as the 
Rink Linker
10 also exist, and these follow a similar trend to the ester linkers above. The acid-
sensitive ester linkers discussed can conversely also be cleaved by using a small nucleophilic 
base such as NaOMe, to give the cleaved product as the methyl ester. Where this type of 
cleavage is undesired, a linker can be made that sterically hinders attack by nucleophiles 
such as a small base 
 
1.5 Traceless Linkers
11,12 
 
  In the ester linkers shown above the trace left at the point of attachment to resin  
takes the form of a carboxylic acid functional group. In a well-planned synthesis the trace 
could be part of the desired molecule,  but  this  is  not always  the  case. Sometimes  it  is 
desirable to have a linker that allows cleavage to happen such that the point of attachment is 
not apparent in the cleaved product. Trialkylsilanes have been used as traceless linkers since 
they  are  amenable  to  ipso  substitution  and  can  therefore  be  cleaved  to  give  aromatic 
compounds marked only with a hydrogen atom at the former point of attachment to the resin. 
Furthermore,  trialkylsilanes  tolerate  a  wide  variety  of  conditions  including  very  basic  
14
reagents,  and  transition  metal  catalyzed  reactions.  Plunkett  and  co-workers  have  used 
traceless linkers of this nature to make small libraries of benzodiazepines
13, Scheme 1.3.  
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The cleavage conditions are typically harsh, and depend on the chemical nature of the 
linker and on the electronic properties of the aromatic ring. The ipso substitution is favoured 
by a more electron-rich environment and so the cleavage is easier for systems with electron-
donating groups attached to the aromatic ring. The cleavage can be facilitated by switching 
from  a  trialkylsilane  to  a  trialkylgermanium  linker.
14  The  germanium  analogue  of  8  is 
cleaved  by  anhydrous  TFA,  or  elemental  bromine
15  to  give  benzodiazepine  9,  or  its  7-
bromoanalogue, respectively. 
 
1.6 Safety Catch Linkers 
 
As stated before, linkers, substrates and reagents are chosen so that they will tolerate 
each other during the solid-phase portion of a synthetic route. Sometimes a targeted region of 
chemical space requires that reactions and substrates must be used that perturb this reactant, 
substrate, linker “symbiosis”. In such cases a less reactive linker is needed; a linker whose 
lability can be turned on and off.  
  Safety catch linkers must undergo an activation step for their labile characteristics to 
be turned on. Wagner used this strategy in preparing a library of diphenylmethyl derivatives 
14,
16 Scheme 1.4. A functionalized arene 11 was linked to the support via a stable carbon-
sulfur bond. The sulfur was alkylated to give the sulfonium salt 13 which was cleaved via a 
palladium catalyzed cross-coupling reaction. Interestingly, this example used the cleavage  
15
step to introduce diversity, an example of a productive cleavage. It is important to note that, 
when using a safety catch linker, the resin-bound substrate must be able to tolerate not just 
the cleavage conditions, but the typically harsh activation conditions. 
 
O
SH
Br
S
X
X
DIEA, DMF, heat
S
X S X
Et3OBF4
DCM
Ar
ArB(OH)2, [Pd(dppf)Cl2]
K2CO3, THF
10
11
12
13 14  
Scheme 1.4 
 
1.7 Chameleon Catch Linkers 
 
Considering the high demands of purity required by DOS, linker design inspired by 
purity is essential. A chameleon catch strategy switches the nature of the linker during the 
synthetic sequence so that it is cleaved using different conditions to the original linker. In 
doing so, only linker that has undergone the synthetic sequence is cleaved and all un-reacted 
linker is left on resin, ensuring high purity of the cleaved product. It differs from a safety 
catch linker in that the products can be obtained by cleaving some samples prior to switching 
the linker to give one set of products and cleaving some samples after switching the linker to 
give a different range of products. This maximizes diversity. 
Barrett  and  co-workers  revealed  this  method  in  their  route  to  cyclohexanones,
17 
Scheme 1.5. During the sequence, relatively acid-stable esters 15, derived from Merrifield 
resin, were converted into acid-sensitive cyclic enol ethers 16. Diels-Alder reactions then 
gave cyclic enol ethers 17. Mild acidic cleavage conditions were then used to cleave only 
material derived from enol ether 16 and thus the cyclahexanones 18 were produced in high 
purity. 
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Work within the Hartley group has exploited this elegant type of linker to provide 
access to a wide array of different privileged structures from the same starting esters,
18,19,20,21 
Scheme 1.6. Using novel titanium carbenoids, relatively acid-stable resin-bound esters 19 are 
converted into acid-labile enol ethers 20. Mildly acidic conditions then cleave the resin-
bound enol ethers to give the heterocycles 21 in excellent purity. The switch in the nature of 
the  linker  is  productive,  as  the  alkylidenation  adds  diversity  and  builds  the  privileged 
structure. The heteroaromatic scaffolds can then be further decorated when R
2 is a boronate 
group, via Suzuki cross-coupling on resin. See section 3.8 for a more in depth discussion of 
the Hartley methodology. 
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1.8 Cyclative cleavage 
 
  As  mentioned  earlier,  ester-derived  and amide-derived linkers  can be  cleaved by 
small  nucleophiles.  When  the  nucleophile  is  part  of  the  molecule  being  cleaved  then  
17
cyclative cleavage occurs. A resin-bound ester containing a protected nucleophile 22 can be 
deprotected and then cyclized to give a range of products 23, Scheme 1.7. This strategy has 
the advantage that cleavage is productive. A variety of heterocycles have been produced 
using this type of linker, including diketopiperazines
22, diketomorpholines
23, lactones
24, and 
quinolinones
25.   
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Scheme 1.7 
 
Nicolaou and co-workers demonstrated another type of cyclative cleavage involving 
cleavage  via  ring  closing  metathesis  (RCM),  Scheme  1.8.
26  Merrifield  resin  could  be 
converted into the resin-bound ylide 24, which in turn was transformed into the diene 25. 
Grubbs’1
st generation catalyst
27 26 formed the macrocycle and cleaved the product from 
resin in one step. 
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1.9 Enantioselective Solid-Phase Synthesis 
 
The production of stereodiverse libraries is essential for the production of selective 
drugs, and the complete understanding of complex biological systems. In particular, routes 
that  allow  access  to  a  range  of  stereoisomers  on  the  same  scaffold  are  of  interest.  
18
Enantioselective routes using  solid phase techniques are  still uncommon, but some  very 
elegant work has been reported.
28 
The aldol reaction is a powerful tool in the stereoselective construction of carbon-
carbon bonds. In the production of a library of spiroketals Waldmann and co-workers have 
used chiral boron enolates to perform this reaction on solid-supported aldehydes,
 29 Scheme 
1.9. An aldehyde linked to a polystyrene support via a Wang linker 28 was treated twice with 
the preformed boron enolate 29 to give the aldol adduct 30. It is notable that the aldehyde 
must be treated twice with six equivalents of the enolate; a large excess of reagent  is a 
common disadvantage of SPS. A further aldol reaction, followed by release and cyclization 
induced by cleavage of the p-alkoxybenzyl ether groups yielded the desired spiroketals 32 in 
good  overall  yield  and  high  diastereoselectivity.  The  route  proves  that  even  demanding 
solution phase transformations can be used effectively in the SPS of libraries. 
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Another powerful reaction in the production of non-racemic compounds is the Diels-
Alder cycloaddition. More fine work by Waldmann demonstrated how this reaction can also 
be adapted to solid phase,
30 Scheme 1.10. Resin bound aldehydes 33 were treated with the 
Danishefsky diene 35 in the presence of the formidable chromium catalyst 34. The cyclized 
product  36  could  be  released  from  resin  to  give  the  dihydropyranone  in  excellent 
enantiomeric excess (> 98% in some cases), or further functionalized via Michael addition to 
give a library of trisubstituted tetrahydropyranones also in good enantiomeric excess. It is 
notable that the high level of stereocontrol is achieved with only 5 mol% of catalyst. 
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Scheme 1.10 
 
Schreiber  and  co-workers  recently  reported  an  enantioselective  route  to 
dihydroisoquinolines
31 using a ligand and metal system developed by Knochel,
32 Scheme 
1.11.  Resin-bound  dihydroisoquinoline  37  was  alkylated  to  give  the  imminium  salt  38. 
Phenyl acetylene was added to the imminium via Knochel’s copper QUINAP system to give 
the chiral isoquinoline 39 in 84% yield and 75 % ee. Importantly, by using both enantiomers 
of QUINAP, separately, both enantiomeric series of isoquinolines could be accessed.  
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1.9 Conclusion 
   
By  exploring  broad  swathes  of  chemical  space,  diversity  orientated  synthesis  is 
proving to be an essential tool for the deciphering of biological systems. SPS is an excellent 
method to produce the large libraries necessary for DOS. With automation, a huge array of 
compounds  can  be  made  very  quickly  and  with  minimal  human  effort  in  the  lab.  It  is 
important to capitalize upon these advantages, yet it is also important to respect human input. 
Human effort that is not necessary in the lab must be used in careful and intelligent planning 
and development. While producing a vast number of compounds means there are a lot of 
different samples to test, it does not necessarily mean that a broad range of chemical space is 
being investigated. For this reason a good SPS must allow for the introduction of a wide 
range of diversity. Furthermore, as biological systems are sensitive to the three dimensional 
shape and chirality of substrates, stereocontrol in the synthetic route is paramount. Several 
excellent examples have been discussed in this section, but the need for different, unique, 
stereodiverse solid phase routes is still great.   
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Chapter 2 
Piperidines 
 
2.1 Introduction 
 
  The  piperidine  ring  is  a  privileged  structure,
33  exhibiting  a  range  of  biological 
activities. From the hemlock plant to the poison arrow frogs of South America piperidines 
are found in nature everywhere. Their interesting attributes as potential drugs have not been 
ignored; Watson and colleagues noted that over 12,000 discrete piperidine entities have been 
described in clinical or preclinical studies.
34 Clearly, there has been a lot of synthetic interest 
in this small heterocycle. Short, stereocontrolled routes are of particular interest, as three-
dimensional control is imperative for the isolation of specific biological attributes. 
           Many different methods have been used to construct piperidines and these have been 
reviewed.
35 Popular strategies include reductive amination, intramolecular Michael addition, 
Mannich  reaction,  ring-closing  metathesis,  radical cyclization,  Diels-Alder  cycloaddition, 
and nucleophilic addition to pyridinium salts. Some recent examples and types of cyclization 
are discussed below, followed by a review of methods employed for the construction of 
piperidines on solid phase, or by post-cleavage modification.  
 
2.2 Reductive Amination 
 
  Davis and co-workers reported an elegant synthesis of lasubin II, a member of the 
Lythraceae  family  of  natural products,  isolated  from one of the Lagerstroemia genus  of 
shrubs.
36 The key reaction in the route is a reductive amination leading to the formation of a 
piperidine ring, Scheme 2.1. The sulfinyl group is removed from the β-amino alcohol 40 
with HCl, neutralization causes cyclization to the imine, which is reduced with LiAlH4 to 
give  the  piperidine  41  in 76%  yield as a  single  diastereomer. Deprotection followed by 
tosylation causes another cyclization to give lasubin II 42.   
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2.3 Intramolecular Michael Addition 
           
An earlier synthesis by Pyne and co-workers cyclizes vinyl sulfoxides, via Michael 
type addition, to give 2-substituted piperidines.
37 In one example, vinyl sulfoxide 43 cyclized 
to give predominantly piperidine 45 in good yield and excellent diastereoselectivity. Pyne 
proposes a likely mechanism for the transformation in which a hydroxide anion supplied by 
triethylbenzylammonium hydroxide attacks the carbonyl of vinyl sulfoxide 43 to give the 
anion  44  which  would  be  stabilized  by  the  electron  withdrawing  CF3  group.  The 
stereochemistry of the outcome can be explained by assuming that the anion 44 is positioned 
so that the electron lone pair on sulfur is syn coplanar with the C=C double bond, and thus 
the nitrogen would then attack from the opposite face to the large Ar group. 
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2.4 Intramolecular Mannich Reaction 
 
  The nuphar alkaloids are a range of terpenoid alkaloids isolated from the Nuphar 
genus of aquatic plants. They exibit a range of interesting attributes such as anti-fungal, 
immunosuppressive, and anti-tumor activity. The core structure of the Nuphar alkaloids is a 
trisubstituted  piperidine  ring.  Davis  and  co-workers  used  their  intramolecular  Mannich 
methodology to produce one of these alkaloids,
38 Scheme 2.3. The β-amino ketone 46 is 
cyclized by activation of the imine with tosic acid mono-hydrate  in benzene to give the 
piperidine 47 in good yield as a single isomer which is taken through several more steps to 
give the nuphar alkaloid 48. 
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2.5 Ring Closing Metathesis (RCM) 
 
  (+)-α-Conhydrine, first isolated from the seeds and leaves of Cronium maculatum L, 
is one member of the anti-viral and tumor-suppressant family of alkaloids containing the 2-
(1-hydroxyalkyl) piperidine unit. Jamieson and Sutherland have used their ether-directed, 
stereoselective  aza-Claisen  rearrangement,  followed  by  RCM,  to  produce  this  small 
alkaloid.
39  The  trichloroacetimidate  49 underwent  aza-Claisen rearrangent to  provide  the 
trichloroamide  50  in  good  yield  and  excellent  diastereoselectivity.  Hydrolysis  of  the 
trichloroacetate group followed by acylation gave the diene 51 which, when treated with 
Grubbs’ 1
st generation catalyst 26, cyclized in quantitative yield to give the piperidinone 52. 
Reduction of the double bond, followed by removal of the protecting group, and reduction of 
the lactam then gave (+)-α-conhydrine 53. 
  
24
HN
O
OMOM
HN
O
OMOM
HN
OH
26
several 
 steps
51  52% 52 53
PCy3
Ru
PCy3
Ph Cl
Cl
100%
HN
CCl3
O
OMOM
HN
CCl3
O
OMOM
PdCl2(MeCN)2
PhMe
1) 2M NaOH
2) ClCOCH2CH=CH2
    NEt3, DCM
49 50  55% 
dr = 94:6
 
Scheme 2.4 
 
2.6 Radical Cyclization 
 
  The  pseudodistomins  are  a  range  of  natural  products  whose  scaffold  contains  a 
piperidine-based cyclic amino alcohol.  These small alkaloids can be isolated from tunicates, 
also called sea squirts, such as the Ascidiacea. They exibit a range of interesting biological 
activities. Naito and co-workers saw the potential of a radical cyclization between the oxime 
ether and the aldehyde in carbamate 54 to produce the basic scaffold of a pseudodistomin 
type alkaloid,
40 Scheme 2.5. The major product is 3,4-anti piperidine 56, which was isolated 
in  good  yield, and  as  an 80:20  mixture with  the  corresponding  3,4-syn  compound.  The 
proposed mechanism involves the the oxophilic stannyl radical attacking the carbonyl group 
of oxime 54 to make ketyl radical 55. Naito suggests that the electronic repulsion between 
the oxime and the stannyloxy group lead to an anti configuration in the transition state 55, 
and therefore predominantly the anti piperidine 56. In addition, it is argued that the radical 
stabilizing  influence of the oxygen atom in the oxime encourages 6-exo-trig cyclization, 
eliminating 7-endo-trig cyclization. 
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2.7 Reductive Hydroamination 
 
  Pseudodistomin D is from the pseudodistomin family of natural products described 
earlier,  and  is  found  in  the  Okinowan  sea  squirt  pseudodistomina  kanoko.  Along  with 
calmodulin antagonistic activity, pseudodistomin D also exhibits potent cytotoxicity against 
murine leukemia, and human epidermoid carcinoma KB cells. Trost et al. used dynamic 
kinetic asymmetric cycloaddition of isocyanate 58 onto vinyl aziridine 57 to produce a chiral 
urea 60, which was further manipulated to give diamine 61,
41 Scheme 2.6. Silver tosylate 
induced reductive hydroamination of alkyne 61 to give the piperidine 62 in good yield as one 
diastereomer, and with no pyrrolidine side products. Simple deprotection of the TBS group 
gave pseudodistomin D. 
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  The  lack  of  pyrrolidine  side  products  and  the  perfect  diastereoselectivity  are  of 
interest. Trost proposed that the silver ion coordinates to the alkyne causing cyclization, by 
the kinetically favored 5-exo-dig mode of cyclization to give the pyrrolidine 63, which is in 
rapid  equilibrium  with  piperidine 65  via  bicycle  64,  Scheme  2.7.  Sole formation  of  the  
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piperidine 62, could arise because the equilibrium lies heavily to the side of 65 and hence 62 
is formed by reduction of the dominant species. Another possible explanation is that due to 
the faster reduction rate of an sp
2 to an sp
3 carbon in a six-membered ring as compared to a 
five-membered ring
42 the imine 65 is preferentially reduced in the presence of imine 63.  
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2.8 Diels-Alder Cycloaddition 
 
  Pipecolic acid is a metabolite of lysine that is found in human physiological fluids, 
and appears to be involved in signaling in the central nervous system.
43 Diaz-de-Villegas and 
co-workers used an asymmetric Diels-Alder cycloaddition to form a precursor 67 to (R)-4-
oxopipecolic acid 68,
44 Scheme 2.8. Reaction of Danishefsky’s diene 35
45 with the chiral 
imine 66 in the presence of even a catalytic amount of Lewis acid gives the piperidinone 67 
as  a  single  diastereomer  in  good  yield.  However,  the  best  results  were  obtained  with 
stoichiometric amounts of zinc iodide. 
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  The  stereoselectivity  can be  explained  by the chelation  of the zinc  by the imine 
nitrogen atom and the oxygen atom of the closest benzyloxy group, Figure 2.1. The chiral 
protecting group rotates to minimize 1,3-allylic strain so that the non-coordinated O-benzyl 
group and the phenyl of the phenethyl group are matched in blocking the si-face. Thus, 
attack occurs solely from the re-face. When the other enantiomer of the phenethyl chiral 
protecting group is used, a mismatch occurs, and a mixture of diastereomers is formed.  
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  While the aza-Diels-Alder reaction has become a powerful tool in the formation of 
piperidines,  the  inverse-electron-demand  Diels-Alder  reaction  of  azadienes  is  far  less 
common. However, recent work by Carretero and co-workers has highlighted just such a 
method.
46 Carretero used a Lewis acid and a chiral ligand to effect the cycloaddition of enol 
ethers, and N-tosylated chalcones, Scheme 2.9. The electron rich enol ether was added to the 
N-tosylimine 69 in the presence of a nickel catalyst and the chiral ligand DBFOX-Ph to give 
piperidine 70. Reaction times were long, but yields were good, endo selectivity was excellent 
and enantiomeric excess ranged from 77-92%. A range of R
2 substituents was tolerated. 
However, substitution at the iminic carbon was limiting, with only electron-poor to electron 
neutral aryl groups working well, giving good yields and enantiomeric excesses between 90 
and 92%.  
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  The resultant piperidines can then be cyclized further via nucleophilic displacement 
of the Lewis-acid-coordinated alkoxy group from hemiaminal 71 to give benzothiadiazine 
derivatives 73 after reduction or alkylation of intermediate quinolinium ion 72, Scheme 2.10. 
Asymmetric  routes  to  benzothiadiazines  are  of  interest  as  these  alkaloids  have  shown 
potential in the treatment of learning and memory disorders, and neurodegenerative disease.  
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2.9 Nucleophilic Addition to Pyridinium Salts 
 
  Palinavir 74 is a potent HIV protease inhibitor with a piperidine core,
47 Figure 2.2.  
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A  key  intermediate  in  the  synthesis  of  palinavir  is  the  piperidine  (2S,4R)-4-
hydroxypipecolic acid 79. Brooks and Comins used a strategy involving the nucleophilic 
addition to a pyridinium salt to synthesize this key intermediate,
48 Scheme 2.11. Reaction of 
the disubstituted pyridine 75 with the chloroformate 76 gave the pyridinium salt 77. Addition 
of vinylmagnesium bromide, followed by hydrolysis yielded the piperidinone 78 with a dr of 
93:7. Recrystallization gave diastereomerically pure piperidinone 78 in a 78% yield. This 
was then converted into (2S,4R)-4-hydroxypipecolic acid 79 in several steps.  
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2.10 Solid-Phase Synthesis of Piperidines 
 
There are many different ways to make piperidines, each with their own advantages 
and disadvantages.  However, only a select few of these methods have been adapted to solid-
phase synthesis. Many solid-phase methods start with the piperidine already intact and then 
functionalize the piperidine. A synthetic pathway that builds the piperidine core on resin is 
very rare. Several methods involve the use of a Diels-Alder cycloaddition using a solid-
supported reactant, but barring one other example these are the only literature methods.  
Elegant work by Hall and co-workers took advantage of a novel tandem Diels-Alder 
cycloaddition/allylboration,  to  produce  diverse  piperidine  analogues,
49  Scheme  2.12. 
SASRIN linked maleimides 80 were treated with diene 81, and benzaldehyde to give the 
resin-bound piperidine 82. A reaction temperature of 80 
oC, and a ratio of 1:5:10 maleimide 
80/diene 81/aldehyde was needed for the reaction to go to completion within a reasonable 
time, as is common with aza-diene cycloadditions. However, the reaction proceded with 
100% endo selectivity, and release from resin with TFA-DCM (1:200) gave the piperidine 
83 in good yield. While this solid phase sequence has not been broadly tested, the solution-
phase analogue has been thoroughly investigated and tolerates a wide range of dienes and 
aldehydes.  
  
30
O
O
N
O
O
N
B
NMe2
O O
PhCHO (10 equiv.)
PhMe, 80
 oC, 14 h
O
O
N
O
O N
HO
Ph
81
80 82
O
HO
N
O
O N
HO
Ph
83  62%
TFA-DCM (1:200)
5 equiv.
Me2N
Me2N
 
Scheme 2.12 
 
  In  the  only  solid-phase  asymmetric  synthesis  of  piperidines,  Zech  and  Kunz 
employed a more conventional aza-Diels-Alder reaction whereby a resin-bound aza sugar, 
acting as a chiral auxiliary, was converted to an imine. Cycloadditon with Daneshefsky’s 
diene 35 afforded various asymmetric piperidine analogues,
50 Scheme 2.13. Resin-bound 
imine  84  was  treated  with  ZnCl2,  and  Daneshefsky’s  diene  35  to  yield  the  resin-bound 
piperidine 85. This was then cleaved with tetrabutylammonium fluoride, and acetic acid in 
THF  to  give  the  piperidine  86,  in  good  yield  and  typically  good  to  excellent 
diastereoselectivity. While the auxiliary was not removed, there is a literature procedure for 
its cleavage.
51 Alternatively, the resin-bound piperidine 85 could be alkylated by addition of 
an alkyl cuprate to give a resin-bound 2,4-disubstituted piperidinone. 
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  Another method developed by Rutjes, Hiemstra and co-workers relies on an acid 
catalyzed  cyclization  of  a  carbamate  and  an  acetal,
52  Scheme  2.14.  The  resin  bound 
carbamate  87  was  treated  with  catalytic  p-toluenesulfonic  acid  for  30  min  to  induce 
cyclization, which  was followed by  reaction  with 1H-benzotriazole  to give  stable resin-
bound piperidine 88. Removal of the benzotriazole group with BF3
.OEt2 followed by attack 
with a nucleophile, and removal from resin with NaOMe, gave the piperidines 89. Yields 
were  typically  good,  though  some  R  groups  and  nucleophiles  gave  poor  results.  The 
piperidines were produced as the 2,4-anti diastereomers. 
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 2.11 Conclusion 
 
  Even simple piperidines show excellent biological activity, and the core structure is 
often seen in more complex systems. New synthetic routes to such a privileged structure are 
always  welcome, especially  when new stereogenic centers are introduced in a controlled 
way. Every method has its advantages and weaknesses, so each particular target will benefit 
from a particular method, thus the more routes available to the synthetic chemist, the better. 
With  industrial  demand  for  stereoselectivity,  diversity,  and  pure  amounts  of  compounds 
never higher, solid-phase stereodiverse routes to piperidines are attractive. Such methods 
would allow the production of large libraries of specific compounds, all distinctly different 
from each other.   
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Chapter 3 
Alkenation reactions 
 
3.1 Introduction 
 
   Alkenation reactions or transformations that produce carbon-carbon double bonds are 
of paramount importance in organic synthesis. Not only do these reactions bring two carbons 
together,  but  due  to  the  reactive  nature  of  carbon-carbon  double  bonds  further 
transformations are possible. Indeed the 1979 Nobel Prize was awarded to George Wittig 
(shared with H. C. Brown) largely due to his development of the Wittig alkenation. The most 
commonly used alkenation reactions are the Wittig, the Horner-Wadsworth-Emmons, and 
the  Peterson  reactions,  although  Julia  and  modified  Julia  reactions  are  becoming  more 
popular. However, there are several titanium promoted alkenation reactions, including the 
Takeda and Petasis reactions that have special attributes, giving them a niche in the synthetic 
world.  
 
3.2 The Wittig Reaction 
 
  The  Witttig  alkenation
53,54  is  particularly  attractive  as  it  requires  only  mild 
conditions, and no ambiguity exists as to the location of the double bond being formed. 
Before Wittig chemistry double bond formation from a carbonyl substrate was achieved 
through nucleophilic attack followed by elimination; rearrangement sometimes occurred and 
the position of the double bond formed was sometimes difficult to predict and control.  
  In the Wittig reaction a phosphonium salt 90 formed from the addition of PPh3 to an 
alkyl halide is deprotonated with a base, usually an alkyllithium or phenyllithium, to give the 
resonance stabilized ylide 91. It is thought that the ylide reacts with aldehydes or ketones to 
give the oxaphosphetane 93, possibly via the betaine 92. However, evidence for the betaine 
is scarce. Once the oxaphosphetane is produced, fragmentation occurs and the alkene 94 is 
produced together with an equivalent of triphenylphosphine oxide. The immense strength of 
the phosphorus oxygen double bond is the driving force of the reaction. 
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Scheme 3.1 
 
There are generally two different kinds of ylide. A stabilized ylide is produced when 
either R
1 or R
2 contains an electron-withdrawing group on the α-carbon atom. When such a 
group  exists  the  formation  of  the  oxaphosphetane  is  reversible  and  the  thermodynamic 
product (the E isomer) is formed. If the R groups on the ylide are, instead, electron-donating, 
then the oxaphosphetane formation is not reversible, and the kinetic product (the Z isomer) is 
formed. The use of a lithium base slows down the elimination of triphenylphosphine oxide 
and therefore reduces the Z selectivity of the Wittig reaction when a non-stabalized ylide is 
used.  In  fact, using  the Wittig-Schlosser  reaction  it  is possible to obtain  near  perfect E 
selectivity,
55 Scheme 3.2. When bromoethane is treated with PPh3 and BuLi the ylide 95 is 
produced together with one equivalent of LiBr. If the aldehyde is added at -78 
oC, the LiBr 
slows the elimination of triphenylphosphine oxide. When the temperature is raised in the 
presence of PhLi the configuration of the pseudo-phosphetane switches to trans. Protonation 
of the pseudo-phosphetane with 
tBuOH yields the alkene 98 with 99% selectivity for the E 
geometry. 
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3.3 Horner-Wadsworth-Emmons (HWE) Reaction 
 
  The HWE reaction
56 is a widely used variation of the Wittig reaction. A phosphonate 
ester 99 is used instead of a triphenylphosphonium salt. The reaction only works when either 
R
1,  or  R
2  is  an  electron-withdrawing  group.  The  carbanion  100  is  produced  by  the 
deprotonation of the phosphonate ester 99 with a base, Scheme 3.3; NaH is shown here but 
other strong bases also work. Reaction of the carbanion with an aldehyde or ketone gives the 
alkene 101, via a mechanism similar to the Wittig reaction, and produces a water-soluble  
by-product 102. The alkene is typically produced in good yield as the E isomer. Due to the 
increased reactivity of the carbanion, the method can be used to alkenate hindered ketones 
that would not undergo the Wittig alkenation. 
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3.4 Peterson Alkenation 
 
  In what could be considered as the silicon version of the Wittig reaction, the Peterson 
alkenation
57 uses an α-silyl carbanion 104 to attack an aldehyde or ketone to give a mixture 
of  diastereomeric  β-hydroxyalkyltrimethylsilanes  105,  and 106,  Scheme  3.4.  A Grignard 
type nucleophile 104 is shown but the α-silyl carbanion can take other forms as well. Each β-
hydroxyalkyltrimethylsilane 105 or 106 then eliminates in a stereospecific manner dependant 
on acidic or basic conditions to give the alkene as either the Z or E geometric isomer.  
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  When acidic conditions are used on β-hydroxysilane 105 anti-elimination takes place 
via protonated intermediate 107 to give the alkene 108, Scheme 3.5. 
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  On the other hand basic conditions convert β-hydroxysilane 105 into an oxyanion 
109,  which  following  180
o  rotation  around  the  carbon-carbon  bond,  forms 
oxasilacyclobutane 110. Now syn-elimination of the oxasilacyclobutane 110 gives the other 
geometric isomer, alkene 111. 
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  The  Peterson  reaction  can  be  used  with  very  hindered  ketones,  when  the  Wittig 
reaction does not work. It has the advantage that only one geometric isomer is produced from 
each β-hydroxysilane, but unfortunately suffers from poor stereocontrol in the synthesis of 
the β-hydroxysilanes 105 and 106. 
  
3.5 Julia Alkenation 
 
  The original Julia alkenation was developed in 1973 by Marc Julia and Jean-Marc 
Paris,
58 Scheme 3.7. The phenylsulfone 112 is metalated, after which addition to an aldehyde 
113 affords the β-alkoxysulfone 114. Acylation of 114 to give the β-acyloxysulfone provides 
a  good  leaving  group,  facilitating  single-electron-donor-induced  reductive  elimination  to 
give the alkene 116. Typically the method gives high E selectivity. The reaction is difficult 
to  perform,  requiring  4  distinct  steps.  However,  it  has  found  frequent  use  in  important 
synthetic schemes. 
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  Kocienski et al. showed that the reaction is stereoselective rather than stereospecific, 
Scheme  3.8.
59  The  E-geometrical  isomer  124  predominates  regardless  of  which 
diastereomeric sulfone 117 or 120 is used, and the E:Z ratio depends on the bulk of R
1 and 
R
2. This is because the radicals 118 and 119, formed by single electron transfer and loss of 
sulfinate, can very rapidly interconvert by pyramidal inversion. The carbanions 121 and 122 
can also interconvert in this way. Presumably the rate determining step is elimination of the 
acylate anion and involves a product like transition-state so that steric interactions between 
R
1 and R
2 disfavour the formation of the Z geometric isomer 123. 
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In an attempt to address the synthetic difficulties of the classical Julia alkenation, a 
one pot method called the modified Julia alkenation has been developed, Scheme 3.9. This 
method has been extensively reviewed by Blakemore.
60 Instead of a phenylsulfone 112 the 
modified Julia alkenation uses a heterocyclic sulfone, usually a 1-phenyl-1H-tetrazol-5-yl, or 
benzothiazol-2-yl sulfone 125. The β-alkoxysulfone, 126, or 130, forms as before, but now 
there  is  no  need  for  acylation  as  the  heterocylic  group  is  transferred  via  a  Smiles 
rearrangement  to  the  β-oxygen  giving  sulfinate  128 or 132.  Spontaneous  elimination  of 
sulfur dioxide and lithium benzothiazole gives the alkene 123 or 124. While the reaction is 
easier to perform, stereocontrol suffers. The anti diastereomer 126 yields the E isomer 124 
and the syn diastereomer 130 yields the Z isomer 123. In some cases it would seem that the 
syn and anti diastereomers 126 and 130 can interconvert via retroaddition-addition, and so 
stereochemistry is not always set by the formation of the alkoxy sulfone. When unbranched 
aliphatic aldehydes are used the Z isomer is produced in moderate excess. This is possibly 
because during the Smiles rearrangement the E pathway requires the spirocylic intermediate 
127 to take an eclipsed-gauche arrangement of R
1 and R
2. The spirocyclic Z precursor 131 
does not suffer this problem. However the sulfinate salt 132 must adopt an eclipsed gauche 
configuration of R
1 and R
2 in order to place the eliminating groups in the antiperiplanar 
arrangement  necessary  for elimination, and  this  possibly  hinders the  formation of the Z 
isomer 123. 
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When α,β-unsaturated aldehydes, including aryl aldehydes, are used stereoselectivity 
improves dramatically. Smith and co-workers used a modified Julia alkenation in their total 
synthesis of the potent cytotoxic agent (–)-callystatin A,
61 Scheme 3.10. When sulfone 133 
was metalated with NaHMDS and HMPA, the α,β-unsaturated aldehyde 134 could be added  
40
to give the desired alkene 135 in poor yield but excellent stereoselectivity. The poor yield 
was a result of β-elimination of the sulfone. 
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  Julia and co-workers propose that this increased stereoselectivity results from the loss 
of the BTOLi group from the spirocyclic precursors 127 and 131 before elimination can 
occur,
62 Scheme 3.11. Should this happen the zwitterionic conformers 136 and 137 would be 
produced. Fast equilibrium to the more stable 137 would precede loss of SO2 to give the E 
alkene 124. The α,β-unsaturation of R
2 helps to stabilize the positive charge thereby allowing 
the carbocation to be formed. 
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  Later in the total synthesis of (–)-callystatin A, Smith and co-workers used a 
conventional Julia alkenation to complete the scaffold of the target molecule,
61 Scheme 3.12. 
Metalation of the sulfone 138 followed by addition of the aldehyde 139, acylation, and 
reductive elimination gave the desired alkene 140 in high yield and good stereoselectivity. 
As is demonstrated by this total synthesis, the classical and modified Julia alkenation 
complement each other well to give the synthetic chemist a very useful tool in the 
construction of alkenes.  
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3.5 Titanium Alkylidenes 
 
         While the Wittig-type reactions are extremely powerful and general tools in organic 
synthesis they suffer in cases when the carbonyl contains an acidic α-hydrogen atom, as the 
Wittig-type  alkenations  typically  require  strong  bases.  Wittig-type  reactions  have  been 
known to cause epimerization of α-protons through enolate formation and even epimerize β-
protons via retro-Michael addition. Furthermore the alkenation of carboxylic acid derivatives 
such as amides and esters generally is not possible using any of the above methods. To 
overcome these problems a range of titanium carbenoid reagents have been developed. These 
reagents are non basic so they do not deprotonate acidic α-protons or cause retro-Michael 
additions. They are also small and reactive and will, therefore, react with even hindered 
ketones. Most importantly they can alkylidenate carboxylic acid derivatives such as esters, 
and amides. These reagents and their use have been comprehensively reviewed recently,
63 
but their key features will be summarized briefly. 
 
3.6 Tebbe Methylenation 
 
   The  Tebbe  reagent
64  is  the  titanium  aluminium  complex  141  formed  from  the 
reaction  of  Cp2TiCl2,  and  AlMe3  in  toluene.
65  The  reagent  is  very  sensitive  to  air  and 
moisture, but is nonetheless available commercially as a toluene solution. The Tebbe reagent 
reacts in the presence of a Lewis base, like pyridine, to give titanocene methylidene 142, 
which can methylenate aldehydes, ketones, and a range of carboxylic and carbonic acid 
derivatives like esters, and amides, Scheme 3.13.    
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Titanocene methylidene 142 is formed via the base-induced elimination of AlClMe2 
from titanocycle 141. This reactive species acts as a Schrock carbene; an electron deficient 
16  electron  titanium  complex  in  a  high  oxidation  state,  nucleophilic  at  carbon  and 
electrophilic at titanium, Scheme 3.14. The nucleophilic reagent reacts with carbonyl groups 
to  give  the  alkene  143  and  an  equivalent  of  Cp2Ti=O,  via  the  decomposition  of 
oxatitanacyclobutane 144 in a manner similar to the phosphetane in the Wittig reaction. The 
formation of the very strong titanium-oxygen bond gives the reaction a strong driving force. 
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  The  main  advantage  of  the  Tebbe  reagent  over  Wittig-like  reagents  is  that  it 
methylenates esters, amides, thioesters, and carbonates. The reactivity of the reagent depends 
on the electronics of the substrate, and therefore, due to nucleophilic nature of the Shrock 
carbene, the Tebbe reagent will methylenate more electrophilic carbonyls preferentially. This 
means that aldehydes and ketones will be methylenated in the presence of esters and amides. 
While the use of a Lewis base is necessary to start the reaction, only a mild Lewis base is 
required,  and  thus  base  sensitive  groups  are  tolerated  in  the  reaction.  Furthermore  the 
reaction does not require heating. Unfortunately, the reaction is limited to methylenation and 
due to the instability of the reagent the procedure can sometimes be tricky.  
        Roush and co-workers have used the Tebbe Reagent in their synthesis of the bicyclic 
core of HIV-1 integrase inhibitor integramycin,
66 Scheme 3.15. The cis fused decalin 145, 
obtained  from  a  highly  stereoselective  intra-molecular  Diels-Alder  cycloaddition,  was 
methylenated with the Tebbe reagent at low temperature to give the desired diene 146 in 
69% yield. Several transformations later and the bicyclic core of integramycin was produced. 
It  is  important  to  note  that,  despite  the  acid-sensitive  protons  α  to  the  carbonyl,  no  
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epimerization of the chiral centers occurred. This can be attributed to the mild non-basic 
conditions of the Tebbe methylenation. 
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  While electronics are the main factor in determining the reactivity of a substrate 
towards Tebbe methylenation, sterics also play a role. In cases where two carbonyl groups 
have similar electronic properties sterics will determine the regioselectivity of the reaction. 
Work by Steglich and co-workers demonstrates the methylenation of a methyl ester in the 
presence of a bulky silyl ester,
67 Scheme 3.16. Using one equivalent of Tebbe reagent and 
low temperature the diester 148 was selectively methylenated to provide the enol ether 149 
in very good yield. 
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3.7 Petasis Reagents 
 
The  simplest  Petasis  reagent  is  dimethyltitanocene  150.
68  It  is  relatively  air  and 
moisture tolerant and can be stored as a solution in a mixture of toluene and THF at low 
temperature for months. The reagent can be produced by the method of Payack et al. by the 
reaction of methylmagnesium chloride with titanocene dichloride;
69 this can be done on a 
kilogram  scale.
70  Dimethyltitanocene  150  will  undergo  α-elimination  under  thermal  or  
44
microwave conditions, Section 7.6,
71,72 to give the same Schrock carbene 142, as is produced 
by the Tebbe reagent, Scheme 3.17. Meurer and co-workers have investigated the reaction 
mechanism for the Petasis reaction by using atmospheric pressure chemical ionization mass 
spectrometry  to  find  the  signals  corresponding to the oxatitanocyclobutane 144,  and  the 
products  of  its  dissociation,  which  eventually  lead  to  the  desired  alkene  and  titanocene 
oxide.
73  
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  Unlike the Tebbe reagent, the Petasis reagent is not limited to methylenation. Work 
by Petasis and Bzowej demonstrated the use of functionalized Petasis reagents.
74  When 
bis(benzylic)titanocenes were heated in the presence of esters in toluene the corresponding 
enol ethers were produced. The particular example shown, Scheme 3.18, produced only the Z 
isomer in quantitative yield. Typically yields and Z to E selectivity were moderate to good. 
Unfortunately,  the  range  of  possible  functionalized  Petasis  reagents  is  not  broad.  Only 
reagents that cannot undergo a fast β-elimination are effective. Otherwise this undesired β-
elimination  out  competes  the  desired  α-elimination,  and  the  Schrock  carbene  is  never 
generated.  
 
Ti
Cl
Cl 152
O
O
O
Cl
151 153 100%
 PhMe, 55 
oC
3 equiv.
 
Scheme 3.18 
 
  The favored geometry of the alkene can be explained by considering the two possible 
oxatitanacyclobutane intermediates 156 and 157,
75 Scheme 3.19. When an ester 154 reacts 
with a Schrock carbene 155, generated from a functionalized Petasis reagent, two different 
oxatitanacyclobutanes are possible: 156, and 157. Intermediate 156 will lead to the E alkene,  
45
and intermediate 157 will lead to the Z alkene. The reaction is likely to be under kinetic 
control so the E:Z ratio is dependant on the relative energies of the transition states leading to 
156  and  157.  The  oxygen  attached  to  R
1  acts  as  a  spacer  and  thus  minimizes  steric 
interactions with the OR
1 group. So, unless R
3 is very small, intermediate 156 is favored, and 
the Z alkene is produced in preference.  
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Dimethyltitanocene has found a wide variety of uses in the literature. Its mechanism 
of reaction is very similar to the Tebbe alkenation, and so, due to its comparative ease of 
synthesis, it is used in similar situations as the Tebbe alkenation. The simple benign reaction 
conditions make it an attractive reagent to methylenate carbonyl groups containing acidic α-
protons. In their studies towards the total synthesis of kainic acid, Parsons and co-workers 
used dimethyl  titanocene  to  methylenate a  ketone  containing  a  sensitive α-chiral  center, 
Scheme 3.20.
76 When ketone 160 was treated with the Petasis reagent in THF and heated 
under reflux the alkene 161 was produced in good yield, and the sensitive chirality was left 
untouched. The transformation also demonstrates the chemoselectivity of the reaction as the 
ketone is alkenated preferentially in the presence of an ester. 
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  The  Petasis  methylenation has  been  combined  with  other reactions to allow new 
synthetic strategies. Sigmatropic rearrangements have proved to be very powerful tools for 
the organic chemist. One popular strategy involves methylenation of an allylic ester to form 
a precursor for a Claisen rearrangement. In a paper demonstrating the utility of p-menthane-
3-carboxaldehyde as a chiral auxiliary, Spino et al. used just such a strategy in the synthesis 
of (+)-cuparenone 165
77, Scheme 3.21. The starting allylic ester 162 was methylenated with 
dimethyltitanocene to give the enol ether 163, which was heated under reflux in toluene to 
give the product of the Claisen rearrangement 164 in a very good yield from ester 162 as 
essentially  one  diastereomer.  Following  removal  of  the  chiral  auxiliary  by  ozonolysis: 
cyclization, methylenation and hydrogenation gave (+)-cuparenone 165.  
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3.8 Takeda Reagents 
   
While  Petasis  reagents  allow  for  more  than  just  methylenation,  functionalized 
versions of these reagents are rarely used in the literature. The award-winning group of 
Takeda and co-workers have produced a synthetic method that produces complex titanium 
alkylidenes via the reduction of thioacetals.
78 Importantly, a range of thioacetals can be used 
to access titanium carbenoids, notably thioacetals that contain hydrogens β to the thioacetal, 
and hence, after formation of the titanium reagent, β to the Schrock carbene. The titanium 
alkylidenes  can  then  be  used  to  alkylidenate  aldehydes,  ketones,  esters,  thioesters,  and 
benzamides. The geometry of the alkene formed is governed by the same rules as for the 
Petasis reagents since the mechanism of reaction of the Schrock carbene is the same for both  
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the  Takeda  and  the  Petasis  reactions.  While  stereoselectivity  is  poor  or  unreliable  for 
aldehydes, ketones, and thioesters; esters and benzamides are converted to the corresponding 
enol ethers and enamines with good and perfect Z selectivity. 
  The reagents are generated by reduction of titanocene dichloride with magnesium in 
the  presence  of  triethylphosphite  to  produce  a  low-valent  titanium(II)  complex  167,
79 
Scheme  3.22.  The  reaction  is  extremely  water-sensitive  and  4  Å  molecular  sieves  are 
essential  for  the  reaction  to  proceed  reliably.  The  low-valent  complex  167  reduces  the 
thioacetal  166  to  give  the  Schrock  carbene  168,  thus  oxidizing  the  titanium  back  to 
titanium(IV).  The  nature  of  the  thioacetal  166  is  important.  Diphenylthioacetals,  and 
dithianes  derived  from  1,3-propanedithiol  are  both  reduced  effectively,  however 
diphenylthioacetals  are  slightly  more  reactive  and  generally  preferable.  The  reaction  is 
technically demanding, but when given careful attention, yields consistent results.   
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Scheme 3.22 
 
The fact that additional functionality can be introduced with the titanium alkylidene 
is the key feature of the Takeda reagents. A variety of different thioacetals have been used to 
produce  the  desired  Schrock  carbenes,  including:  dithio-orthoformates  169
80,81, 
triphenyltrithio-orthoformate  170
80,  2-silyl-1-bis(phenylthio)ethanes  171
82,  benzylic  and 
homobenzylic thioacetals 172, 173, 174,
83,18,19,20,84,85 Figure 3.1. While the Takeda reaction 
tolerates a broad spectrum of functionality some groups cause problems in the reagent itself. 
Bromo  and  chloro  groups  can  react  with  the  low  valent  titanium(II)  species  167.  Aryl 
chlorides are somewhat tolerated but dechlorination can occur. Unprotected amine groups 
generally cause problems and need to be protected so that no free hydrogen atoms exist on 
the amine.  
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  Takeda methodology has not been used in the synthesis of piperidines, but has been 
used to produce various heterocycles. Due to the inherent advantages of the Takeda reaction, 
intramolecular alkenation  is possible. Takeda and co-workers have capitalized on this to 
produce the challenging 7 membered cyclic enol ether 176,
86 Scheme 3.23. The thioacetal 
175 was treated with low-valent titanium species 167 to provide the cyclic enol ether 176 in 
a modest yield. The modest yield is due in large part to competing intermolecular alkenation.  
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Hartley and co-workers have used the Takeda alkenation as an integral part of their 
methodology towards a wide variety of aromatic heterocycles,
 Scheme 3.24. Originally the 
method was aimed at benzofuran synthesis.
18 A benzaldehyde-derived dithiane 177 is treated 
with the low-valent titanium complex 167 to produce a Schrock carbene that alkylidenates a 
Merrifield  resin-bound  ester  178  to  give  resin-bound  enol  ether  179.  The  enol  ether 
undergoes acid hydrolysis to cleave from resin and form the benzofuran 180. The method 
exploits  the  functionality  and  reactivity  of  the  Takeda  alkenation,  the  ease  of  work  up 
allowed by solid-phase synthesis, and the purity ensured by a chameleon catch strategy, 
Section 1.7. The Takeda alkenation’s mild reaction conditions are especially important when 
the R group is a boronate group. The fact that the reactive group is tolerated means that more 
diversity can be introduced by means of a Suzuki cross-coupling.
19 
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  The  Hartley  methodology  has  also  proven  to  be  very  adept  at  producing 
indoles, Scheme 3.25.
83 The reaction pathway is very similar to that discussed above. A 
benzaldehyde-derived dithiane 181 is treated with the low-valent titanium complex 167 to 
produce a Schrock carbene that alkylidenates a Merrifield resin-bound ester 178 to give 
resin-bound enol ether 182. The choice of protecting groups is crucial and the carbamate 
nitrogen atom must have no free hydrogen atoms. The enol ether undergoes acid hydrolysis 
to cleave from resin and form the indole 183. Once again the fact that the reactive boronate 
ester is tolerated means that more diversity can be introduced by means of a Suzuki cross-
coupling.
21 Only indoles and benzofurans have been presented, but analogous routes give 
benzothiophenes
20 and quinolines.
84  
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3.9 Takai reagents 
   
1,1-Bimetallic reagents, also called modified Takai reagents, have proved to be useful 
alkylidenation reagents, showing up frequently in the literature. Takai and co-workers first 
produced titanium bimetallics by treating dibromomethane (1.5 equiv.) and zinc dust (4.5 
equiv.) in THF with TiCl4 (1.1 equiv.) in DCM to give the bimetallic 184. After stirring for 
15 min, a ketone (1 equiv.) was added, which reacted with the bimetallic reagent to give 
alkenes,
87 Scheme 3.26.  
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   It would seem that the reaction proceeds via the dihaloalkane reacting with zinc dust 
to form a di-zink 188, Scheme 3.25. Takai and co-workers showed that if the di-zinc 188 was 
preformed fewer equivalents of all reagents were necessary. The di-zinc 188 is hard to make, 
but its formation can be expedited with a catalytic amount of lead(II).
88 When diiodomethane  
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is treated with zinc dust no di-zinc 188 is produced. If a small amount of lead(II)chloride is 
added, the necessary di-zinc 188 is produced efficiently. The first addition of zinc to the gem 
dihalide is thought to be a fast addition, and the second addition a slow one. Transmetalation 
of  monozinc  185  would  give  the  more  covalent  organolead  intermediate  186.  Now  the 
second iodide is replaced quickly by zinc to give the bimetallic 187. It  is believed that 
replacement  of  the  lead  by  zinc  is  fast  and  yields  the  di-zinc  188,  which  undergoes 
transmetalation  to  give the titanium  zinc  bimetallic 184. The pre-formed di-zinc  188  (2 
equiv.), TiCl4 (1 equiv.), and the ketone (1 equiv.) in THF can be stirred at RT to give the 
desired alkene. 
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Tochtermann and co-workers found that, alternatively to the preformed di-zinc 188, 
comercially available Nysted reagent 190 will effect methylenation in the presence of TiCl4, 
Scheme  3.27.
89  When  ketone  189  was  treated  with  Nysted  reagent  and  TiCl4  in  THF, 
methylenation  took  place  at  room  temperature  to  give  alkene  191  in  a  good  yield. 
Interestingly when the ketone 189 was treated with Wittig conditions, epimerization occurred 
at C-6.  
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Scheme 3.27 
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Nicolaou et al. used a 1,1-bimetallic reagent in their synthesis of the fused polycyclic 
skeleton of vannusal A, a triterpene isolated from a tropical marine ciliate,
90 Scheme 3.28. 
Ketone 192 was treated with zinc dust, PbCl2, TMSCl, diiodomethane, and TiCl4 to give the 
alkene 193 in very good  yield. RCM using Grubbs 2
nd generation catalyst 194 gave the 
protected  fused  polycycle  195.  Nicolaou  et  al.  specifically  chose  the  bimetallic  reagent 
because of the epimerisable center α, to the ketone, and to prevent loss of the OTES group 
via retro Michael addition.  
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Scheme 3.28 
 
  Takai reagents are similar to 1,1-bimetallic reagents, and can incorporate diversity by 
allowing the use of gem-dihaloalkanes.
91,88 The method differs from that above in the use of 
a base, usually tetramethylethylenediamine (TMEDA). The reaction mechanism is still to be 
established.  The  reagent  can  be  used  to  alkylidenate  a  range  of  carbonyl  compounds 
including esters, amides, and thioesters. All hetero-substituted alkenes were produced with 
Z-selectivity except enamines which were produced as the E-isomer.  
  Following unsuccessful attempts via elimination, Dujardin and co-workers turned to 
Takai chemistry in their syntheis of dihydropyrans,
92 Scheme 3.29. The (R)-mandelic acid 
derivative 196 was subjected to  the  Takai reagent  generated  from  1,1-dibromoethane  to 
produce the dieneophile 197 in modest yield. Alkenation occurred solely on the less hindered 
site and with  good selectivity  for the Z  geometrical isomer. Alkene 197 was taken  as  a  
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mixture  of  geometrical  isomers  and  subjected  to  europium  catalyst  induced  Diels-Alder 
cycloadditon to give the dihydropyran 199 in good yield as one enantiomer. Interestingly 
only the Z isomer underwent reaction; the E isomer appeared to suffer overwhelming steric 
hindrance in the favored endo transition state.  
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Scheme 3.29 
 
3.10 Conclusions 
  Whereas  the  Wittig-type  reactions  are  still  far  more  widely  used,  titanium-based 
alkylidenations have found a niche in the synthetic landscape. A range of strategies have 
developed that capitalize on their special qualities. The typically mild reaction conditions 
and reactivity allow titanium alkylidenes to be used broadly yet selectively for a multitude of 
synthetic situations. Most importantly where Wittig-type reagents fail to alkenate carboxylic 
acid derivatives, titanium carbenoids have demonstrated considerable utility in transforming 
esters,  and  amides  into  hetero-substituted  alkenes.  As  shown  above,  access  to  hetero-
substituted alkenes  not only adds to accessible chemical  space, but opens up a range of 
synthetic possibilities. Indeed, titanium carbenoids are used frequently by the top names in 
chemistry, and have proven to be an indispensable tool to the organic chemist.  
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Chapter 4 
Previous Work 
 
4.1 Strategy 
 
Previous work in the Hartley group, inspired by the lack of stereodiverse solid-phase 
routes to piperidines, had built on the Hartley solid-phase methodology to investigate a solid-
phase route to enantiomerically-enriched 2-substituted piperidines, Scheme 4.1. 
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Scheme 4.1 
 
  The strategy would involve the use of novel chiral titanium alkylidene 201, generated 
from thioacetal 200 to produce a series of amino-ketones 204 on solid phase. The bulky 
chiral group would act as a protecting group during the generation of the organotitanium 
reagent 201, and the alkylidenation of resin-bound esters 202
93 to give resin-bound enol  
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ethers 203. Cyclization of the amino ketones would give an iminium salt 205. The chiral 
group  would then  control  the  reduction  of the iminium  ion 205  giving  enantiomerically 
enriched 2-substituted piperidines 206. No longer needed, the phenethyl chiral protecting 
group would be removed to give stereodiverse piperidines 207.  
  Dr. Mhairi Gibson had used this strategy to produce several 2-substituted piperidines 
207, however, the reaction conditions were not optimized and the enantiomeric purity of the 
piperidines had not been determined.  
   
4.2 Substrate Synthesis 
 
Dr. Gibson’s work began with the synthesis of the thioacetal substrate 200. The key 
feature of the substrate 200 was the protecting group. Using a bulky chiral group not only 
promised  stereocontrol,  but  also  had  the  potential  to  protect  the  amine  during  the 
alkylidenation.  Using  α-phenethylamine  as  a  building  block  of  the  thioacetal  200  was 
particularly attractive as it is affordable, bulky, and readily available in both enantiomeric 
forms.
94 Furthermore, the benzylic nitrogen-carbon bond can be reductively cleaved, and 
thus  the  phenethyl  group  can  easily  be  removed.  Efforts  to  introduce  the  group  using 
displacement were unsuccessful,  however, reductive  amination proved effective,  Scheme 
4.2. Using a method developed by Takeda and co-workers, alcohol 208 was produced from 
2,3-dihydrofuran.
86 The alcohol 208 could be oxidized using a modification of the Swern 
conditions  to  give  the  aldehyde  209,  which  underwent  reductive  amination  with  either 
enantiomer of α-phenethylamine to give the thioacetal substrate (S)-200, or (R)-200.  
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4.3 Amino Ketone Synthesis 
 
  For the thioacetal substrate 200 to be an effective precursor it would have to be stable 
during  the  challenging  solid-phase  Takeda  alkylidenation.  Typically,  amino  groups 
complicate  Takeda  alkylidenations,  possibly  by  coordination  to  titanium.  Amino  groups 
should  contain  no  free  protons  to  be  successfully  used  as  substrates  for  Takeda 
alkylidenation.  Previous  work  within  the  Hartley  group  had  shown  that  a  dithiane  210 
bearing  a  tert-butylcarbamate  group  was  an  unsuitable  substrate.
83  Investigation  of  the 
substrate showed that when treated with Takeda conditions followed by an aqueous acid 
quench, two aromatic compounds, 211 and 212, were isolated, Scheme 4.3. Toluidine 211 
was probably formed from the desired intermediate titanium benzylidene 213,  Figure 4.1. 
Thiol 212 on the other hand was probably the product of monoinsertion of titanium(II) to 
give the titanium(IV) species 214. Intramolecular deprotonation of the carbamate would then 
give the thiol 212 and prevent formation of the alkylidenating reagent 213. 
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Despite these concerns, the thioacetal substrates 200 were treated with low-valent 
titanium reagent 167. The reaction mixture was then added to resin-bound esters 202. The 
resin was washed, and cleavage with TFA-DCM (10:90) gave the desired amino-ketones 204 
in  good  yield  and  good  purity.  Seemingly,  neither  coordination  of  titanium,  nor 
intramolecular deprotonation was a problem. When looking closely at titanium(IV) species 
214 the molecule appears pre-arranged for proton transfer, whereas  in the more flexible 
complex 215, a putative intermediate in the generation of titanium alkylidine 201, the amino 
and titanium groups are more separated. Furthermore, the free protons on the amino groups 
of complexes 214 and 215 have very different acidic qualities, Scheme 4.4. Deprotonation of 
aniline 216 is relatively easy due to conjugation of the resultant anion with the carbamate 
protecting  group  and  the  neighboring  phenyl  group.  Secondary  amine  218  is  relatively 
difficult to deprotonate as it contains neither of these stabilizing groups. Thus intramolecular 
deprotonation would be significantly more difficult for complex 215 than complex 214. 
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Scheme 4.4 
 
 Steric bulk of the protecting group would account for the inability of the titanium to 
coordinate with the amine. Dr. Gibson used the thioacetal substrate (S)-200 to prepare a 
series of amino-ketones (S)-204, Scheme 4.5, Figure 4.2. 
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Figure 4.2 Yields of amino ketones (S)-204 
 
  The corresponding series of amino ketones (R)-204 produced from thioacetal (R)-200 
was also prepared in similar yields. It is likely that amino ketone 200h fails to form because 
the nucleophilic nitrogen atom of the pyridine ring coordinates to titanium, thus preventing 
formation or reaction of titanium alkylidene 201. 
 
4.4 Diastereoselective Cyclization via Reductive Amination 
 
  Shipman  and  coworkers  had  previously  devised  a  method  of  preparing  chiral  2-
substituted piperidines using the α-phenethyl group to control the stereochemistry, Scheme 
4.6.
95 Starting from chiral methyleneaziridines 220, their strategy involved the opening of the 
aziridine  with  a  Grignard  reagent,  and  copper  iodide  to  give  the  metalloenamine  221.  
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Alkylation  with  1,3-diiodopropane  gave  the  imine  222  which  cyclized  to  give  the 
piperidinium salt (S)-205a. Reduction of the iminium ion with the bulky reducing agent 
NaBH(OAc)3, gave the desired piperidine (2S, 1’S)-206a in moderate yield with excellent 
diastereoselectivity. 
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Scheme 4.6 
 
Shipman proposed that the high level of stereocontrol can be attributed to the fact that 
the iminium ion (S)-205a exists in half chair conformations 223 and 224, Scheme 4.7. The 
phenethyl group arranges itself so that the benzylic hydrogen atom is projected towards the 
propyl  group,  thereby  minimizing  1,3-allylic  strain.  The  hydride  must  attack  axially  to 
directly give a chair conformation. Therefore, the only two paths of attack available to the 
hydride are those shown. Hydride attack from the Si face of conformation 223 is blocked by 
the bulky phenyl  group, so, formation of piperidine 225 is unlikely. On the other  hand, 
hydride  attack  from  the  Re  face  of  conformation  224  is  relatively  uninhibited.  Thus, 
preferential formation of piperidine (2S, 1’S)-206a is ensured. A bulky reducing agent is 
essential due to the reliance on steric interaction with the phenethyl group. When Shipman 
and co-workers used NaBH4 in place of NaBH(OAc)3 the diastereomeric ratio in the crude 
mixture dropped from 95:5 to 88:12. 
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Scheme 4.7 
   
  Cyclization of the amino ketones 204 proved to be difficult. By using a large excess 
of desiccant in the presence of NaBH(OAc)3 the amino-ketones 204 could be cyclized to 
give piperidines 206, Scheme 4.8, Figure 4.3. Amino ketones (R)-204a, (R)-204b, and (R)-
204i  cyclized  well.  Electron-rich  amino  ketones  (R)-204f  and  (R)-204g  cyclized  poorly. 
Amino ketone (R)-204f proved to be impossible to cyclize effectively, while the only way to 
produce piperidine (2S, 1’R)-206g in reasonable yield was by repeated treatment of amino 
ketone (R)-204g  with the cyclization  and  reduction conditions.  The  (S)  series  of  amino-
ketones  cyclized  poorly,  and  column  chromatography  was  necessary  to  purify  desired 
piperidine 206 from uncyclized material. Clearly, the cyclization procedure was not reliable. 
Unfortunately, due to time constraints, the diastereomeric purity of the piperidines formed 
was not investigated. 
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Figure 4.3 Yields of disubstituted piperidines 206 
 
4.5 Removal of the Chiral Protecting Group 
 
   The  chiral  protecting  group  could  be  removed  via  high  pressure  hydrogenation. 
Using Pd(OH)2, the 2-substituted piperidines (R)-207a, and (S)-207b were produced from 
the N-protected piperidines 206, Scheme 4.9. Unfortunately the removal of the phenethyl 
group was not generally applicable. In the case of (2S, 1’R)-206g the harsh conditions caused 
the exocyclic and endocyclic N-benzylic group to be cleaved giving a mixture of products. 
Hydrogenation  of  the  piperidine  (2S,  1’R)-206i  removed  the  phenethyl  group  but  also  
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reduced the alkene moiety. The deprotection of piperidines 206 derived from (S)-201 was not 
attempted. Enantiomeric purity was not determined due to time constraints. 
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4.6 conclusions 
 
  The work by Dr. Gibson had shown great potential and demonstrated the viability of 
the  method.  However,  even  though  the  method  was  promising,  there  were  still  major 
concerns that needed to be addressed. Namely, the cyclization had to be less capricious, the 
hydrogenation had to be more general, and the enantiomeric purity of the piperidines 207 
formed had to be determined. Furthermore, yields of amino ketones 204 were not always 
reproducible, and therefore, the alkylidenation step needed to be optimised.  
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Chapter 5 
Synthesis of 2-Substituted Piperidines 
 
5.1 Improving the Solid-Phase Alkylidenation 
 
At the start of my work, SPS of amino ketones 204 had been demonstrated by Dr. 
Gibson, but the sequence was not yet consistently reproducible. Often, amino ketones were 
produced  in  poor  yields  and  insufficient  purity  for  high  throughput  synthesis.  This 
necessitated optimization of the alkylidenation reaction. 
  The reactive organotitanium species 155 has a free coordination site, which we wish 
to  be  occupied  by  the  carbonyl  group  of  154,  but  could  also  be  occupied  by  the 
triethylphosphite used in generating organotitanium reagent 155, Scheme 5.1. We believed 
that by using the more bulky triisopropylphosphite in place of triethylphosphite, 18 electron 
complex 226 would be more likely to dissociate due to the increased sterics, and therefore 
aid in the formation of oxatitanacyclobutane 156, eventually leading to the desired alkene. 
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Scheme 5.1 
  
Unfortunately, the switch to triisopropylphosphite did not have an appreciable affect 
on the alkylidenation reaction, Scheme 5.2. When titanocene dichloride was reduced in the 
presence  of  triisopropylphosphite,  a  colour  change  from  red  to  black  was  observed 
suggesting that the low-valent complex 227 was formed. Alkylidenation was also successful, 
but while the amino ketone  (R)-204b  was produced,  the  yield was poor and purity  was 
mediocre. 
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Scheme 5.2 
   
We  tried  several  more  modifications  of  the  procedure,  including:  microwave 
irradiation  of  the  solid  phase  step,  different  methods  of  reactant  addition,  and  different 
reaction times for different steps of the sequence, but the results remained unsatisfactory. 
Finally, suspecting that trace moisture in the argon source was poisoning the reaction, we 
inserted a column of desiccant (CaH2, or CaO) between the argon source and the reaction 
vessel, Figure 5.1.  
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Figure 5.1 
 
By ensuring that the all argon used in the reaction and preparation of reagents was 
treated in this way, the yields improved and purity was ensured, Scheme 5.3. The purity of 
the products could be further improved by dissolving the trifluoroacetate salt of the amino 
ketone (R)-204b  in 1M  HCl(aq), and extracting the product from the aqueous  layer  with 
DCM. 
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5.2 A More Elegant Cyclization 
 
  While the use of 25 equivalents of desiccant followed by  NaBH(OAc)3  gave the 
desired N-protected piperidines 206, we were not satisfied with the conditions. Despite the 
logistics of using 25 equivalents of Na2SO4, the yields of N-protected piperidines 206 were 
not reliable. We envisaged that a Lewis acid could coordinate to, and thus activate, the 
carbonyl of amino ketone 204, Scheme 5.4. Cyclization would then give the iminium salt 
205, which, as shown by Shipman and co-workers,
95 could be reduced by NaBH(OAc)3 to 
give piperidines 206 in good yield and high diastereoselectivity.  
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  We imagined that the oxophilic Lewis acid chlorotrimethylsilane (TMSCl) should 
limit the coordination of the Lewis acid to the more Lewis basic nitrogen atom, encouraging 
oxonium ion formation and cyclization. Furthermore, the reagent would provide a chloride 
counterion, is volatile, and would yield only volatile side products. This would mean that 
before the reduction stage, any side product and any excess TMSCl could be removed in 
vacuo leaving only the pure, non-volatile piperidinium salt. The reaction was performed in a 
Schlenk tube to facilitate controlled evaporation. The amino ketone (S)-204a was treated 
with with TMSCl in DCM and then all volatile components of the reaction mixture were 
removed in vacuo, Scheme 5.5. Reduction with NaBH(OAc)3 gave the desired piperidine 
(2S, 1’S)-206a in good yield and purity. Diastereomeric purity was not determined at this 
stage as we were unable to obtain a sample of the minor diastereomer to positively identify it 
in the 
1H NMR spectrum of the crude mixture.   
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Scheme 5.5 
 
 
  A range of different conditions and bulky reducing agents were screened to optimize 
the  reaction,  Table  5.1.  The  use  of  5  equivalents  of  TMSCl  was  essential  to  drive  the 
cyclization  to  completion.  NaBH(OAc)3  effected  reduction  of  the  iminium  ion  without 
problem above –10 
oC, however, lower temperatures gave no product. Diisobutylaluminium 
hydride  (DIBAL),  sodium  cyanoborohydride  (NaCNBH3),  and  L-Selectride  all  gave 
incomplete reaction. The best conditions used 5 equivalents of TMSCl, and 2 equivalents of 
NaBH(OAc)3 at RT, or –10 
oC. Following removal of the chiral phenethyl group, there was 
no difference in the enantiopurity of the piperidines produced from reduction at RT or at –10 
oC, and RT was deemed more convenient. 
 
Table 5.1 Cyclization and reduction of amino ketone (S)-204a 
 to give piperidine (2S, 1’S)-206a  
equiv. 
TMSCl 
reducing agent 
 (2 equiv.) 
temperature of 
reduction 
yield of piperidine 
(2S, 1’S)-206a 
2 equiv.  NaBH(OAc)3  RT  66% 
5 equiv.  NaBH(OAc)3  RT  90% 
5 equiv.  NaBH(OAc)3  –78 
oC  no product 
5 equiv.  NaBH(OAc)3  –40 
oC  no product 
5 equiv.  NaBH(OAc)3  –10 
oC  90% 
5 equiv.  DIBAL  RT  reaction incomplete 
5 equiv.  NaCNBH3  RT  reaction incomplete 
5 equiv.  L-Selectride  RT  reaction incomplete 
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5.3 Removal of the Chiral Protecting Group 
 
  The chiral protecting group can be removed via high pressure hydrogenation. When 
the substituent at the 2-position is a simple alkyl group, the high pressure procedure gives 
unprotected piperidines in good yield, Scheme 5.6. However, the harsh procedure caused 
problems when the 2-position of the piperidine 206 was aromatic, Section 4.5. 
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Scheme 5.6 
 
We  investigated  atmospheric  pressure  hydrogenolysis  of  the  phenethyl  protecting 
group using Pd/C. The deprotection proceeded to give the 2-substituted piperidine (S)-207a 
as the hydrochloride salt in excellent yield, Scheme 5.7. The addition of HCl was essential to 
form the hydrochloride salt and ensure that the small, potentially-volatile compound did not 
evaporate  during  workup.  Most  importantly,  the  reaction  proceeded  cleanly.  After 
deprotection, pure material could be obtained by simply washing the piperidine salt 207 with 
EtOAc, and separating the wash from the solid product. From the solid-phase alkenation 
through  cyclization,  reduction,  and  deprotection,  no  time-intensive  purification  was 
necessary.  Furthermore,  the  model  for  induction  of  stereochemistry,  Scheme  4.7,  was 
consistent with the absolute stereochemistry assigned by optical rotation. The piperidine (S)-
207a is a natural product isolated from the hemlock plant, called (S)-coniine. The optical 
rotation  (S)-207a  matched that  of  (S)-coniine
96  signifying  that  we  had  produced  the  (S) 
enantiomer in excess. 
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5.4 Stereoisomeric Purity 
 
  Confident in the yield and chemical purity of our synthetic route, we investigated the 
sterechemical purity of the final piperidines 207. In Shipman’s synthesis of (S)-coniine,
95 
Mosher’s method was used to determine enantiomeric excess.
97 Chiral derivitizing agents 
(CDA) are commonly used to determine enantiomeric purity, and can even be applied in the 
assignment of absolute configuration.
98 (R)-Mosher’s acid (R)-229 is a particularly popular 
CDA and, after conversion to its corresponding acid chloride (S)-230, Scheme 5.8, it can be 
used to make the Mosher’s amide of secondary amines.  
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Scheme 5.8 
 
Shipman and co-workers started with an uneven mixture of enantiomers (R)- and (S)-
coniine, (R)-207a and (S)-207a, respectively. From the optical rotation they knew that the (S) 
enantiomer was in excess, but they did not know by how much. Reaction of the mixture with 
Mosher’s acid chloride (S)-230 gave a diastereomeric mixture of the Mosher’s amides 231 
and 232, Scheme 5.9. The enantiomeric mixture had been converted to a diastereomeric 
mixture  and  so  the  two  compounds  231  and  232  could  be  differentiated  by  NMR 
spectroscopy. The fluorine atoms in the CF3 group are shielded to different degrees in the 
diastereomers 231 and 232, and appear at different shifts  in the 
19F NMR spectrum. By 
integrating the peaks corresponding to the two CF3 groups, the relative amounts of 231 and 
232 in the sample were determined. Hence, the relative amounts of (R)-207a and (S)-207a in 
the original sample were known.  
  
70
N
H
(S)-207a
(S)-230, NEt3, DMAP
N
O
CF3
MeO
231
N
H
(R)-207a
N
O
CF3
MeO
232  
Scheme 5.9 
 
Unfortunately in our hands the method failed. Despite separate reaction of (S)-207a 
with both enantiomers of Mosher’s acid chloride only one identical peak was ever visible in 
the 
19F  NMR  spectrum.  This  is  perhaps  because  the  relative  amount  of  the  minor 
diastereomer was too small to be detected by the NMR machine, which for all its advantages 
is only moderately sensitive. 
We turned our attention to chromatographic methods. Chiral gas chromatography is a 
very  sensitive  method  for determination  of  enantiomeric  purity.  Low  boiling  points  are 
essential when using gas chromatography (GC), so to prepare the piperidines for analytical 
gas chromatography, the amine group was converted into a trifluoroacetamide. Secondary 
amines have strong intermolecular hydrogen bonds, while tertiary amides do not have a good 
hydrogen  bond  donor.  Furthermore,  fluoroalkanes  have  only  weak  intermolecular 
interactions. This is perhaps best demonstrated by considering the boiling points of n-hexane 
and  perfluoro-n-hexane.  While  perfluoro-n-hexane  is  much  heavier  than  its  hydrogen 
analogue, perfluoro-n-hexane boils at a significantly lower temperature than n-hexane. 
Reaction of piperidine (S)-207a with triethylamine and trifluoroacetic anhydride gave 
the corresponding trifluoroacetamide (S)-233a in good yield, Scheme 5.10.  
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Amide (S)-233a existed as a 2:1 mixture of geometric isomers, Scheme 5.11. As 
would be expected, the amide bond can rotate around its axis, but this rotation is slowed by 
conjugation between the nitrogen lone pair and the carbonyl group. Although this rotation 
allows  rapid  E-Z  interconversion  at  room  temperature,  it  is  slow  relative  to  the  NMR 
timescale, and the two geometric isomers were well resolved in the 
1H NMR spectrum. 
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  The  trifluoroacetamide  (S)-233a  proved  to  be  a  good  candidate  for  chiral  GC 
analysis. Conditions that separated the two enantiomers on a Supelco -DEX 120 column 
were easily found. The analysis showed that our route had produced the piperidine (S)-207a 
in a very respectable 90 % ee. It is clear that with an er of 95:5, 
19F NMR spectroscopy did 
not detect the minor diastereomer in a 95:5 mixture of the Mosher’s amides 231, and 232. As 
mentioned  above,  the  enantiomeric  excess  of  (S)-233a  was  identical  regardless  of  the 
temperature used in the reduction of the iminium salt (S)-205a. Reduction with NaBH(OAc)3 
at RT and at –10 
oC gave identical results. 
  While conversion to the trifluoroacetamide helps to make amines more suitable for 
analysis with GC, some compounds are just too heavy. For this reason, an alternate method 
was  employed  for  the  heavier  piperidines,  using  chiral  high  performance  liquid 
chromatography  (HPLC),  a  method  that  can  analyze  large,  non-volatile  compounds. 
Reaction  of  the  piperidine  (R)-207b  with  benzoyl  chloride  and  triethylamine  gave  the 
benzamide (R)-234b Scheme 5.12. Like the trifluoroacetamide (S)-233a, the benzamide (R)-
234b  existed as two geometrical  isomers. Unfortunately,  the  two  isomers  were  not  well 
resolved  by 
1H  NMR  spectroscopy  at  RT.  To  analyze  the  complicated  spectrum,  and 
characterize the benzamide properly, the temperature of the probe had to be changed. The 
probe could either  be  cooled to  slow  the  rotation  and  thus  resolve  the  two  geometrical  
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isomers, or heated so that interconversion was fast on the NMR timescale. As we did not 
have  access to  a  cryoprobe,  heating was the only  option available. When  the 
1H NMR 
spectrum was obtained at 50 
oC, the results were easily interpretable, and the benzamide (R)-
234b could be characterized with confidence.  
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Scheme 5.12 
   
Separation and analysis of the two enantiomers (R)-234b and (S)-234b with chiral 
HPLC proved to be challenging. Using a Chiralcel OD-H column, the (R) enantiomer eluted 
before the (S) enantiomer. A simple, binary hexane-isopropanol solvent system produced 
peaks with large tails. When (R)-234b was in excess over (S)-234b, the peak corresponding 
to the minor (S) enantiomer was obscured by the tail of the peak corresponding to the major 
(R) enantiomer. After much experimentation with different solvent conditions, it was found 
that by using  a more complex  solvent  system (hexane-isopropanol-methanol 98:1:1), the 
peak shape could be changed so that the peaks were well separated. This system was used 
when (R)-234b was in excess over the later eluting component (S)-234b. In the opposite 
case, when the  second  component  (S)-234b  was  in  excess,  a binary  hexane-isopropanol 
solvent system could be used.  
  Confident that we had developed conditions to analyze enantiomeric purity of the 
piperidines 207 produced by our solid-phase method, we aimed to demonstrate our work by 
developing a small library of compounds in both the (2R) and (2S) stereoisomeric forms.  
 
5.5 Library Synthesis 
 
  We aimed to prepare a library that would demonstrate the key aspects of our  
method. The library should demonstrate the ability to produce diverse products by producing 
piperidines with varied groups at the 2-position. Both the (2R) and (2S) stereoisomeric forms 
of  each  piperidine  would  have  to  be  synthesized  to  show  that  our  synthetic  route  is 
stereodiverse.  Both  conventional  and  stereochemical  purity  of  the  final  piperidines  207 
needed to be high to demonstrate the method’s applicability to diversity-orientated synthesis.   
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  Five different resin-bound esters were prepared from Merrifield resin, Scheme 5.13, 
Figure 5.2. Resin 202a was prepared from butyric acid, and allowed access to the small 
natural product coniine. Production of this compound would not only demonstrate the ability 
of the method to control stereochemistry when the group at the 2-position was small, but as 
discussed  in  section  5.3,  also  allowed  us  to  confirm  that  our  model  for  stereochemical 
induction  was  consistent  with  the  absolute  stereochemistry  of  the  piperidines  produced. 
Resin 202b was produced from dihydrocinnamic acid, and investigated the result of steric 
bulk separated from the point of stereochemical induction. Resin 202c was produced from 3-
methoxybenzoic acid, and we hoped would demonstrate that the new atmospheric pressure 
hydrogenolysis of the chiral auxiliary tolerated 2-arylpiperidines. Enantiopure resin 202d 
was  prepared  from (S)-(+)-2-methylbutyric  acid  and would investigate the  ability  of the 
chiral  auxiliary  to  control  diastereomeric  purity  in  cooperation  and  in  competition  with 
directing effects in the substrate. Furthermore, along with resin 202c, resin 202d explored the 
effects  of  steric  bulk  adjacent  to  the  site  of  stereochemical  induction.  Resin  202e  was 
prepared from (R)-(+)-citronellic acid, and as with resin 202d probed the effects of existing 
chirality on the stereochemical outcome of the reduction. We assumed that the alkene would 
be reduced during removal of the auxiliary, but that this would not increase the complexity 
of the products.  
 
RCO2H (15 equiv.), 
CsCO3 (15 equiv.), 
KI (25 equiv.)
DMF, 80 
oC
Cl
O
R O
3  
Scheme 5.13 
 
O
O
O
O
O
O
OMe
O
O
O
O
202a 202b 202c
202d 202e  
Figure 5.2 Resin-bound esters prepared for library synthesis  
 
  As the piperidines 207 were the target compounds, none of the intermediates were 
isolated. The synthetic scheme was followed from resin-bound ester 202 to piperidine 207,  
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Scheme 5.14. The five resin-bound esters were treated with the titanium alkylidene (R)-201, 
generated from (R)-200, to make the amino ketones (R)-204 via the resin-bound enol ethers 
(R)-203.  Cyclization  conditions  gave  the  N-protected  piperidines  206  which  underwent 
hydrogenolysis to give the piperidines 207. The route was repeated with all five resin-bound 
esters, but using the (S) enantiomer of the titanium alkylidene (S)-201. The isomeric purity of 
all  10  piperidines  produced  was  determined  using  the  methods outlined  in  Section  5.5. 
Piperidines 207a, and 207d were small enough to be analyzed by GC. They were converted 
into the corresponding trifluoroacetamides 233a, and 233d and stereoisomeric purity was 
determined  by  chiral  GC.  Piperidines  207b,  207c,  and  207e  were  converted  to  the 
corresponding benzamides 234b, 234c, and 234e, and analyzed with chiral HPLC. Only 
benzamide (R)-234b required a complex eluent mixture. A simple binary hexane-isopropanol 
solvent system provided sufficient separation for all other examples analyzed by HPLC. 
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Scheme 5.14 
 
  All piperidines were produced in excellent chemical purity, and good overall yield 
(based on the original loading of the Merrifield resin) for the 5 steps from the starting resins 
202,  Figure  5.3.  A  general  similarity  in  the  yield  of  the  two  stereoisomeric  piperidines  
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arising from each resin-bound ester 202a-e showed that the synthetic transformations were 
reliable. Efficient production of piperidine 207c proved that aromatic substituents at C-2 of 
the  piperidine  were  tolerated  by  the  hydrogenolysis  under  atmospheric  pressure.  Clean 
reduction of the alkene of 206e demonstrated that while alkenes were not tolerated by the 
method, a single product would likely be obtained.  
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Figure 5.3 Yields of piperidines 207 from resin-bound esters 202 
 
The stereoisomeric purity of the piperidines was good to excellent. The enantiomeric 
purity of piperidines 207a-c produced from titanium reagents (R)-201, and (S)-201 would  
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have been expected to be equal and opposite, and only small differences were observed. 
These could have arisen during reduction of the iminium ion if the conditions were slightly 
different, but washing of the salt of the final piperidine could also account for small changes, 
if homochiral material packs differently from heterochiral material (lattice energy affects 
solubility). Increasing steric bulk of the substituent at the 2-position appears to increase the 
diastereoselectivity  in the reduction of the  iminium ions 205, unless the bulk is directly 
adjacent to the point of induction of stereochemistry. The larger the R group, the more the 
phenethyl group will project the small proton towards the R group to minimize 1,3-allylic 
strain. In doing so, the phenethyl group blocks axial attack on the half-chair conformation 
235 of the ion 205 more consistently, Scheme 5.15. However, if the R group contains a large 
amount of steric bulk at the carbon atom adjacent to C-2 of the iminium ion, then this steric 
bulk  will  also  block  the  reducing  agent.  Therefore,  hindrance  to  attack  is  a  result  of 
hindrance from the phenethyl group and hindrance from the R group. The facial selectivity 
will be proportional to the steric hindrance to attack from one face over steric hindrance to 
attack from the other face. In the case of examples 205a, 205b, and 205c where the R group 
does not contain a stereocenter, the hindrance due to the R group is equivalent on both faces. 
When  hindrance  from  the  R  group  is  significant  compared  to  the  hindrance  from  the 
phenethyl group, the ratio of hindrance on the face blocked by the phenethyl group to the 
hindrance on the other face will be reduced, and facial selectivity will be reduced. An R 
group  with  bulk  adjacent  to  C-2  lessens  the  influence  of  the  phenethyl  group,  and  this 
accounts for the lower enantiomeric purity observed for piperidine 207c. 
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  Diastereomeric piperidines 207d and 207d’ were obtained from chiral resin-bound 
ester 202d, and diastereomeric piperidines 207e and 207e’ were obtained from chiral resin-
bound ester 202e. In all cases the phenethyl  group had controlled the favoured absolute 
configuration at C-2. The discrepancy in the diastereomeric purities in products arising from 
the (R), and (S) phenethyl  groups is a result of matched and mismatched chiral centres, 
Scheme 5.16. Consider reduction of the reacting conformers 238 and 239 of diastereomeric 
iminium ions 205d and 205d’, respectively. In both cases, the R group and the phenethyl 
group project their hydrogen atoms inward towards each other in an effort to minimize 1,3-
allylic strain. In the matched case, iminium ion 238, the ethyl and the phenyl group from the 
R group and the phenethyl group, respectively, both block the upper face. When the opposite 
enantiomer of the phenethyl group is used, the mismatched case arises and the opposite is 
true. In reacting conformer 239, the bulky substituents from the R group and the phenethyl 
group block opposite faces. As is evidenced from the results, the phenethyl group wins out 
and controls the stereochemistry of the 2-position. However, the diastereomeric purity is 
lower than in the matched case. The overall diastereoselectivity in both cases is low due to 
the bulky group adjacent to C-2 that reduces stereodifferentiation between the two faces.  
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Scheme 5.16 
 
  A similar effect operates in the reduction leading ultimately to piperidines 207e and 
207e’. In both cases, the stereoselectivity is high because the R group is bulky, but there is a  
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CH2 group next to C-2 of the iminium ions 205e and 205e’. The effect of the more distant 
chiral centre is weak, and matched and mismatched cases give similar diastereoselectivities. 
Absolute stereochemistry of (S)-207a, and (S)-207b was assigned by comparison of 
their  optical  rotations  with  literature  values.
96  As  described  earlier,  these  literature 
comparisons agreed with the predictions made by the model for stereochemical induction, 
Scheme 4.7. We therefore assigned the absolute stereochemistry of piperidines 207c, 207d, 
and  207e  using  the  model.  Furthermore,  all  piperidines  synthesized  using  the  titanium 
reagent (S)-201 had positive optical rotations and their trifluoroacetamides (S)-233a and (R)-
233d, and benzamides (R)-234b, (R)-234c and (R)-234e eluted first on chiral GC and chiral 
HPLC,  respectively.  These  consistencies  in  optical  rotation  and  chromatography  further 
confirm the assignments of absolute stereochemistry.  
 
5.6 Conclusion 
 
We have developed a stereodiverse route to 2-substituted piperidines. Overall yields 
are  good  (26-60%)  and  the  stereochemistry  at  the  2-position  can  be  controlled  to  give 
piperidines with high levels of isomeric purity (76-96% ee). A range of substituents can be 
introduced  at  the  2-position,  though  groups  containing  bulk  separated  from  the  site  of 
stereochemical induction will give the best results. We imagine that this route would be 
useful in the production of large, diverse libraries in a DOS.  
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Experimental 
 
All reactions under an inert atmosphere were carried out using oven dried or flame dried 
glassware. Solutions were added via syringe. THF was freshly distilled from sodium 
benzophenone. Dichloromethane, and triethyl phosphite were distilled from CaH2 prior to 
use. Petroleum ether refers to the fraction boiling at 40-60 °C. Reagents were obtained 
from commercial suppliers and used without further purification unless otherwise stated. 
The  solid  phase  reactions  were  carried  out  in  normal  glassware,  but  with  the  resin 
(particle size = 150-300 µm diameter) contained within porous polypropylene reactors 
that had an internal volume of 2.4 mL, and a pore size of 74 µm. Purification by column 
chromatography was carried out using silica gel, mesh size 35-70 µm as the stationary 
phase. 
1H  and 
13C  NMR  spectra  were  obtained  on  a  Bruker  DPX/400  spectrometer 
operating at 400 and 100 MHz respectively. All coupling constants are measured in Hz. 
DEPT was used to assign the signals in the 
13C NMR spectra as C, CH, CH2 or CH3. 
Mass spectra (MS) were recorded on a Jeol JMS700 (MStation) spectrometer. Infra-red 
(IR) spectra were obtained on a Perkin-Elmer 983 spectrophotometer. A Golden Gate
TM 
attachment that uses a type IIa diamond as a single reflection element was used in some 
cases so that the IR spectrum of the compound (solid or liquid) could be directly detected 
(thin  layer)  without  any  sample  preparation.  Optical  rotations  were  determined  as 
solutions irradiating with the sodium D line (λ = 589 nm) using a AA series Automatic 
polarimeter. [α]D values are given in units 10
-1degcm
2g
-1.  
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 Merrifield resin bound esters  202 
 
Merrifield  resin-bound  esters  were  prepared  following  the  published  procedure  for 
loading  Merrifield  resin.
93  Five  polypropylene  reactors  charged  with  Merrifield  resin 
[0.311 milliequiv. reactor
-1, 163 mg of Merrifield resin with a loading of 1.91 milliequiv. 
(of benzylic chloride) g
-1] were stirred in DMF (35 mL) straight from the bottle, with 
CsCO3 (1.517 g, 4.66 mmol), KI (0.130 g, 7.83 mmol), and the carboxylic acid (4.65 
mmol) at 80 °C for 20 h. The reactors were washed with DMF:H2O (9:1, 2), THF (2), 
MeOH (2), DCM (1), and MeOH (1) to give the desired resin bound esters contained 
within  porous  polypropylene  reactors,  which  were  dried  under  vacuum.  The  same 
procedure was used to prepare reactors with a loading of 0.325 milliequiv. reactor
–1 [170 
mg Merrifield resin with a loading of 1.91 milliequiv. (of benzylic chloride) g 
-1].  
 
Preparation of resin-bound enol ethers  203 
 
Note: any Ar used during this procedure should be passed through a column of desicant 
(CaH2, or CaO) placed between the argon source and the reaction vessel. 
 
Cp2TiCl2 (0.93 g, 12 equiv.), Mg (100 mg, 13.2 equiv., predried at 250 °C overnight) and 
freshly activated 4-Å molecular sieves (0.25 g) were twice heated, gently, by heat-gun 
under reduced pressure (0.3 Torr) for about 1 min, shaking the flask between heatings, 
and then placed under argon. Dry THF (5 mL) was added followed by dry P(OEt)3 (1.3 
mL, 24 equiv.). After stirring for 3 h, the thioacetal (R)-200 or (S)-200 (3 equiv.) in dry 
THF (5 mL) was added to the mixture and stirring continued for 15 min. Resin-bound 
ester  202  [0.311  milliequiv./reactor  from  Merrifield  resin  with  a  loading  of  1.83 
milliequiv.  (chloride)  g
–1,  or  0.325  milliequiv./reactor  from  Merrifield  resin  with  a 
loading of 1.91 milliequiv. (chloride) g
–1] contained in a porous polypropylene reactor 
and prepurged with argon was added. After 17 h the reactor was removed from the flask 
and washed with THF (5×) then alternately with MeOH and DCM (3×), and finally with 
MeOH then Et2O. The reactor containing the resin-bound enol ether was then dried under 
vacuum. 
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Preparation of chiral piperidines  207 
 
A reactor containing a resin-bound enol ether 203 was shaken with TFA (4%) in DCM (5 
mL) for 1 h. The solution was removed and the reactor was washed with DCM (3×). The 
combined  organics  were  concentrated  under  reduced  pressure  to  give  the  salt  of  the 
intermediate amino ketone 204, which was re-dissolved in DCM and washed (2×) with 1 
M NaOH. The organic layer was dried with MgSO4, filtered and concentrated in vacuo to 
give the free base. TMSCl (5 equiv.) was added to a solution of the resulting amino 
ketone (0.311 mmols, or 0.325 mmols, 1 equiv.) in dry DCM (1.5 mL) under argon 
contained in a Schlenk tube. After stirring at RT for 6 h, solvent was carefully removed 
under vacuum (0.3 Torr). The resulting iminium salt was dissolved in dry DCM (1.5 mL) 
under argon, cooled to 0 °C and NaBH(OAc)3 (2 equiv.) was added. After stirring for 18 
h at RT the solution was treated with 1 M NaOH at 0 °C, washed with 1 M NaOH (3×) 
and then brine, dried with MgSO4, and concentrated in vacuo to give a piperidine 206. 
10% Pd/C (25 mol%) was added to a solution of the disubstitued piperidine (1 equiv.) 
and 6 M HCl (2 equiv.) in ethanol (1.5 mL). The atmosphere was changed to H2, and the 
reaction  was  stirred at 65  °C  for 5 h. The  reaction  mixture  was  centrifuged  and the 
supernatant  liquid  was  decanted  through  a  filter.  Concentration  in  vacuo  gave  the 
piperidine hydrochloride salt 207 as a solid which was then washed with EtOAc. 
 
4,4-Bis-(phenylsulfanyl)-butan-1-ol
86  208
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SPh
 
 
A solution of 2,3-dihydrofuran (3.8 ml, 50 mmols, 1 equiv.) in 50 mL of DCM is cooled 
to  0 
oC.  Thiophenol  (10.3  mL,  100  mmols,  2  equiv.),  followed  by  borontrifluoride 
diethyletherate  (6.35  mL,  55  mmols,  1.1  equiv.),  were  added  to  a  solution  of  2,3-
dihydrofuran (3.8 mL, 50 mmols, 1 equiv.) in DCM (50 mL) under Ar at 0 
oC. The 
reaction stirred 3.5 h at RT and was quenched with 32 mL of water. The reaction mixture 
was washed with 1M NaOH (4), and satd. NaCl (1). The organic layer was dried over 
MgSO4 and solvent removed in vacuo to give the desired alcohol 208 as an oil (11.89 g, 
82%). IR (thin film): 1024, 1064, 1438, 1581, 2873, 3058 cm
-1. H (CDCl3, 400 MHz) 
1.47 (1H, broad s, OH), 1.81-1.92 (4H, m, CH2), 3.65 (2H, t, J= 6.0, CH2OH), 4.47 (1H, 
t, J= 6.4, CHS2), 7.25-7.37 (6H, m, H arom.), 7.47-7.51 (4H, m, H arom.). C (CDCl3, 
100 MHz): 30.10 (CH2), 32.30 (CH2), 58.21 (CH), 62.29 (CH2), 127.73 (CH), 128.91  
82
(CH), 132.72 (CH), 134.13 (C). m/z (EI): 290 (M
+, 5%), 250 (10), 180 (49), 141 (80), 82 
(100), 71 (100). HRMS: 290.0799. C16H18OS2 requires (M
+) 290.0799. Data agrees with 
literature.
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(1’R) N-[4,4-Bis(phenylsulfanyl)butyl]-N-[1’-phenylethyl]amine  (R)-200 
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4,4-Bis(phenylsulfanyl)butan-1-ol 208 (11.92 g, 41 mmol) was dissolved in DCM (315 
mL). DMSO (29 mL, 41 mmol) and triethylamine (40 mL, 28 mmol) were added. The 
reaction mixture was cooled to 0 °C. Sulfur trioxide pyridine complex (25.57 g, 160 
mmol) was added in 3 g batches. The ice bath was removed and the mixture was stirred 
under Ar at RT for 20 h.  The reaction was quenched with aqueous saturated NaHCO3 
(120 mL). The mixture was extracted with DCM (3) and the organic  extracts were 
combined, washed with water (3) then satd. NaCl (1). The organic layer was dried 
over  MgSO4  and  concentrated  in  vacuo  to  yield  crude  4,4-
bis(phenylsulfanyl)butyraldehyde 209 as a cloudy  yellow oil (11.88 g). 4Å molecular 
sieves (4.8 g) and half of the crude aldehyde (5.94 g, 21 mmol) were dissolved in DCM 
(215 mL). Enantiomerically pure (R)-phenylethylamine (5.7 mL, 41 mmol) was added, 
and the reaction mixture became cloudy. After 3 h of stirring under Ar at RT NaBH4 
(0.87  g,  23  mmol)  was  added.  The  mixture  was  stired  overnight.  The  reaction  was 
quenched with water (6mL), and then washed with water (3), and satd. NaCl (1). The 
organic  layer  was  dried  over  MgSO4,  and  concentrated  in  vacuo.  Column 
chromotography  (SiO2),  [petroleum  ether-ethyl  acetate  (1:1)]  followed  by  column 
chromatography  (SiO2),  [eluting  first  with  DCM-petroleum  ether  (4:1)  to  remove 
impurities, and then petroleum ether-ethyl acetate (1:1)] gave the desired amine (R)-200 
as a pale yellow oil (4.067 g, 49%). Rf [petroleum ether-ethylacetate (1:1)] 0.18. []D 
+24.6 (c 1.21, DCM) IR (thin film): 3313 (N-H), 3058, 2958, 2925, 1581, 1479, 1450 
cm
-1. H (CDCl3, 400 MHz) 1.33 (3H, d, J= 6.6, CH3), 1.73-1.81 (2H, m, CH2), 1.82-1.89 
(2H, m, CH2), 2.40 (1H, dt,  J= 11.6, 6.8, CH
AH
BN), 2.47 (1H, ddd, J= 11.6, 7.5, 6.2, 
CH
AH
BN), 3.73  (1H, q, J= 6.6, CHCH3), 4.40 (1H, t, J= 6.8, CHS2), 7.28 (11H, m, H 
arom.), 7.43 (4H, m, H arom.). C (CDCl3, 100 MHz): 24.39 (CH3), 27.55 (CH2), 33.58 
(CH2), 46.93 (CH2), 58.17 (CH), 58.19 (CH), 126.51 (CH), 126.60 (CH), 126.82 (CH),  
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127.60  (CH),  127.63  (CH),  128.39  (CH),  128.85  (CH),  132.65  (CH),  132.70  (CH), 
134.24 (C), 134.26 (C), 145.76 (C). m/z (EI): 393 (M
+, 58%), 284 (M
+-SPh, 100%). 
HRMS: 393.1586. C24H27NS2 requires (M
+) 393.1585. Microanalysis C, 73.25; H, 6.99; 
N, 3.66; S, 16.09. C24H27NS2 requires C, 73.28; H, 6.87; N, 3.56; S, 16.28 
 
(1’S) N-(4,4-Bis-phenylsulfanylbutyl)-N-[1’-phenylethyl]amine  (S)-200 
 
PhS
H
N
SPh
H  
 
In the same way, the other half of the 4,4-bis-(phenylsulfanyl)butyraldehyde 209 (5.94 g, 
21 mmol) was dissolved in DCM (215 mL) and treated with enantiomerically pure (S)-
phenylethylamine (5.7 mL, 41 mmol) to give the desired amine (S)-200 as a pale yellow 
oil (3.8 g 46% yield). []D –24.3 (c 1.08, DCM).  All other data in agreement with that 
for (R)-200. 
 
 
(1’R) 1-(1’-Phenylethylamino)-7-phenylheptan-3-one hydrochloride salt (R)-204b 
 
H2
N
O Me H
Cl  
 
 
Starting with resin-bound ester 202b (0.311 milliequiv.), following enol ether preparation 
using (R)-200 gave the resin bound enol ether (R)-203b. The reactor containing the resin-
bound enol ether (R)-203b was shaken with TFA (4%) in DCM (5 mL) for 1 h. The 
solution  was  removed  and  the  reactor  was  washed  with  DCM  (3×).  The  combined 
organics were concentrated under reduced pressure to give the amino ketone (R)-204b. 
The crude product was dissolved in hot 1M HCl and extracted with DCM to give the HCl 
salt in 57% yield.  
 
1H NMR (CDCl3, 400 MHz) δ: 1.51 (2H, m, CH2), 1.81-1.90 (2H, m, CH2), 1.88 (3H, d, 
J= 6.8, CH3), 2.34 (2H, t,  J= 7.2, CH2), 2.48-2.59 (1H, m, CH
AH
BN), 2.58-2.68 (1H, m,  
84
CH
AH
BN),  2.66  (2H,  t,  J= 7.2,  CH2),  2.83  (2H,  t,  J=  8.0,  CH2), 4.20-4.24 (1H,  m, 
CHCH3), 7.08-7.18 (3H, m, arom.), 7.23-7.28 (2H, m, arom.), 7.37-7.40 (1H, m, arom.), 
7.42-7.46 (2H, m, arom.), 7.54 (2H, d J 7.2, arom.), 9.77 (1H, broad s, NH
AH
B), 10.06 
(1H, broad S, NH
AH
B). 
1H NMR Consistent with, but different from data for the TFA 
salt.
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(2S, 1’S) 2-Propyl-1-(1’-phenylethyl)piperidine  (2S, 1’S)-206a 
 
N
H
 
 
(1’S) 8-(1’-phenylethylamino)octan-4-one trifluoroacetic acid salt (S)-204a in DCM was 
washed (2×) with 1 M NaOH, dried with MgSO4, filtered and concentrated in vacuo to 
give (1’S) 8-(1’-phenylethylamino)octan-4-one as the free base. TMSCl (1.13 mL, 8.90 
mmol, 4.4 equiv.) was added to a solution of (1’S) 8-(1’-phenylethylamino)octan-4-one 
(0.499 g, 2.02 mmol, 1 equiv.) in dry DCM (10 mL) under argon contained in a Schlenk 
tube. After stirring at RT for 5 h, solvent was  carefully removed under vacuum (0.3 
Torr). The system was purged with Ar. The iminium salt was dissolved in dry DCM (10 
mL), cooled to 0 °C and NaBH(OAc)3 (0.856 g, 4.04 mmol, 2 equiv.) was added. After 
stirring under Ar for 18 h at RT the solution was treated with 1 M NaOH at 0 °C, washed 
with 1 M NaOH (3×), brine (1×), dried with MgSO4, and concentrated in vacuo to give 
(2S, 1’S) 2-propyl-1-(1’-phenylethyl)piperidine (2S, 1’S)-206a as a deep red oil (0.423 g, 
90% yield). H (CDCl3, 400 MHz) 0.84 (3H, t, J= 7.2, CH3CH2), 1.17 (3H, d, J= 6.4, 
CH3CH), 1.18-1.65 (10H, m, CH2), 2.13 (1H, m, CH
AH
BN), 2.28 (1H, m, CH
AH
BN), 2.65 
(1H, m, H2), 3.92 (1H, q, J= 7.2, CHCH3), 7.12 (1H, t, J= 7.2, H arom.), 7.21 (2H, m, H 
arom.), 7.34 (2H, d, J = 7.6, H arom.). 
1H NMR Consistent with literature data.
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(2S) 2-Propylpiperidine hydrochloride salt  (S)-207a (prepared via high pressure 
hydrogenation) 
 
N
H2 Cl
 
 
A mixture of (2S, 1’S) 2-propyl-1-(1’-phenylethyl)piperidine (2S, 1’S)-206a (0.189 g, 
0.82 mmol, 1 equiv.), and 20% Pd(OH)2/C (0.053 g, 10 mol%) in EtOH (6 mL) was 
hydrogenated at 40 
oC, and 40 PSI, for 24 h. The reaction mixture was passed through a 
cotton wool plug directly into saturated ethereal HCl. The solution was concentrated to 
yield a light brown solid. The solid was washed with hot ether to give (S)-207a as a  light 
beige solid. (0.1295 g, 97% yield). For characterization data see (2S) 2-propylpiperidine 
hydrochloride salt (S)-207a (library synthesis)  
 
(2S) 2-Propylpiperidine hydrochloride salt   (S)-207a (prepared via atmospheric 
pressure hydrogenation) 
 
N
H2 Cl
 
 
10%  Pd/C (102 mg, 25  mol%) was added  to  a solution of (2S, 1’S) 2-propyl-1-(1’-
phenylethyl)piperidine (2S, 1’S)-206a (92.9 mg, 0.40 mmol, 1 equiv.) and 6 M HCl (0.14 
mL, 0.84 mmol, 2 equiv.) in ethanol (2 mL). The atmosphere was changed to H2, and the 
reaction  was  stirred at 65  °C  for 5 h. The  reaction  mixture  was  centrifuged  and the 
supernatant  liquid  was  decanted  through  a  filter.  Concentration  in  vacuo  gave  the 
piperidine  as  a  solid  which  was  then  washed  with  EtOAc  to  give  pure  (2S)  2-
propylpiperidine  hydrochloride  salt  (S)-207a  as  a  solid  (64.5  mg,  98%).  For 
characterization data see (2S) 2-propylpiperidine hydrochloride salt (S)-207a (library 
synthesis) 
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(2S) 2-Propylpiperidine hydrochloride salt   (S)-207a (library synthesis)  
 
N
H2 Cl
 
 
Starting  with  resin-bound  ester  202a  (0.325  milliequiv.),  following  enol  ether 
preparation, the chiral piperidine preparation, and using thioacetal (S)-200 gave (2S) 2-
propylpiperidine hydrochloride salt (S)-207a as a solid (31.4 mg, 60% based on loading 
of Merrifield resin). []D
18 +8.1 (c=0.52, EtOH), []D +19.8 (c 0.50, DCM).  Lit:
96 []D 
+6.5 (c=1.2, EtOH). IR (thin film): 2935, 2725, 1590, 1455 cm
-1. H (CDCl3, 400 MHz) 
0.94 (3H, t, J= 7.6, CH3), 1.36-1.53 (3H, m), 1.57-2.10 (7H, m), 2.73-2.85 (1H, m, H6
ax), 
2.87-2.98 (1H, m, H6
eq), 3.44 (1H, broad d, J=11.1, H2), 9.17 (1H, s, NH
AH
B), 9.47 (1H, 
s, NH
AH
B). C (CDCl3, 100 MHz) 13.69 (CH3), 18.53 (CH2), 22.14 (CH2), 22.57 (CH2), 
28.08 (CH2), 35.30 (CH2), 44.71 (CH2), 57.11 (CH). m/z (CI): 128 (M
+, 100%), 84 (25). 
HRMS: 128.1438 C8H16N requires (M
+), 128.1439.  
1H NMR and 
13C NMR data agree 
with literature.
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(2S) N-trifluoroacetyl-2-propylpiperidine  (S)-233a (Determination of enantiopurity of  
(S)-207a) 
 
N
F3C O 
 
Triethylamine in DCM (0.14 mL of a 0.37 M solution, 1.5 equiv.) was added to (2S) 2-
propylpiperidine hydrochloride (S)-207a (5.3 mg, 32 mol, 1 equiv.). The solution was 
cooled to 0 °C and trifluoroacetic anhydride in DCM (0.14 mL of a 0.30 M solution, 40 
mol, 1.2 equiv.) was added. The solution was stirred for 18 h under Ar at RT, and was 
washed with satd. NaHCO3 (2), 1M HCl (2), and satd. NaCl (1). The organic layer 
was dried over MgSO4, and solvent removed in vacuo to give (2S) N-trifluoroacetyl-2-
propylpiperidine  (S)-233a  as  an  oil  (7.0  mg,  97%),  existing  as  a  2:1  mixture  of 
geometrical isomers a, and b. IR (thin film): 2954, 2876, 1686 (C=O), 1457 cm
-1. H 
(CDCl3, 400 MHz): 0.93 (3H
a, t J= 7.3, CH3), 0.94 (3H
b, t J= 7.3, CH3), 1.17-1.79 (10H
a 
& b, m), 2.84 (1H
b, td J=13.7, 1.6, CH
AH
BN), 3.16 (1H
a, td J =13.1, 2.8, CH
AH
BN), 3.78  
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(1H
a, broad d J =13.6, CH
AH
BN), 3.97-4.06 (1H
b, m, H2), 4.36-4.43 (1H
b, m, CH
AH
BN), 
4.66-4.73 (1H
a, m, H2). C (CDCl3, 100 MHz) 12.92 (CH3)
a  &  b, 17.61 (CH2)
b, 17.77 
(CH2)
a, 18.11 (CH2)
a, 18.26 (CH2)
b, 24.31 (CH2)
b, 25.12 (CH2)
a, 27.10 (CH2)
a, 27.52 
(CH2)
b, 30.41  (CH2)
a, 31.14  (CH2)
b, 37.39 (CH2)
a, 40.02  (CH2)
b,  49.14 (CH)
a, 52.52 
(CH)
b. m/z (CI): 224 [(M+H)
+, 100%]. HRMS: 224.1264 C10H17ONF3 requires (M+H
+), 
224.1262.  This was then used on a chiral GC (Supelco -DEX 120 column, 70 °C for 2 
min, then the temperature was increased at a rate of 1 °C min
–1 to 150 °C) to show a 90 
%ee (tS=32.98 min, tR=33.57 min). 
 
(2R) 2-Propylpiperidine hydrochloride salt (R)-207a 
 
N
H2 Cl
 
 
Starting  with  resin-bound  ester  202a  (0.311  milliequiv.),  following  the  enol  ether 
preparation, the chiral piperidine preparation, and using thioacetal (R)-200 gave (2R) 2-
propylpiperidine hydrochloride salt (R)-207a as a solid (38.6 mg, 75% based on loading 
of Merrifield resin). []D
18 –7.3 (c=0.06, EtOH), []D –20.0 (c 0.20, DCM). Lit:
96 []D –
7.3 (c=1.0, EtOH). Other data in agreement with (S)-207a and literature.
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(2R) N-trifluoroacetyl-2-propylpiperidine  (R)-207a (Determination of enantiopurity 
of  (R)-207a)  
 
N
F3C O 
 
Following  the  same  procedure  as  for  (S)-207a  above,  (2R)  2-propylpiperidine 
hydrochloride  (R)-207a  (10.5  mg)  was  converted  into  (2R)  N-trifluoroacetyl-2-
propylpiperidine (R)-233a (12.1 mg, 84% - data agrees with that of other enantiomer). 
This was then used on a chiral GC (Supelco -DEX 120 column, 70 °C for 2 min, then 
the temperature was increased at a rate of 1 °C min
–1 to 150 °C) to show an 89 %ee 
(tS=32.97 min, tR=33.55 min). 
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(2R) 2-Phenylethylpiperidine hydrochloride salt  (R)-207b 
 
N
H2 Cl
 
 
Starting  with  resin-bound  ester  202b  (0.311  milliequiv.),  following  the  enol  ether 
preparation, the chiral piperidine preparation, and using thioacetal (S)-200 gave (2R) 2-
phenylethylpiperidine hydrochloride salt (R)-207b as a solid (30.1 mg, 43% based on 
loading of Merrifield resin). []D +13.5 (c 0.38, DCM), +10.1 (c 0.139, MeOH) Lit:
96 
[]D  +11.1 (c  0.65, MeOH).  IR  (thin  film):  2944,  2719,  1587,  1493, 1455  cm
-1.  H 
(CDCl3, 400 MHz): 1.29-1.45 (1H, m), 1.63-1.78 (2H, m), 1.79-2.13 (4H, m), 2.27-2.45 
(1H, m), 2.61-2.78 (3H, m), 2.80-2.95 (1H, m, CH
AH
BN), 3.31-3.45 (1H, m, H2), 7.13-
7.37 (5H, m, H arom.), 9.30 (1H, s, NH
AH
B), 9.53 (1H, s, NH
AH
B). C (CDCl3, 100 
MHz): 22.05 (CH2), 22.25 (CH2), 28.12 (CH2), 31.09 (CH2), 34.58 (CH2), 44.68 (CH2), 
56.56 (CH), 126.11(CH), 128.32 (CH), 128.44 (CH), 140.04 (C). m/z (CI): 190 (M
+, 
100%), 84 (25). HRMS: 190.1597 C13H20N requires (M
+), 190.1596. 
1H NMR and 
13C 
NMR data correspond with the literature.
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(2R) N-Benzoyl-2-phenylethylpiperidine  (R)-234b (Determination of enantiopurity of  
(R)-207b) 
 
N
O
 
 
Triethylamine (10.0 L, 0.07 mmol, 3 equiv.) was added to (R)-207b (5.2 mg, 0.023 
mmol, 1 equiv.)  in  DCM  (0.30  mL).  The  solution  was cooled  to 0 °C  and  benzoyl 
chloride (5.0 L, 0.05 mmol, 2 equiv.) was added. The solution stirred under Ar 18 h 
while warming to RT, and was then washed with water (1). The organic layer was dried 
over MgSO4, filtered and concentrated in vacuo to yield the crude benzamide as a yellow 
oil. Column chromatography (SiO2, Petroleum ether-EtOAc 9:1) gave (2R) N-Benzoyl-2-
phenylethylpiperidine (R)-234b as a colorless oil (3.8 mg, 56 %).  Rf (SiO2, Hex-EtOAc 
2:1): 0.51. IR (thin film): 2931, 1621 (C=O), 1495 cm
-1. H (CDCl3, 400 MHz, 50 °C):  
89
1.32-1.69 (6H, m), 1.71-1.83 (1H, m), 1.97-2.08 (1H, m), 2.41-2.61 (2H, m), 2.84-2.98 
(1H, m, CH
AH
BN), 3.75-4.16 (1H, m, CH
AH
BN), 4.28-4.64 (1H, m, H2), 7.05-7.11 (2H, 
m, H arom.), 7.13-7.18 (3H, m, H arom.), 7.21-7.30 (5H, m, H arom.). C (CDCl3, 100 
MHz, 50 
oC): 19.28 (CH2), 26.14 (CH2), 28.67 (CH2), 32.14 (CH2), 32.89 (CH2), 125.95 
(CH), 123.65 (CH), 128.27 (CH), 128.43 (CH), 128.46 (CH), 129.14 (CH), 137.35 (C), 
141.84 (C), 170.89 (C). m/z (EI): 293 (M
+, 20%), 188 (70), 105 (100), 77 (33). HRMS: 
293.1778 C20H23ON requires (M
+), 293.1780. Chiral HPLC (Chiralcel OD-H, hexane-
isopropanol-methanol  98:1:1, 0.5mL  min
–1)  showed 96  %ee (tR=55.45  min,  tS=62.17 
min). 
 
(2S) 2-Phenylethylpiperidine hydrochloride salt  (S)-207b 
 
N
H2 Cl
 
 
Starting  with  resin-bound  ester  202b  (0.311  milliequiv.),  following  the  enol  ether 
preparation, the chiral piperidine preparation, and using thioacetal (S)-200 gave (2S) 2-
phenylethylpiperidine hydrochloride salt (S)-207b as a solid (31.2 mg, 44% based on 
loading of Merrifield resin). []D –13.9 (c 0.47, DCM), –10.1 (c 0.089, MeOH). Lit:
96 
[α]D –11.3 (c 0.95, MeOH). Other data in agreement with (R)-207b and literature.
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(2S) N-Benzoyl-2-phenylethylpiperidine  (S)-234b (Determination of enantiopurity of  
(S)-207b) 
 
N
O
 
 
Following  the  same  procedure  as  for  (R)-207b  above,  (2S)  2-phenylethylpiperidine 
hydrochloride  salt  (S)-207b  (6.0  mg)  was  converted  into  (2S)  N-Benzoyl-2-
phenylethylpiperidine  (S)-234b  (4.4  mg,  56%  -  data  agrees  with  that  of  other 
enantiomer). Chiral HPLC (Chiralcel OD-H, hexane-isopropanol 98:2, 0.8 mL min
–1) 
showed 94 %ee (tR=35.65 min, tS=41.27 min).  
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(2R) 2-(3'-Methoxyphenyl)piperidine hydrochloride salt  (R)-207c 
 
N
H2 Cl
OMe  
 
Starting  with  resin-bound  ester  202c  (0.325  milliequiv.),  following  the  enol  ether 
preparation, the chiral piperidine preparation, and using thioacetal (S)-200 gave (2R) 2-
(3'-methoxyphenyl)piperidine hydrochloride salt (R)-207c as a solid (24.9 mg, 34% based 
on loading of Merrifield resin). []D +27.8 (c 1.32, DCM) IR (thin film): 2920, 2704, 
1602, 1496 cm
-1. H (CDCl3, 400 MHz): 1.45-1.58 (1H, m), 1.68-1.77 (1H, m), 1.90-2.16 
(4H, m), 2.68-2.81 (1H, m, H6
ax), 3.14 (1H, broad d, J=11.7, H6
eq), 3.75 (3H, s, CH3O), 
3.82-3.91 (1H, m, H2), 6.85 (1H, dd, J= 8.2, 2.1, H6’), 7.08 (1H, broad d, J= 7.7, H4’), 
7.19-7.24 (2H, m, H2’ & H5’), 9.45-9.61 (2H, m, NH2). C (CDCl3, 100 MHz): 21.60 
(CH2), 23.11 (CH2), 30.52 (CH2), 45.63 (CH2), 55.51 (CH3), 61.38 (CH), 112.21 (CH), 
115.87 (CH), 119.84 (CH), 129.95 (CH), 137.90 (C), 159.91 (C). m/z (CI): 192 (M
+, 
100%).  HRMS:  192.1388  C12H18ON  requires  (M
+),  192.1388.    Consistent  with,  but 
different from data for the racemic free base.
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(2R)  N-Benzoyl-2-(3’-methoxyphenyl)piperidine    (R)-234c  (Determination  of 
enantiopurity of  (R)-207c) 
 
N
O
OMe  
 
Triethylamine  (18.5  L,  130  µmol,  3  equiv.)  was  added  to  (2R)  2-(3'-
methoxyphenyl)piperidine hydrochloride salt (R)-207c (10.0 mg, 44 µmol, 1 equiv.) in 
DCM (0.50 mL). The solution was cooled to 0 °C and benzoyl chloride (10.2 L, 90 
µmol, 2 equiv.) was added. The solution stirred under Ar 18 h while warming to RT, and 
was  then  washed  with  water  (1).  The  organic  layer  was  dried  over  MgSO4,  and 
concentrated  in  vacuo  to  yield  the  crude  benzamide  as  a  yellow  oil.  Column  
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chromatography  (SiO2,  Petroleum  ether-EtOAc  9:1)  gave  (2R)  N-benzoyl-2-(3’-
methoxyphenyl)piperidine (R)-234c as a solid (10.1 mg, 78%). Rf (SiO2, Hex-EtOAc 
2:1): 0.45. IR (thin film): 2947, 1629 (C=O), 1490 cm
-1. H (CDCl3, 400 MHz, 50 °C): 
1.59-1.72 (4H, m), 1.90-2.00 (1H, m, C3H
AH
B), 2.38 (1H, broad d, J = 14.0, C3H
AH
B), 
2.93-3.00 (1H, m, C6H
AH
B), 3.82 (3H, s, CH3O), 4.00-4.20 (1H, m, C6H
AH
B), 5.50-5.60 
(1H, m, H2), 6.81 (1H, dd, J=8.2, 2.5, H6’), 6.88 (1H, broad s, H2’), 6.92 (1H, d, J=7.7, 
H4’), 7.30 (1H, t, J=8.0, H5’), 7.36-7.39 (3H, m, H arom.), 7.42-7.47 (2H, m, H arom.). 
C (CDCl3, 100 MHz, 50 °C): 19.85 (CH2), 26.03 (CH2), 28.29 (CH2), 55.31 (CH3), 
112.00  (CH),  113.19  (CH),  119.10  (CH),  126.63  (CH),  128.50  (CH),  129.38  (CH), 
129.77 (CH), 136.90 (C), 141.26 (C), 160.47 (C), 171.37 (C). m/z (EI): 295 (M
+, 90%), 
190 (95), 105 (100), 77  (50).  HRMS:  295.1570 C19H21O2N requires (M
+), 295.1572.  
Chiral HPLC (Chiralcel OD-H, hexane-isopropanol 97:3, 0.8 mL min
–1) showed 76 %ee 
(tR=32.05 min, tS=42.25 min). 
 
 
 
(2S) 2-(3’-Methoxyphenyl)piperidine hydrochloride salt  (S)-207c 
 
N
H2 Cl
OMe  
 
Starting  with  resin-bound  ester  202c  (0.325  milliequiv.),  following  the  enol  ether 
preparation, the chiral piperidine preparation, and using thioacetal (R)-200 gave (2R) 2-
(3’-methoxyphenyl)piperidine hydrochloride salt (S)-207c as a solid (25.0 mg, 34% based 
on loading of Merrifield resin). []D –24.6 (c 0.26 , DCM). Other data in agreement with 
(R)-207c. 
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(2S)  2-N-Benzoyl-2-(3’-methoxyphenyl)piperidine    (S)-234c  (Determination  of 
enantiopurity of  (S)-207c) 
 
N
O
OMe  
 
Following  the  same  procedure  as  for  (R)-207c  above,  (2S)  2-(3'-
methoxyphenyl)piperidine hydrochloride salt (S)-207c (10.2 mg) was converted into (2S) 
N-Benzoyl-2-(3’-methoxyphenyl)piperidine (S)-234c  (9.9 mg,  75%  - data  agrees  with 
that of other enantiomer). Chiral HPLC (Chiralcel OD-H, hexane-isopropanol 97:3, 0.8 
mL min
–1) showed 80 %ee (tR=32.14 min, tS=41.63 min). 
 
(2R, 2’S) 2-[But-2’-yl]piperidine hydrochloride salt  207d 
 
N
H2 H Cl
 
 
Starting  with  resin-bound  ester  202d  (0.325  milliequiv.),  following  the  enol  ether 
preparation, the chiral piperidine preparation, and using thioacetal (S)-200 gave (2R, 2’S) 
2-[but-2’-yl]piperidine  hydrochloride  salt  207d  as  a  solid  (20.2  mg,  35%  based  on 
loading of Merrifield resin). []D +19.1 (c 1.15, DCM) IR (thin film): 2932, 2733, 1590, 
1448 cm
-1. H (CDCl3, 400 MHz): 0.93 (3H, t, J= 7.4, CH3CH2), 1.08 (3H, d, J= 6.6, 
CH3CH), 1.21-2.08 (9H, m) , 2.84 (2H, m, CH2N), 3.52 (1H, broad d, J=12.1, H2), 8.88 
(1H, s, NH
AH
B), 9.41 (1H, s, NH
AH
B). C (CDCl3, 100 MHz): 11.48 (CH3), 14.10 (CH3), 
22.31 (CH2), 22.83 (CH2), 23.78 (CH2), 26.21 (CH2), 36.99 (CH), 45.73 (CH2), 61.74 
(CH).  m/z  (CI):  142  (M
+, 100%),  84  (25).  HRMS:  142.1598  C9H20N  requires  (M
+), 
142.1596. 
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(2R, 2’S) N-trifluoroacetyl-2-[but-2’-yl]piperidine  233d (Determination of the 
diastereomeric purity of  207d) 
 
N
H
O CF3 
 
Triethylamine  (5.9  µL,  42  µmol,  1.5  equiv.)  was  added  to  (2R,  2’S)  2-[but-2’-
yl]piperidine hydrochloride salt 207d  (5.0 mg, 28 µmol, 1 equiv.) in DCM (0.25 mL). 
The solution was cooled to 0 °C and trifluoroacetic anhydride (4.7 µL, 34 µmol, 1.2 
equiv.) was added. The solution stirred 18 h under Ar while warming to RT, and was then 
washed with saturated NaHCO3 (2), 1M HCl (2), and brine (1). The organic layer 
was  dried  over  MgSO4,  filtered,  and  concentrated  in  vacuo  to  give  (2R,  2’S)  N-
trifluoroacetyl-2-[but-2’-yl]piperidine 233d as an oil (6.3 mg, 94%), existing as a 2.3:1 
mixture of geometric isomers a, and b. IR (thin film): 2962, 1688 (C=O), 1455 cm
-1. H 
(CDCl3, 400 MHz): 0.87 (3H
a+b, t, J= 7.3, CH3CH2), 0.928 (3H
b, d J=6.3, CH3CH), 
0.934 (3H
a, d J= 6.6, CH3CH), 0.96-1.08 (1H
a+b, m), 1.24-1.45 (1H
a+b, m), 1.46-1.78 
(5H
a+b, m), 1.88-1.98 (2H
a+b, m), 2.75 (1H
b, broad t J=12.8, H6
ax), 3.12 (1H
a, td J =13.0, 
1.9, H6
ax), 3.52-3.56 (1H
b, m, H6
eq), 3.78 (1H
b, broad d, J=13.6, H6
eq), 4.27-4.33 (1H
a, 
m, H2), 4.36-4.43 (1H
b, m, H2). C (CDCl3, 100 MHz): due to presence of the other 
diastereomer and geometrical isomers the carbon spectrum is too complex to analyze. m/z 
(CI): 238 [(M+H)
+, 100%]. HRMS: 238.1421 C11H19ONF3 requires (M+H
+), 238.1419.  
This was then used on a chiral GC (Supelco -DEX 120 column, 70 °C for 2 min, then 
the temperature was increased at a rate of 1 °C min
–1 to 150 °C) to show a dr (RS:SS) = 
87:13 (tRS=38.32 min, tSS=40.12 min). 
 
(2S, 2’S) 2-(But-2’-yl)piperidine hydrochloride salt  207d’ 
 
N
H2 H Cl
 
 
Starting  with  resin-bound  ester  202d  (0.325  milliequiv.),  following  the  enol  ether 
preparation, the chiral piperidine preparation, and using thioacetal (R)-200 gave (2S, 2’S)  
94
2-(but-2’-yl)piperidine  hydrochloride  salt  207d'  as  a  solid  (15.0  mg,  26%  based  on 
loading of Merrifield resin). []D –16.7 (c 0.27, DCM) IR (thin film): 2931, 2736, 1590, 
1452 cm
-1. H (CDCl3, 400 MHz): 0.91 (3H, t, J= 7.4, CH3CH2), 1.08 (3H, d, J= 6.9, 
CH3CH), 1.19-2.08 (9H, m), 2.73-2.92 (2H, m, CH2N), 3.53 (1H, broad d, J= 12.8, H2), 
8.92 (1H, s, NH
AH
B), 9.18 (1H, s, NH
AH
B). C (CDCl3, 100 MHz): 11.26 (CH3), 15.64 
(CH3), 22.24 (CH2), 22.88 (CH2), 24.48 (CH2), 25.46 (CH2), 37.39 (CH), 45.84 (CH2), 
62.51 (CH). m/z (CI): 142 (M
+, 100%), 84 (10). HRMS: 142.1594 C9H20N requires (M
+) 
142.1596. 
 
(2S, 2’S) N-trifluoroacetyl-2-(but-2’-yl)piperidine  233d’ (Determination of the 
diastereomeric purity of  207d') 
 
N
H
O CF3 
 
Triethylamine in DCM (0.12 mL of a 0.37 M solution, 1.5 equiv.) was added to (2S, 2’S) 
2-[but-2’-yl]piperidine  hydrochloride  salt  207d’  (5.2  mg,  29  µmol,  1  equiv.).  The 
solution was cooled to 0 °C and trifluoroacetic anhydride in DCM (0.12 mL of a 0.30 M 
solution, 1.2 equiv.) was added. The solution stirred 18 h at RT, and was washed with 
satd. NaHCO3 (2), 1M HCl (2), and satd. NaCl (1). The organic layer was dried over 
MgSO4, and solvent removed in vacuo to give the (2S,2’S) N-trifluoroacetyl-2-(but-2’-
yl)piperidine 233d’ as an oil (6.9 mg, 99%), existing as a 2.3:1 mixture of geometrical 
isomers a, and b.  IR (thin film): 2961, 1686 (C=O), 1459, 1215, 1192, 1137, 1105 cm
-1. 
H (CDCl3, 400 MHz): 0.79 (3H
a, d J= 6.7, CH3CH), 0.82 (3H
b, d J= 6.8, CH3CH), 0.94 
(3H
a+b, t J= 7.4, CH3CH2), 1.08-1.23 (1H
a+b, m), 1.24-1.29 (1H
a+b, m), 1.46-1.78 (4H
a+b, 
m), 1.88-1.98 (2H
a+b, m), 2.75 (1H
b, broad t J=13.6, H6
ax), 3.10 (1H
a, td J =13.9, 2.9, 
H6
ax), 3.58-3.65 (1H
b, m, H6
eq), 3.79 (1H
b, broad d, J=13.6, H6
eq), 4.32-4.43 (1H
a+b, m, 
H2). C (CDCl3, 100 MHz): due to presence of the other diastereomer and geometrical 
isomers the carbon spectrum is too complex to analyze. m/z (CI): 238 [(M+H)
+, 100%]. 
HRMS: 238.1421. C11H19ONF3 requires (M+H
+), 238.1419.  This was then used on a 
chiral GC (Supelco -DEX 120 column, 70 °C for 2 min, then the temperature was 
increased at a rate of 1 °C min
–1 to 150 °C) to show a dr (RS:SS) = 20/80 (tRS=38.07 min, 
tSS=39.82 min) 
  
95
(2R, 2’R) 2-[2’-6'-Dimethylhept-1'-yl]piperidine hydrochloride salt  207e 
 
N
H2 H Cl
 
 
Starting  with  resin-bound  ester  202e  (0.325  milliequiv.),  following  the  enol  ether 
preparation, the chiral piperidine preparation, and using thioacetal (S)-200 gave (2R, 2’R) 
2-[2’-6'-dimethylhept-1'-yl]piperidine hydrochloride salt  207e as a solid (23.3 mg, 29% 
based on loading of Merrifield resin). []D +14.3 (c 0.71, DCM) IR (thin film): 2927, 
2711, 1607, 1433 cm
-1. H (CDCl3, 400 MHz): 0.85 (3H, d, J= 6.6, CH3C6’), 0.86 (3H, d, 
J= 6.6, CH3C6’), 0.92 (3H, d, J= 6.4, CH3C2’), 1.08-2.01(16 H, m), 2.73-2.87(1H, m, 
H6
ax), 2.94-3.04 (1H, m, H6
eq), 3.44 (1H, broad d, J=11.0, H2), 9.16 (1H, s, NH
AH
B), 
9.42 (1H, s, NHAHB). C (CDCl3, 100 MHz) 20.04 (CH3), 22.21 (CH2), 22.43 (CH2), 
22.51 (CH3),  22.71  (CH3), 24.41(CH2),  27.90 (CH), 28.63  (CH2), 28.85  (CH), 36.05 
(CH2), 39.19 (CH2), 40.91 (CH2), 44.78 (CH2), 55.44 (CH). m/z  (CI): 212 (M
+, 100%), 
84 (25). HRMS: 212.2379 C14H30N requires (M
+), 212.2378. 
 
(2R, 2’R) N-Benzoyl-2-[2’-6’-dimethylheptyl]piperidine  234e (Determination of the 
diastereomeric purity of  207e) 
 
N
H
O
 
 
Triethylamine (5.7 L, 40 mol, 3 equiv.) was added to (2R, 2’R) 2-[2’-6'-dimethylhept-
1'-yl]piperidine hydrochloride salt 207e (3.4 mg, 14 mol, 1 equiv.) in DCM (0.30 mL). 
The solution was cooled to 0 °C and benzoyl chloride (3.2 L, 0.03 mmol, 2 equiv.) was 
added. The solution stirred under Ar 18 h while warming to RT, and was then washed 
with water (1). The organic layer was dried over MgSO4, filtered and concentrated in 
vacuo  to  yield  the  crude benzamide  as  a  yellow oil.  Column  chromatography  [SiO2, 
Petroleum  ether-EtOAc  (9:1)]  gave  (2R,  2’R)  N-Benzoyl-2-[2’-6’-
dimethylheptyl]piperidine  234e  as  an  oil  (4.0  mg,  92%).  Rf  [SiO2,  Petroleum  ether-
EtOAc (3:1)]: 0.65. IR (thin film): 2927, 2866, 1631 (C=O) cm
-1. H (d6 DMSO, 400  
96
MHz, 80 °C): 0.84 (3H, d, J = 6.2, CH3C2’), 0.91 (6H, d, J = 6.6, CH3C6’), 1.09-1.90 
(16H, m), 2.95-3.08 (1H, m, H6
ax, partly obscured by water peak), 3.72-3.90 (1H, m, 
H6
eq), 4.38-4.54 (1H, m, H2), 7.31-7.39 (2H, m, H arom.), 7.42-7.48 (3H, m, H arom.). 
C (CDCl3, 100 MHz, 50 
oC): 19.33 (CH2), 20.06, 22.57, 22.65, 24.78, 26.36, 27.99, 
29.44, 29.90, 37.63, 39.38, 126.72 (CH), 128.37 (CH), 129.08 (CH), 137.51 (C), 171.03 
(C). m/z (EI): 315 (M
+, 15%), 188 (95), 105 (100), 77 (20). HRMS: 315.2562 C21H33ON 
requires (M
+), 315.2560.  Chiral HPLC (Chiralcel OD-H, hexane-isopropanol 99:1, 0.8 
mL min
–1) showed dr (RR:SR) = 99.5:0.5 (tRR=16.28 min, tSR=19.58 min). 
 
(2S, 2’R) 2-[2’-6'-Dimethylhept-1'-yl]piperidine hydrochloride salt  207e’ 
 
N
H2 H Cl
 
 
Starting  with  resin-bound  ester  202e  (0.325  milliequiv.),  following  the  enol  ether 
preparation, the chiral piperidine preparation, and using thioacetal (R)-200 gave (2S, 2’R) 
2-[2’-6'-dimethylhept-1'-yl]piperidine hydrochloride salt 207e' as a solid (21.2 mg, 26% 
based on loading of Merrifield resin). []D –15.1 (c 3.18, DCM) IR (thin film): 2957, 
2722, 1455 cm
-1. H (CDCl3, 400 MHz): 0.841 (3H, d, J= 6.6, CH3C6’), 0.844 (3H, d, J= 
6.6, CH3C6’), 0.87 (3H, d, J= 6.5, CH3C2’), 1.08-2.00 (16 H, m), 2.82 (1H, m, H6
ax), 
2.92-3.06 (1H, m, H6
eq), 3.45 (1H, broad d, J=11.6, H2), 9.09 (1H, s, NH
AH
B), 9.37 (1H, 
s, NH
AH
B). C (CDCl3, 100 MHz): 15.24 (CH3), 22.25 (CH2), 22.35 (CH2), 22.56 (CH3), 
22.65 (CH3), 24.62 (CH2), 27.87 (CH), 27.93 (CH2), 28.90 (CH), 37.75 (CH2), 39.07 
(CH2),  40.39  (CH2),  44.74  (CH2),  55.52  (CH).  m/z  (CI):  212  (M
+,  100%).  HRMS: 
212.2376 C14H30N requires (M
+), 212.2378. 
 
(2S, 2’R) N-Benzoyl-2-[2’-6’-dimethylheptyl]piperidine  234e’ (Determination of the 
diastereomeric purity of  207e') 
 
N
H
O
 
  
97
Triethylamine in DCM (0.17 mL of a 0.37 M solution, 63 mol, 1.5 equiv.) was added to 
207e’  (10.3  mg,  42  mol,  1  equiv.).  The  solution  was  cooled  to 0  °C  and  benzoyl 
chloride in DCM (0.26 mL of a 0.19 M solution, 49 mol, 1.2 equiv.) was added. The 
solution was stirred for 18 h at RT, and then was washed with satd. NaCl (1). The 
organic layer was dried over Na2SO4, filtered, and solvent removed in vacuo to yield the 
crude benzamide as a yellow oil. Column chromatography [SiO2, Petroleum ether-EtOAc 
9:1] gave (2S, 2’R) N-Benzoyl-2-[2’-6’-dimethylheptyl]piperidine 234e’ as an oil  (9.5 
mg, 72%) Rf (SiO2, Petroleum ether-EtOAc 3:1): 0.63. IR (thin film): 2926, 1625 (C=O) 
cm
-1. H (d6-DMSO, 400 MHz, 80 °C): 0.84 (3H, d, J = 6.4, CH3C2’), 0.90 (6H, d, J = 
6.6, 2  CH3C6’), 1.05-1.74 (16H, m), 2.96-3.05 (1H, m, H6
ax, partly obscured by water 
peak), 3.78 - 3.93 (1H, m, H6
eq), 4.33-4.48 (1H, m, H2), 7.32-7.38 (2H, m, H arom.), 
7.42-7.49 (3H, m, H arom.). C (CDCl3, 100 MHz, 50 
oC): 19.17 (CH2), 22.56, 22.66, 
24.67 (CH2), 28.00, 28.35 (CH2), 37.53 (CH2), 39.30 (CH2), 126.60 (CH), 128.37 (CH), 
129.08 (CH)  m/z (EI): 315 (M
+, 15%), 188 (100), 105 (95), 77 (20), 28 (17). HRMS: 
315.2562 C21H33ON requires (M
+), 315.2565.  Chiral HPLC (Chiralcel OD-H, hexane-
isopropanol 99:1, 0.8mL/min) showed dr (RR:SR) = 98.5:1.5 (tRR=16.19 min, tSR=19.04 
min). 
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Chapter 6 
Petasis-Ferrier Rearrangement 
 
6.1 Discovery and Mechanism 
 
Controlled  rearrangements  have  become  important  transformations  in  organc 
synthesis, especially when synthetically challenging compounds can be obtained from 
readily  synthetically  available  compounds.  One  very  elegant  example  is  the  Petasis-
Ferrier  rearrangement.  The  Petasis-Ferrier  rearrangement  is  used  to  produce  the 
biologically important heterocycles, tetrahydrofurans
101 and tetrahydropyranones
102, from 
dioxalanones and dioxanones respectively, each  available from a simple condensation 
reaction.  
1,3 Dioxalan-4-ones 240 are synthesized via the straightforward condensation of 
α-hydroxy acids and aldehydes, Scheme 6.1. Petasis and Lu found that the dioxalanones 
240 could be methylenated to give the corresponding enol ethers 241 which when treated 
with 
iBu3Al rearranged to give the tetrahydrofurans 242 with good to excellent 2,4,5-syn 
selectivity.  
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Scheme 6.1 
 
  The  reaction presumably  proceeds  by  Lewis  acid activation of the system  by 
coordination to the oxygen atom of the enol ether 241 to give the species 243, Scheme 
6.2. Following this activation, the lone pair on the oxygen atom that is antiperiplanar to 
the carbon-oxygen bond assists the ring to open and form the reactive aluminium enolate 
244. The oxonium ion 244 now cyclizes via a 5-(enolendo)-endo-trig mechanism to give 
the  Lewis-acid-coordinated  tetrahydrofurananone 245.  Intramolecular  hydride addition 
from 
iBu3Al then gives the tetrahydrofuran 242. 
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Scheme 6.2 
 
Interestingly, even if the 2,4-anti diastereomer of the dioxalanone 240 is used the 
final tetrahydrofuran is produced in the same high syn:anti ratio as when the 2,4-syn 
dioxalanone is used. Petasis and Lu proposed explanations for this,
101 Scheme 6.3. Lewis-
acid-coordinated  2,4-syn  enol  ether  246,  would  likely  proceed  according  to  the 
mechanism proposed above to give the aluminium coordinated tetrahydrofuranone 250 
and ultimately the desired tetrahydrofuran. The 2,4-anti diastereomer 247, would first 
form Z-oxonium ion 249 and then isomerise to give the E-oxonium ion 248 which is 
expected to be more stable. As seen previously E-oxonium ion 248 would lead to the 2,5-
syn tetrahydrofuran. It is also possible that the cyclization of the Z-oxonium ion 249 to 
the aluminium coordinated tetrahydrofuranone 251 is an equilibrium process and thus the 
reaction proceeds to give the thermodynamically favored 2,5-syn product.  
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100
 
 The  Petasis-Ferrier  rearrangement  is  better  known  for  its  application  to 
tetrahydropyranones,  Scheme  6.4.  Dioxanones  252  are  readily  available  from  simple 
condensation of β-hydroxyacids and aldehydes. Petasis methylenation of dioxanones 252 
yields enol ethers 253. Petasis and Lu found that when triisobutylaluminium was added to 
the enol ether 253 a mixture of epimeric 2,6-syn tetrahydopyranols 254 were produced. 
Oxidation of the epimeric alcohols 254 furnished the 2,6-syn tetrahydropyranones 255 in 
good yield. 
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Scheme 6.4 
 
  The  rearrangement  starts  with the  coordination  of  triisobutylaluminium  to the 
enolic oxygen atom, Scheme 6.5. Cleavage of the adjacent carbon-oxygen bond assisted 
by the antiperiplanar lone pair of the other oxygen atom gives the enolate 257. Bond 
rotation gives the conformation represented by enolate 258. The R
1 group occupies the 
lowest energy pseudo-equatorial position in the 6-membered ring transition state leading 
to Lewis-acid-coordinated tetrahydropyranone 259. Intramolecular hydride addition from 
the triisobutylaluminium produces the epimeric tetrahydropyranols 254. 
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6.2 Phorboxazole A 
 
Smith et al. have used the Petasis-Ferrier rearrangement to produce a variety of 
different tetrahydropyran-containing natural products,
103,104,105,106 Figure 6.1.  
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In  the  total  synthesis  of  (+)-phorboxazole  A  260,
106  pioneering  work 
demonstrated the power of the Petasis-Ferrier rearrangement by using the transformation 
to construct the highlighted 2,6-syn tetrahydropyranol units. 
Initially, in the synthesis of the tetrahydropyranol adjacent to the oxazole, Smith 
and  co-workers  had  difficulties  effecting  the  rearrangement.  This  prompted  them  to 
screen several Lewis acids on a model system not only to optimize the yield, but also to 
prevent the reduction of the initially formed tetrahydropyranone to epimeric alcohols, as 
the  stereoselectivity  of  the  reduction  was  not  reliable.  In  the  model  system Me2AlCl 
provided  better  yields  than 
iBu3Al  and  was  incapable  of  the  undesired  reduction. 
However, when these findings were applied to the enol ether 261 the rearrangement still 
failed to occur, Scheme 6.6.  
 
N
O O
O
OPMB
O
H H
BPSO
O
N
O
O
OPMB
O
OTBS
H H
BPSO
Me2AlCl
OTBS
261 262
H
H H
H
 
Scheme 6.6 
 
Smith postulated that, since the oxazole nitrogen atom is a strong Lewis base, the 
Lewis acid does not coordinate enough to the less Lewis basic oxygen atom of the enol 
ether. Smith believed that if the enol ether oxygen atom could be moved to the side of the 
alkene closest to the oxazole, that the Lewis acid, which is capable of di-coordination, 
would be able to coordinate the oxazole nitrogen and reach across to the enolic oxygen, 
thus allowing the rearrangement to occur, Figure 6.2.  
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 The  necessary  enol  ether  264  was  prepared  from  dioxanone  263  by  Petasis 
methylenation at two sites with excess dimethyltitanocene, Scheme 6.7. Now Me2AlCl 
effected  the  desired  rearrangement  at  low  temperature  and  afforded  the 
tetrahydropyranone 265 in very good yield as a single diastereomer.  
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Scheme 6.7 
 
6.3 Conclusion 
 
Starting  from  dioxanones,  synthetically  available  from  a  simple  condensation 
reaction,  the  Petasis-Ferrier  rearrangement  enables  the  production  of  synthetically 
valuable  2,6-syn  tetrahydropyranones.  As shown  above,  the  rearrangement  has  found 
significant use in the total synthesis of complex natural products, and can be considered a 
proven synthetic method. Strangely there was no nitrogen analogue of this rearrangement 
in the literature.  
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Chapter 7 
Microwave-Assisted Organic Synthesis 
 
7.1 Introduction 
 
Microwave energy is emerging as a new source with which to heat and drive 
chemical  transformations.  Once  considered  a  last  resort  to  force  tricky  reactions, 
microwave  irradiation  is  becoming  an  important  tool  for  everyday  synthesis  and  the 
design  of  experiments.
107,108  Early  microwave  chemistry  took  place  in  conventional 
kitchen appliances, but now there are a wide variety of specialized microwaves dedicated 
to synthesis. The extreme increases in reaction rate have attracted much attention from 
academics and industrialists alike.  
Conventional heating relies on heat transfer from a heat source, through a reaction 
vessel, and finally into the reaction medium. This  has a  host of negative effects: the 
exterior of the reaction is hotter than the interior, power is wasted in the heating of the 
exterior, and temperature is difficult to control and monitor. Microwave-assisted organic 
synthesis (MAOS) overcomes these problems via direct coupling of microwave energy to 
the reagents and solvents in the reaction vessel. With MAOS heating a reaction mixture is 
fast, efficient, and easy to control.  
Applying an electromagnetic field causes dipoles or ions to align with that field. If 
the field oscillates then the dipoles or ions will try to reorient with the change in the field, 
and give off energy in the form of heat. The most efficient heating occurs when the 
electromagnetic field oscillates at a frequency that is slow enough for the dipoles to align 
with  but  not  follow  the  applied  electromagnetic  field.  Typically  the  frequency  of 
chemical microwaves is 2.45 GHz. Different solvents respond to microwave irradiation 
to varying degrees. The two factors that are most indicative of a medium’s ability to 
convert electromagnetic radiation into heat are the dielectric loss (ε”), and the dielectric 
constant (ε’).  The  dielectric  loss describes  the  efficiency with which  electromagnetic 
radiation  is  converted  into  heat.  The  dielectric  constant  describes  the  ability  of  the 
molecules to be polarized by the electromagnetic field. The ratio of (ε”/ε’) is described as 
the loss factor (tanδ). A larger value of tanδ indicates a reaction medium that is more 
suited to MAOS. The loss factors of various solvents are summarized in table 7.1. 
 
 
  
105
Table 7.1 loss factors of some standard solvents
107 
Solvent  Tanδ 
Ethanol  0.941 
DMSO  0.825 
Methanol  0.659 
DMF  0.161 
Water  0.123 
Acetonitrile  0.062 
THF  0.047 
Dichloromethane  0.042 
Toluene  0.040 
Hexane  0.020 
 
Due to their very polar nature and high boiling points ionic liquids make excellent 
solvents  for  MAOS.  Larhed  and  co-workers  have  used  the  ionic  liquid  1-butyl-3-
methylimidazolium  hexafluorophosphate  (bmimPF6)  to  perform  Heck  reactions,
109 
Scheme 7.1. When an aryl halide 266 in the ionic solvent was treated with an acrylate 
267 and standard Heck conditions, the desired cinnamic esters 268 could be obtained in 
only 5 minutes in high yield. This is in stark contrast to the long reaction times of several 
hours  necessary  when  employing  reflux  conditions  by  conventional  heating,  and  a 
conventional solvent. More challenging examples required slightly longer reaction times, 
but  even  when  electron-rich  aryl  halides  were  used,  reactions  were  finished  in  45 
minutes. Purification was simple as the reaction medium was completely non-volatile. 
Distillation isolated the product and also left the reaction medium ready for a subsequent 
Heck  reaction.  Indeed  the  catalytic  ionic  system  could be  recycled  5  times  and  still 
provide  yields  in  excess  of  90%,  each  time  requiring  simple  distillation  to  separate 
product from reaction medium. Aside from the creative purification procedure, the high 
temperature made possible by a very high boiling solvent, and the ability of microwave 
energy to achieve this temperature are exploited to drastically shorten the reaction time 
for this very useful transformation.  
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Scheme 7.1 
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7.2 Microwave Effects: 
 
Due to the vast increase in reaction rate sometimes observed with MAOS there is 
a  great  deal  of  controversy  concerning  the  existence  of  a  microwave  effect.  Some 
scientists believe that the rate increase is the result solely of thermal effects, that rate 
increase is caused by the rapidly  achieved high temperatures. Others believe that the 
ability of the applied electromagnetic field to orientate molecules plays a part in the short 
reaction times.
110 The Arrhenius equation [K = A exp(-Ea/RT)] is helpful in visualizing 
the claimed non-thermal microwave effects. The pre-exponential constant A is related to 
the probability of molecular impacts. The organized vibration of polar molecules at the 
reaction interface could plausibly effect A and increase the rate. It is also argued that the 
applied field can organize polar species, affecting entropy, and the activation energy. 
Stabilization of polar intermediates could also play a role in rate increase. If a reaction 
proceeds via a polar transition state the applied electromagnetic field should stabilize the 
polar species. When polarity increases from reactants to transition state the stabilizing 
effects of the applied field would decrease the  activation energy of the reaction, and 
speed up the reaction. The reasons for the dramatic rate increase sometimes observed 
with MAOS will be discussed for many years to come, however, the effects of this rate 
increase can be enjoyed today. 
 
7.3 Isochoric Microwave Irradiation for High Temperatures 
  
Microwave  irradiation  is frequently used to heat a conventional  solvent far in 
excess of its boiling point, by heating the reaction in a sealed tube. Fürstner and Seidel 
use this strategy to good effect in their route to arylboronates 272. The Suzuki cross 
coupling reaction has become one of the most widely used transformations in chemistry, 
and  many  literature  procedures  use  microwave  energy  to  drive  the  reaction.
111  A 
microwave-assisted route to the precursor pinacol arylboronates needed for the Suzuki 
reaction would further streamline the technique. Fürstner’s route gives pinacol boronates 
from aryl chlorides using a Pd-heterocyclic carbene complex,
112 Scheme 7.2. The use of 
aryl chlorides is significant as they are more readily available, but less reactive than their 
bromine and iodine analogues. No doubt the microwave technology employed plays a 
key role in enabling use of the less reactive chloro substrate. The catalytic system is made 
up of Pd(OAc)2, and an N-heterocyclic carbene produced in situ by deprotonation of the 
imidazolium salt 270. An aryl chloride 269 is treated twice with the catalytic system in  
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the presence of bis(pinacol)borane 271 at 110 
oC for 10 minutes. After this very short 20 
minute reaction time, the desired arylboronates 272 are isolated in good yield.  
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Scheme 7.2 
 
7.4 Reaction Development  
 
  Stadler  and  Kappe’s  optimization  of  the  Biginelli  reaction  demonstrates  the 
powerful  ability  of  microwave-assisted  synthesis  to  speed  up  reaction  development, 
Scheme  7.3.
113  Due  to  the  very  short  reaction  times,  MAOS  allows  many  different 
parameters to be tested very quickly. Furthermore, results are obtained so fast that test 
runs can be performed in series, not parallel. Information gained from one test run can 
easily provide input into the design of the next test run. Using these advantages, the 
catalyst,  reaction  temperature,  and  reaction  time  for  the  microwave-assisted  Biginelli 
reaction  were  optimized  in  only  a  few  hours  of  experiment  time.  With  optimized 
conditions  in  hand, a 48 member library of dihydropyrimidines 276 was produced in 
good average yield and within 12 h.  
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7.5 Fine Control of Reaction Temperature 
 
 Microwave-assisted chemistry also finds itself at the forefront of natural product 
synthesis. Ley and co-workers have recently reported the total synthesis of azadirachtin 
279.
114 A key Claisen rearrangement is driven by microwave energy to give the allene 
278 necessary for the radical cyclization that forms the core ring structure of the complex 
and beautiful natural product 279, Scheme 7.4. While conventional heating failed even in 
the presence of Claisen rearrangement promoting Lewis acids, and after extended periods 
of  time, microwave  energy  effected  the  desired  reaction  in minutes with  no additive 
necessary. Pulsing of the microwave energy was important and prevented decomposition 
at the extreme temperature. Here the control made possible by microwave technology is 
key. Since heating only occurs in the reaction vessel, and not in the surroundings, very 
precise heating and cooling can be achieved with the convenience of an on-off switch. 
While many  advantages of microwave  chemistry  come from the dull axe of extreme 
temperatures,  the  method  also  has  an  elegant  side  displayed  in  this  beautiful  total 
synthesis. 
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Scheme 7.4  
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7.6 Petasis Methylenation 
 
Two examples of microwave-assisted Petasis methylenation exist in the literature. 
Ley  and  co-workers  first  used  the  stategy  to  methylenate  a  key  intermediate  in  the 
synthesis of spongistatin 1,
72 Scheme 7.5. When ketone 280 was heated conventionally at 
120 
oC for 3 h with dimethyltitanocene in toluene, the alkene 281 was produced in a 71% 
yield.  However,  adding  a  small  amount  of  ionic  liquid  (1-ethyl-3-methylimidazoline 
hexafluorophosphate), and using microwave irradiation to heat the reaction at 160 
oC for 
10 min produced alkene 281 in an 82% yield. When a conventional solvent is used with a 
low tanδ value, achieving high temperature with microwave energy can be difficult. Ley 
and co-workers overcame this problem by adding the ionic liquid to the solvent which 
acts as a sponge for the microwave energy. Importantly, even at the extreme temperature 
the mild methylenating reagent leaves both chiral centres untouched, avoiding enolization 
or retro-Michael addition. 
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Scheme 7.5 
 
More  work  in  this  area  has  highlighted  the  utility  and  selectivity  of  the 
microwave-assisted  Petasis  methylenation.  Gallagher  and  co-workers  were  having 
trouble  finding  a  route to pyruvate  based  enol ethers  283.  However,  they  found  that 
microwave energy efficiently drove the Petasis reaction giving the desired products,
71 
Scheme 7.6. When pyruvate-based oxalates 282 were treated with dimethyltitanocene, 
and heated for just 30 minutes with microwave energy, only the less hindered carbonyl 
was alkenated to form enol ethers 283 in good yield. Enamines could also be produced 
from oxalate monoamides. Conventional heating gave very poor results and even after 24 
h,  the  reaction  had  failed  to  go  to  completion.  In  30  min  the  extreme  temperature 
achieved with microwave energy had driven the reaction entirely to completion; leaving 
the tert-butyl ester functionality completely unreacted. 
  
110
O
X
O
O
tBu X
O
O
tBu
Cp2TiMe2 (1.5 - 3 eq.),
         PhMe-THF
MW, 0.5 - 1.5 h, 150 
oC
X = O-alkyl, N-dialkyl
282 283  20-80%
 
Scheme 7.6 
 
7.7 Conclusion 
 
The advent of MAOS means that the choice of heat source has become a key 
variable to be considered for maximizing success in the laboratory. While microwave 
energy is a powerful new tool, it is not a suitable heating source for all applications, and 
the  method  suffers  when  it  comes  to  scaling  up.  However,  when  compared  to 
conventional heating in efficiency, control, and speed, microwave irradiation is a superior 
heat source. The speed with which information can be gathered and applied to reaction 
optimization is particularly impressive and significant. Every year an increasing number 
of  microwave-assisted  routes  are  published,  and  the  method  is  gaining  popularity  in 
industry  as  well.  As  demonstrated  by  the  microwave-assisted  Petasis  methylenation, 
some reactions benefit greatly from the special attributes of microwave energy. As with 
many examples, the reaction shows great promise, but has not been fully explored.   
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Chapter 8 
β-Amino Acids to Piperidinones 
 
8.1 Modified Petasis-Ferrier Rearrangement 
 
We initially envisaged a nitrogen analogue of the Petasis-Ferrier rearrangement. 
The  good  yields  and  the  excellent  selectivity  of  the  reaction,  Scheme  6.1,
101  were 
attractive attributes and we imagined that perhaps we could produce pyrrolidines 286 via 
a  similar  reaction  pathway,  Scheme  8.1.  A  direct  analogue  would  start  with 
oxazolidinones 284 and proceed to give pyrrolidines 286 via enol ethers 285.  
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An important factor in the rearrangement would be electron density around the 
nitrogen atom of  the  enol ether  285. Only  if  the  nitrogen atom  had enough electron 
density to assist cleavage of the C-O bond would rearrangement occur. Although N-alkyl 
oxazolidinones  proved to be too unstable  or difficult  to  synthesize, there  are  several 
simple  syntheses  of  amide  and  carbamate  protected  oxazolidinones  in  the 
literature.
115,116,117,118,119 However, an amide or carbamate might not have enough electron 
density  at  the  nitrogen  atom  due  to  conjugation  of  the  nitrogen  lone  pair  with  the 
carbonyl group, Figure 8.1.  
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Figure 8.1 
 
On the other hand a tert-butyl carbamate (Boc) protected oxazolidinone would be 
expected  to  deprotect  in  the  acidic  environment  required  for  the  Petasis-Ferrier 
rearrangement  and  thus  provide the necessary electron density on  the  nitrogen  atom.  
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Fadel and Salaün had synthesized the N-benzoyl oxazolidinone 289 from alanine 287 via 
the Schiff base 288,
120 Scheme 8.2.  We thought that by using di-tert-butyldicarbonate 
(Boc2O) in place of benzoyl chloride that we would be able to access the Boc-protected 
oxazolidinones. 
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Scheme 8.2 
 
The  synthesis  of  the  Boc-protected  oxazolidinone  proved  to  be  challenging. 
Boc2O is not as reactive as an acid chloride and simply replacing benzoyl chloride with 
Boc2O produced no desired product.  After much experimentation it was found that by 
heating to 55 
oC in chloroform, an appreciable amount of product 290, presumably the 
2,4-syn diastereomer, could be obtained, albeit in poor yield, Scheme 8.3.  
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  While there are many ways to methylidenate compounds like oxazolidinone 290, 
we  chose  to  use  dimethyltitanocene  as  it  is  easily  produced  from  cheap  starting 
materials,
69 and can be stored for long periods of time. Furthermore, the reagent breaks 
down to the reactive Schrock carbene by thermolysis and thus the reaction is simple to 
perform, requiring only heat for activation. Purification is also an attractive attribute as 
the  titanium  byproducts  precipitate  out  of  hexane.  Simple  filtration  provides  a  mild 
workup  and  purification  procedure  that  even  acid-sensitive  enol  ethers  tolerate. 
Furthermore,  the  adaptability  of  the  reaction  to  microwave  irradiation  enables  short 
reaction times.
71,72  
  Literature  procedures  for  microwave-assisted  Petasis  methylidenation  call  for 
very high temperatures and harsh reaction conditions,
71,72 Section 7.6.
 The solvents are  
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heated far in excess of their boiling points and in one example a small amount of ionic 
liquid is necessary to aid the absorption of microwave energy. We decided to investigate 
milder  conditions.  To  our  surprise,  reaction  of  the  oxazolidinone  290  with 
dimethyltitanocene for only 10 min at 80 
oC gave the desired enol ether 291 in good 
yield, Scheme  8.4.  While  bringing  the reaction  to 80 
oC  took about 9 minutes,  total 
reaction time was still under 20 minutes. It was later discovered that the conditions could 
be even milder; 10 min at 65 
oC gave a slightly improved yield, 65%.  
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Scheme 8.4 
 
These findings are  in stark contrast to previously  reported microwave-assisted 
Petasis methylidenations. No additive is required, and the temperatures are equivalent to 
those used with conventional heating sources. This is significant, as a commonly given 
reason  for  the  enhanced  reaction  rates  seen  with  MAOS  is  the  very  high  reaction 
temperature when compared to conventional heating, Section 7.2. Possibly, in this case, 
there is a rate enhancement due to selective absorption of the microwave energy by the 
titanium reagent, due to the polar metal-carbon bond. Formation of the Schrock carbene 
is  the  rate-determining  step  in  Petasis  methylenation.
121  The  microwaves  would  pass 
through  the  relatively  microwave-transparent  solvents,  but  would  interact  with  the 
titanium complex leading to α-elimination without significant heating of the bulk solvent. 
  Although methylenation was successful, all attempts to induce the enol ether 291 
to  undergo  rearrangement  were  unsuccessful,  Scheme  8.5.  Trimethylsilyl  chloride 
(TMSCl),  trimethylsilyl  triflate  (TMSOTf),  triisobutylaluminium,  and 
dimethylaluminium chloride all failed to effect the desired transformation. Under a range 
of temperatures and reaction times, only the products of decomposition were ever seen.  
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8.2 A New Aproach 
   
  Clearly, a new approach was necessary. Believing that the carbamate failed to 
rearrange  because  the  ring  failed  to open  and  produce  the  reactive intermediate  293, 
Figure 8.2, we sought an alternative reaction that would not require a ring opening, i.e., a 
synthetic equivalent of the reactive intermediate 293 that would allow access to the target 
pyrrolidines. The important reactive groups of species 293 are the electrophilic iminium 
group and the nucleophilic enolate. The imino enol ether 294 contains an imine group 
which, after activation with an acid, would become a good electrophile, while the enol 
ether provides a nucleophile analogous to the enolate of bifunctional species 293.  
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  We visualized access to the imino enol ethers 294 via microwave-assisted Petasis 
methylenation of imino esters 295, which are readily available from α-amino acids 296, 
Scheme 8.6.  
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  L-Alanine was esterified with SOCl2 in MeOH to give α-amino ester 297 as the 
HCl salt in excellent yield.
122 A standard procedure taken from Roques and co-workers
123 
gave the imino ester 298 in good yield from the condensation of amino ester 297 with 
benzaldehyde, Scheme 8.7.  
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Methylenation of the imino ester 298 posed an interesting situation. While there is 
only one carbonyl group, the electrophilic imine could also be a target for methylenation. 
Furthermore, nucleophilic organometallic reagents have been shown to react selectively 
with  the  imine  functionality  of  imino  esters  derived  from  α-amino  acids.
124  Petasis 
methylenation  proceeds  via  a  Schrock  carbene  and,  therefore,  electrophilicity  largely 
determines  the  reactivity  of  a  substrate  towards  dimethyltitanocene.  Despite  these 
concerns, the ester group was methylenated selectively to give the enol ether 299 as a 
single compound, Scheme 8.8. Once again, the exceptionally mild microwave conditions 
effected  the  methylenation  in  only  10  minutes  at  80 
oC.  Even  milder  conditions, 
maintaining the reaction at only 65 
oC for 10 min gave an improved yield of 78%. 
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The driving force of Petasis methylenation of carbonyl groups is the formation of 
the  strong  titanium-oxygen  bond  in  the  by-product,  titanocene  oxide,  Scheme  8.9. 
Reaction with the imine functionality of imino ester 298 would not produce titanocene 
oxide. Therefore, it seems that the strength of the titanium-oxygen bond not only ensures 
a good yield for the reaction, but also means dimethyltitanocene selectively reacts with 
carbonyls in the presence of imines.  
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Scheme 8.9 
 
  Unfortunately, cyclization of the enol ether 299 was not successful. Once again a 
range of different acids and conditions failed to give the desired products. After aqueous 
workup, only the products of hydrolysis or decomposition were obtained. It is probable 
that the cyclization fails due to its very challenging nature.
125 The 5-(enolendo)-endo-trig 
cyclization required is rare, in fact the original Petasis-Ferrier rearrangement is one of the  
116
few examples. We investigated the possibility of a challenging but easier 6-(enolendo)-
endo-trig cyclization.  
 
8.3 Piperidinones 
 
   Our strategy centred on the use of a one-carbon extension; using the β-imino enol 
ethers 301 as the precursors to 2,4-substituted piperidin-4-ones 302, Scheme 8.10. Thus, 
piperidinones  302  would  be  produced  by  the  acid-induced  6-(enolendo)-endo-trig 
cyclization of imino enol ethers 301 theoretically available from imino esters 300.  
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To validate and then demonstrate our proposed route to piperidinones 302, β-
amino esters 306 - 308 were prepared from β-amino acids 303 - 305, Scheme 8.11, Table 
8.1.  
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Table 8.1 Yields of amino esters from β-amino acids 
amino acid  amino ester  R1  Yield 
303  306  Me  98% 
304  307  Ph  98% 
305  308  PhCH2  100% 
 
  Condensation of the amino esters 306 - 308 with an aldehyde or ketone gave the 
desired imino esters 309a-n, Scheme 8.12, in the yields shown in table 8.2. 
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Table 8.2 Summary of Imino Ester Synthesis 
amino 
ester 
imino 
ester  R
1  R
2  R
3 
conditions 
used
a  yield 
306  300a  Me  Ph  H  A  75%
b 
307  300b  Ph  Ph  H  A  89% 
307  300c  Ph  2,4-(MeO)2C6H3  H  A  94% 
308  300d  PhCH2  Ph  H  A  83% 
306  300e  Me  (E)-4-MeOC6H4CH=CH  H  A  87%
b 
306  300f  Me  2,4-(MeO)2C6H3  H  A  61% 
306  300g  Me  3-Br C6H4  H  A  58% 
307  300h  Ph 
tBu  H  B  90% 
307  300i  Ph  Et  H  B  91%
c 
306  300j  Me  2-F C6H4  H  A  55% 
307  300k  Ph  2-NO2 C6H4  H  A  92% 
307  300l  Ph  Pyrid-3-yl  H  A  90% 
306  300m  Me  Ph  Me  C  74%
d 
307  300n  Ph              –(CH2)5–    C  73% 
a) see text for details 
b) Yield based on aldehyde  
c) 300i:307:EtCHO 80:13:7; d) E:Z ratio was 93:7 
 
Most imino esters were formed using conditions A, i.e., the amino ester was 
stirred  with  the  aldehyde,  triethylamine,  and  Na2SO4  in  DCM  at  RT.  After  aqueous 
workup, any necessary purification was achieved by distillation. Imino esters 300h, and 
300i were made in the same way, but could not tolerate aqueous workup or distillation, as 
the aliphatic imines were too unstable, and required the workup procedure outlined in 
conditions B, i.e., workup and purification involved only precipitation of triethylamine 
salts followed by filtration, and evaporation. While pivaldehyde-derived imino ester 300h 
was isolated as pure product, propionaldehyde-derived imino ester 300i had to be isolated 
as an 80:13:7 mixture of imino ester 300i, free amino ester 307, and propionaldehyde. An 
excess of easily removed volatile pivaldehyde could be used to drive the formation of 
300h  to completion,  however  300i was too  susceptible to  the  formation  of  enamine-
derived side products, and an excess of propionaldehyde could not be used.    
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Ketone-derived imines 300m and 300n failed to form from the treatment of amino 
esters 306 and 307 with ketones, using Na2SO4 as a desiccant. The more challenging 
condensations required conditions C, i.e., the amino ester and ketone were heated at 
reflux  with  triethylamine  in  PhMe  with  azeotropic  removal  of  water.  After  aqueous 
workup any necessary purification was achieved by distillation. 
  One further imino ester was prepared, Scheme 8.13. Anthranilic acid 309 
was esterified with thionyl  chloride in MeOH to give the amino ester 310, and then 
heated to reflux with benzaldehyde and triethylamine in toluene with azeotropic removal 
of water to give the imino ester 311. 
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Scheme 8.13 
 
With an array of imines available, we set out to validate our route to piperidinones 
302. The methylenation of imino ester 300a was attempted using microwave-assisted 
Petasis methylenation with 1.7 equivalents of dimethyltitanocene, Scheme 8.14. After 
reaction, analysis of the crude material by 
1H NMR spectroscopy revealed the appearance 
of two broad, overlying 1H singlets at 4.0 ppm, and an upfield shift of 0.3 ppm for the 
CH2C(OMe)=CH2 of the imino enol ether 301a relative to the CH2CO2Me of the starting 
imino ester 300a. These findings confirmed the presence of the desired enol ether 301a. 
However, it was clear that some ester remained, and the reaction was judged to be about 
75%  complete.  The  crude  material  was  re-treated  with  0.7  equivalents  of 
dimethyltitanocene. Importantly, the glassware used for the second treatment was not 
oven-dried. Following normal workup and purification, which included distillation at 170 
oC, the crude material was once again analyzed by 
1H NMR spectroscopy. Broad singlets 
in the region of 3.5 to 4.0 ppm showed that several enol ethers were present, and signals 
farther upfield displayed peak shapes that resembled those of protons with axial and 
equatorial couplings in a 6-membered ring. Apparently, the enol ether 301a had cyclized 
to give two cyclic enol ethers 313 and 314. Presumably, the high temperature in the 
presence  of  trace  moisture  caused  cyclization  of  imino  enol  ether  301a  to  give  the 
oxonium ion 312 which lost a proton α to the carbonyl group giving a mixture of the two  
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cyclic enol ethers 313 and 314. Simple hydrolysis of the enol ethers with HCl(aq) gave the 
racemic  piperidine  as  the  hydrochloride  salt  315a.  Interestingly,  not  only  had  we 
somewhat  serendipitously  synthesized  our  target  molecule,  but  it  had  been  made 
exclusively  as  the  2,6-syn  diastereomer,  see  Section  8.4  for  assignment  of 
stereochemistry.   
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Scheme 8.14 
 
The excellent stereoselectivity observed is probably secured by a preference for a 
6-membered transition state 318, Scheme 8.15. Acid activates the imino enol ether 301a, 
which could potentially react by two chair-like conformations 316 and 317. The low-
energy conformation 316 has the R
1 group in a pseudo-equatorial orientation, while the 
pseudo-axial orientation of this  group in conformer 317 is disfavored by 1,3-pseudo-
diaxial interactions. The orientation of the R
2 group is set by the E geometry of the imine. 
The relative stability of conformation 316, and the transition state 318 arising from it, 
results in selectivity for the 2,6-syn piperidinone 315a.  
  
120
OMe
Me
N OMe
Ph H
N
H2
Me Ph
O
N
H
Ph Me
H
H
Me
H
H
Ph
MeO
N
H
OMe
N
H
Ph Me
H
H
301a
315a
316 317
318
H+
Cl
 
Scheme 8.15 
   
Formation of the imino enol ether 301a was repeated in oven-dried glassware. 
Treatment of the crude imino enol ether 301a with aqueous acid effected the cyclization 
which, following a wash with DCM and evaporation of the aqueous acid, gave 2,6-syn 
piperidinium salt 315a in good yield from imino ester 300a, Scheme 8.16. A range of 
different acid concentrations was screened, Table 8.3, with 7M HCl(aq) giving the best 
results. It is only because cyclization is so fast that aqueous acid can be used. The acid-
sensitive  imine  and  enol  ether  functionalities  have  little  opportunity  to  undergo 
hydrolysis. 
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Table 8.3 yield of piperidinium salt 315a from imino ester 300a 
concentration of  HCl(aq)  yield of 315a 
12 M  23% 
9 M  59% 
7 M  62% 
2.4 M  59% 
 
While  the  imino  ester  300b  was  also  cleanly  methylenated  with 
dimethyltitanocene, and underwent the desired aqueous-acid-induced cyclization to give  
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diphenylpiperidinium salt  315b, formation  of piperidinium salts  315c and 315m was 
problematic, Scheme 8.17, Table 8.4.  
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Scheme 8.17 
 
Table 8.4 Yields of piperidinones 315 from esters 300 via conditions from scheme 8.17 
imino ester  R
1  R
2  R
3  piperidinone  yield 
300a  Me  Ph  H  315a  62 
300b  Ph  Ph  H  315b  62 
300c  Ph  2,4-(MeO)2C6H3  H  315c  no product 
300m  Me  Ph  Me  315m  Trace 
 
Methylenation of imino ester 300m proceeded cleanly to give enol ether 301m, 
but acidic cyclization conditions gave only a trace of piperidinium salt 315m, isolated by 
crystallization out of a complex mixture. Presumably, the ketone-derived imine is too 
sterically hindered for rapid cyclization and hydrolysis competes. The imino ester 300c 
decomposed  significantly  when  subjected  to  dimethyltitanocene  at  80 
oC  under 
microwave-irradiation,  but  by  heating  the  reaction  to  only  65 
oC  with  microwave 
irradiation  (approximately  7  minutes)  and  maintaining  this  temperature  for  only  3 
minutes, the methylenation could be completed without decomposition. In fact, the lower 
reaction  temperature  gave  improved  results  in  all  microwave-assisted  methylenations. 
Unfortunately, despite clean methylenation of imino ester 300c, cyclization of enol ether 
301c was still problematic. 7M HCl(aq) gave only a 12% yield of the desired piperidinone 
salt 315c by crystallization from a complex mixture. The electron-rich nature of the imine 
probably slowed the cyclization so that hydrolysis competed. The 2,4-dimethoxyphenyl 
group donates electron density to the imine and in doing so reduces the electrophilicity of 
the imine, preventing the nucleophilic enol ether from attacking quickly. 
Piperidinones  315c  and  315m  were  isolated  by  crystallization  from  complex 
mixtures,  but  the  major  products  in  both  cases  were  those  of  imine  and  enol  ether 
hydrolysis.  The  cyclization  is  fast  enough  to  compete  with  hydrolysis  only  when 
electronics  are  favorable  and  the  imine  is  not  sterically  hindered.  We  imagined  that 
anhydrous acid would activate the imines 301 and allow cyclization to the oxonium ions 
320 and the tautomeric enol ethers 321 and 322 to occur without inducing competing  
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hydrolysis,  Scheme  8.18.  After  the  cyclization  was complete,  aqueous  acid could be 
added to hydrolyze the oxonium ions 320 and the tautomeric enol ethers 321, and 322 to 
the desired piperidinones 302. 
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Scheme 8.18 
 
Unsurprisingly,  imino  ester  300a  underwent  microwave-assisted  Petasis 
methylenation and was then cyclized with anhydrous p-toluene sulfonic acid (p-TsOH). 
After acid hydrolysis, the piperidinone 302a was isolated in good yield as exclusively the 
2,6-syn diastereomer, Scheme 8.19, Table 8.5. Similarly, imino ester 300d gave a good 
yield of piperidinone 302d. Methylenation and cyclization of more challenging imino 
ester 300c under the new conditions gave an improved but modest yield of piperidinone 
302c.  α,β-unsaturated  imino  ester  300e  underwent  methylenation-cyclization  to  give 
piperidinone 302e in similarly modest yield despite a higher reaction temperature for the 
cyclization. Following aqueous workup the 
1H NMR spectrum of the crude products from 
the  cyclizations  to  give  piperidines  302c  and  302e  showed  a  mixture  of  the  desired 
piperidinones 302c and 302e and the products of imine and enol ether hydrolysis. We 
believe  that  in  both cases  the 17  h reaction  time was  not  enough  for  the  very slow 
cyclization, and the aqueous acid used to hydrolyze cyclized product also hydrolyzed the 
uncyclized imino enol ether. Despite the anhydrous conditions, the cyclization was so   
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slow that even without competing hydrolysis, the reaction was not viable.  
 
R
1
N OMe
O
R
2
300
1) Cp2TiMe2 (1.8 equiv.)
THF-PhMe, 65 
oC, 10 min
N
H
O
R
2 R
1
R
3
2) p-TsOH (2 equiv.)
   DCM, 17 h 
   rxn. temp from Table 8.5
302
3) 1M HCl(aq) 0.5 h
4) neutralization
R
3
 
Scheme 8.19 
 
Table 8.5 Yields of piperidinones 302 from esters 300 via conditions from Scheme 8.19     
imino 
ester  R
1  R
2  R
3 
cyclization 
temperature  piperidinone  yield 
300a  Me  Ph  H  20 
oC  302a  61 
300c  Ph  2,4-(MeO)2C6H3  H  20 
oC  302c  40
a 
300d  PhCH2  Ph  H  40 
oC  302d  61 
300e  Me  (E)-4-MeOC6H4CH=CH  H  60 
oC  302e  37
b 
a) During the methylenation the temperature is held at 65 
oC for only 3.5 min. 
b) During the methylenation the temperature is held at 65 
oC for only 5 min. 
 
  Still  unhappy  with  the  cyclization  conditions,  we  considered  the  role  of  the 
solvent. Activated imino enol ether 319 cyclizes to give oxonium salt 320, Scheme 8.18. 
DCM is a relatively non-polar solvent and does not stabilize the oxonium ion 320 or the 
transition state leading to it. A more polar solvent would stabilize the transition state and 
encourage cyclization. Just switching from DCM to the polar dimethoxyethane (DME) 
improved the yield of piperidinone 302c to a respectable 51%, Scheme 8.20, Table 8.6. 
Imino esters 300c, 300f, 300g, 300h, and 300i all cyclized using p-TsOH in DME to give 
piperidines 302c, 302f, 302g, 302h, and 302i, respectively. The yields of the reactions 
were all good with the exception of piperidinone 302i. The poor yield of 302i is due to 
the decomposition of the aliphatic imine of imino ester 300i and the corresponding imino 
enol ether 301i into enamine-derived side products. 
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Table 8.6 Yields of piperidinones 302 from esters 300 via conditions from scheme 8.20 
imino ester  R
1  R
2  R
3  piperidinone  yield 
300c  Ph  2,4-(MeO)2C6H3  H  302c  51%
a 
300f  Me  2,4-(MeO)2C6H3  H  302f  58%
b 
300g  Me  3-Br C6H4  H  302g  48% 
300h  Ph 
tBu  H  302h  58% 
300i  Ph  Et  H  302i  35%
b 
300m  Me  Ph  Me  302m  no product 
a) During the methylenation, the temperature is held at 65 
oC for only 3.5 min. 
b) During the methylenation the temperature is held at 65 
oC for only 2.5 min. 
 
  Even though more challenging examples were producing piperidinones in good 
yield, the acetophenone-derived imino ester 300m still failed to undergo reaction to give 
the desired trisubstituted piperidinone, despite the improved conditions. 
A range of different acids were screened in different solvents in an effort to find 
better conditions for the cyclization of enol ether 301m, Scheme 8.21, Table 8.7. While 
most cyclization conditions gave incomplete conversion and a mixture of the syn and anti 
piperidinones, triisobutylaluminium in DMSO effected the cyclization in good yield and 
good diastereoselectivity. The use of a Lewis acid in such a polar Lewis basic solvent is 
unorthodox.  However,  the  more  Lewis  basic  imine  out-competes  the  solvent  for  the 
attention of the Lewis acid. These unconventional conditions allowed one of the most 
challenging  examples  to  successfully  undergo  cyclization  to  give  the  tri-substituted 
piperidinone in the highest yield we had yet seen, and with good 2,6-syn selectivity. The 
slightly elevated reaction temperature was used to ensure that the polar solvent did not 
freeze in the cold Scottish climate.  
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Scheme 8.21  
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Table 8.7 Transformation of imino ester 300m to piperidinone 302m 
solvent  acid (2 equiv.)  temperature   syn/anti  yield 
DME  tosic acid  20 
oC  N/A  no product 
DMSO  tosic acid  28 
oC  74/26  N/A 
DMSO  (Me)2AlCl  28 
oC  63/37  N/A 
DCM  Al(iBu)3  -10 
oC  38/62  N/A 
DMSO  Al(iBu)3  28 
oC  89/11  69% 
N/A – Not determined due to incomplete conversion 
 
Interestingly, the use of triisobutylaluminium in DCM gave an excess of the 2,6-
anti  diastereomer.  Although  this  result  was  very  intriguing,  the  result  was  not 
investigated due to lack of time. 
   The new cyclization conditions proved to be superior in all cases, and a range of 
piperidinones was synthesized to demonstrate the method, Scheme 8.22, Table 8.8. A 
variety  of  imines  cyclized  well,  including  those  from  diversely-decorated  aromatic 
aldehyes 300a, 300b, 300c, and 300j, an α,β-unsaturated aldehyde 300e, an alkyl aryl 
ketone 300m, and a dialkyl ketone 300n, giving the spirocycle 302n.  
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Scheme 8.22 
 
Table 8.8 Yields of piperidinones 302 from esters 300 via conditions from scheme 8.22 
imino ester  R1  R2  R3  piperidinone  yield 
300a  Me  Ph  H  302a  68% 
300b  Ph  Ph  H  302b  70% 
300c  Ph  2,4-(MeO)2C6H3  H  302c  66%
a 
300e  Me  (E)-4-MeOC6H4CH=CH  H  302e  51%
b 
300j  Me  2-F C6H4  H  302j  64% 
300m  Me  Ph  Me  302m  66% 
300n  Ph                     –(CH2)5–    302n  52% 
a) During the methylenation the temperature is held at 65 
oC for only 3.5 min.  
b) During the methylenation the temperature is held at 65 
oC for only 3 min. 
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Imino  esters  300k,  and  300l,  derived  from  aldehydes  with  highly  electron-
withdrawing 2-nitrophenyl, and 3-pyridinyl substituents, failed to undergo transformation 
to the corresponding piperidinones. The cyclization was not the problem in these cases. 
Despite extensive exploration of the methylenation reaction, only complex mixtures of 
products, presumably due to attack on the imine, were ever obtained, Scheme 8.23.  
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Scheme 8.23 
 
  Imino ester 311 could be methylenated, but cyclization of the resulting enol ether 
323 failed, Scheme 8.24. Unfortunately, due to time constraints, cyclization was only 
tried using p-TsOH in DCM. It is possible that the cyclization would have proceeded had 
we used triisobutylaluminium in DMSO.  
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 8.4 Assignment of Relative Stereochemistry 
 
  The relative stereochemistry of the piperidinones was assigned via the Nuclear 
Overhauser Effect (NOE). For piperidines 302a, and 302c - j, irradiation of the protons at  
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either C-2 or C-6 of the piperidinones produced a signal at the other position, Figure 8.4. 
The NOE correlation between the protons at C-2 and C-6 are summarized in Table 8.9 
and show that all the piperidinones have the 2,6-syn relative stereochemistry. 
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Table 8.9 NOE correlations for piperidinones 302 as shown in Figure 8.4 
piperidinone  R
1  R
2 
irradiated 
proton 
NOE 
H
a 
NOE 
H
b 
302a  Ph  Me  H
a (3.96 ppm)     0.93% 
         H
b (3.12 ppm)  0.79%    
302c  2,4-MeOC6H3  Ph  H
a (4.41 ppm)     2.07% 
         H
b (4.10 ppm)  2.34%    
302d  Ph  PhCH2  H
a (3.78 ppm)     1.56% 
         H
b (3.15 ppm)  1.45%    
302e  (E)-4-  Me  H
a (3.59 ppm)     1.57% 
   MeOC6H4CH=CH     H
b (3.07 ppm)  1.70%    
302f  2,4-MeOC6H3  Me  H
a (4.22 ppm)     1.80% 
         H
b (3.11 ppm)  1.79%    
302g  3-Br C6H4  Me  H
a (3.92 ppm)     1.15% 
         H
b (3.10 ppm)  1.11%    
302h 
tBu  Ph  H
a (2.69 ppm)     1.38% 
         H
b (3.89 ppm)  1.32%    
302i  Et  Ph  H
a (2.90 ppm)     1.17% 
         H
b (3.93 ppm)  1.03%    
302j  2-F C6H4  Me  H
a (4.31 ppm)     1.01% 
         H
b (3.15 ppm)  0.95%    
   
This strategy was not viable for the symmetrical 2,6-diphenylpiperidinone 302b 
as the protons at C-2 and C-6 are equivalent. However, our data for piperidinone 302b 
matches literature data for 2,6-syn diphenylpiperidin-4-one.
126 The assignment of the 2,6-
syn relative  stereochemistry  to piperidinone 302b  is further  supported by the 2,6-syn 
relative stereochemistry of 2,6-diarylpiperidinone 302c. Piperidinones 302b, and 302c are 
similar  and one would  expect both  to be  formed  in a similar  manner with  the  same 
relative stereochemistry.  
Trisubstituted  piperidinone  302m  displayed  an  NOE  correlation  between  the 
proton at C-6 and the protons of the methyl group at C-2, Figure 8.5.    
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8.5 γ-Amino Acids to Pyrrolidines 
 
During the investigation of the aqueous acid-induced cyclization, imino ester 327 
was synthesized from γ-aminobutyric acid 325, Scheme 8.25. We hoped that the imino 
enol ether 328 produced by microwave-assisted Petasis methylenation of imino ester 327 
would  cyclize  under  aqueous  acidic  conditions  to  give  an  azepine  330.  However, 
treatment of the imino ester 327 with dimethyltitanocene followed by aqueous acid gave 
the  2,3-anti  pyrrolidine  as  the  HCl  salt  329  as  a  single  diastereomer.  The  anti 
stereochemistry was assigned via consideration of the mechanism. However the coupling 
constant of 7.5 Hz observed in the 
1H NMR spectrum between protons at the C-2 and C-3 
positions is slightly lower than seen in a related compound where the analogous coupling 
constant is 9.8 Hz.
127 Thus the assignment of stereochemistry is very tentative. 
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Scheme 8.25 
  We hypothesize that protonation of the imine 328 gives the iminium ion 331, 
containing a terminal enol ether, Scheme 8.26. The 7-(enolendo)-endo-trig cyclization 
required to form the azepine 334 is slow, and so tautomerization of the iminium ion 331 
via oxonium ion 332 to form iminium ion 333 competes. The latter then undergoes the 
comparatively  easy  5-(enolexo)-endo-trig  cyclization  to  give  pyrrolidine  335,  which 
hydrolyzes to produce the corresponding ketone 329. 
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Unfortunately,  very  little  investigation  into  this  interesting  cyclization  was 
undertaken  due  to  time  constraints.  More  in  depth  examination  of  the  reaction  is 
necessary to determine whether the transformation is useful. 
 
8.6 Conclusions  
 
  Inspired by the Petasis-Ferrier rearrangement, we have developed and thoroughly 
demonstrated a highly diastereoselective route to 2,6-substituted piperidin-4-ones. The 
key  transformations  are  microwave-assisted  Petasis  methylenation  and  Lewis-acid-
induced  cyclization.  The  mild  conditions  and  selectivity  of  the  microwave-assisted 
methylenation  are  unprecedented.  Using  the  same  low  temperatures  as  conventional  
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methods, we were able to obtain full conversion of esters to enol ethers in 10 min or less. 
The selectivity of the reagent for carbonyl groups in the presence of imines allows access 
to imino enol ethers containing both electrophilic and nucleophilic functionality in the 
same molecule. The conditions of the Lewis-acid-induced cyclization are the result of 
extensive optimization and the consideration of many different examples. A variety of 
imino esters derived from condensation with diverse aldehydes or ketones with β-amino 
acids should allow preparation of diverse piperidinones as single diastereomers. Since 
there are good methods for the asymmetric synthesis of β-amino acids,
128 the route should 
also allow the asymmetric synthesis of 2,6-substituted piperidinones.  
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Figure 8.6 Yields of piperidines 302 and the conditions used to obtain these yields  
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EXPERIMENTAL 
 
Where general procedures are given for transformations, the exact quantities used in each 
preparation are listed  under the compound name,  together  with  reaction  times  where 
these vary. Unless otherwise stated, all reactions were carried out using oven dried or 
flamedried glassware. Solutions were added via syringe unless otherwise stated. Diethyl 
ether,  tetrahydrofuran,  dichloromethane,  and  toluene  were  dried  using  a  Puresolv
© 
solvent  drying  system  prior  to  use.  DME  was  freshly  distilled  from  sodium 
benzophenone; DMSO was dried over 4Å molecular sieves for 24 h, and then distilled 
from CaH2 under reduced pressure. Petroleum ether refers to the fraction boiling at 40-60 
°C.  With  the  exception  of  Cp2TiMe2,  produced  via  the  method  of  Payack  et  al.
69 
Reagents were obtained from commercial suppliers and used without further purification 
unless otherwise stated. Purification by column chromatography was carried out using 
silica gel, mesh size 35-70 µm as the stationary phase. All distillations were carried out 
bulb to bulb in a Kugelrohr Apparatus. 
1H and 
13C NMR spectra were obtained on a 
Bruker DPX/400 spectrometer operating at 400 and 100 MHz respectively. All NMR J 
values are given in Hz and are uncorrected. 
1H NMR signals of piperidinones 302 were 
assigned  using  COSY  spectra.  CH3,  CH2, CH,  and C  in  the 
13C  NMR spectra were 
assigned using DEPT. Mass spectra (MS) were recorded on a Jeol JMS700 (MStation) 
spectrometer.  Infra-red  (IR)  spectra  were  obtained  on  a  Perkin-Elmer  983 
spectrophotometer. A Golden Gate
TM attachment that uses a type IIa diamond as a single 
reflection element was used so that the IR spectrum of each compound (solid or liquid) 
could  be  directly  detected  without  any  sample  preparation.Melting  points  were 
determined on a Gallenkamp melting point apparatus. 
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General Esterification procedure 
 
Thionyl chloride (2 equiv.) was added dropwise to a stirred solution of the appropriate 
amino-acid (1 equiv., 0.6 M) in MeOH at –10 
oC under Ar. The solution was heated 
under reflux for 3h. After cooling to RT, all volatile compounds were removed in vacuo 
to give the crude ester. Washing the crude product with hot hexane (3) gave the pure 
amino-ester as the hydrochloride salt. 
 
Imine formation procedure A 
Triethylamine  (2  equiv.),  and  the  desired  aldehyde  (0.8-1.2  equiv.)  were  added  to  a 
stirred suspension of an amino-ester (1 equiv., 0.3 M), and sodium sulfate (1.2 equiv.) in 
dry DCM under Ar at RT. After stirring for 3 h, the mixture was washed with water (2), 
then satd. NaCl (1), dried over Na2SO4, filtered and concentrated in vacuo. Distillation 
yielded the pure imino ester. 
 
Imine formation procedure C  
A solution of triethylamine (2 equiv.), the desired ketone (1.2-1.5 equiv.), and the amino 
ester (1 equiv., 0.3 M) in dry toluene was heated at reflux under Ar with continuous 
removal of water by means of a Dean-Stark trap for the stated reaction time (see below). 
The reaction mixture was cooled to RT, washed with water (2), and satd. NaCl (1). 
The organic layer was dried over Na2SO4, filtered and concentrated in vacuo to yield the 
crude imine. Distillation gave the pure imino ester. 
 
Synthesis of Piperidinones  302 
Although the various piperidinones were made a number of times under a variety of 
conditions, only one procedure is given for each piperidinone prepared, and in each case 
this  is  the  procedure  that  gave  the  best  yield during  the  studies  described. The  best 
combination  is  methylenation  procedure  B  and  cyclization  procedure  D,  but  this 
combined procedure was never used for the preparation of piperidinones 302d, 302f, 
302g, 302h and 302i.  
 
Methylenation procedure A 
A 0.96 M solution of Cp2TiMe2 (1.8-2.1 equiv.) in toluene-THF (1:1 by mass) was added 
to an imino ester (1 equiv.), and sealed in a 10 mL microwave tube under argon. This was 
irradiated  under  100  W  maximum  microwave  power  using  a  CEM  DISCOVERY  
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microwave  system  to  raise  the  internal  temperature  to  80 
oC  (ca.  9  min),  and  the 
temperature maintained with microwave irradiation a further 10 min, before cooling. The 
resultant black solution was concentrated in vacuo and hexane added to precipitate most 
titanium-containing impurities. The hexane extract was filtered and concentrated in vacuo 
to yield the crude enol ether.  
 
Methylenation procedure B 
A 1.30 M solution of Cp2TiMe2 (1.8-2.1 equiv.) in toluene-THF (1:1 by mass) was added 
to an imino ester (1 equiv.), and sealed in a 10 mL microwave tube under argon. This was 
irradiated  under  100  W  maximum  microwave  power  using  a  CEM  DISCOVERY 
microwave  system  to  raise  the  internal  temperature  to  65 
oC  (ca.  7  min),  and  the 
temperature maintained with microwave irradiation a further 2.5-10 min (the exact times 
and maximum internal pressures observed are included for individual transformations 
below),  before  cooling.  The  resultant  black  solution  was  concentrated  in  vacuo  and 
hexane added to precipitate most titanium-containing impurities. The hexane extract was 
filtered and concentrated in vacuo to yield the crude enol ether. 
 
Cyclization procedure A (aqueous acid) 
Using non-dried glassware, 7M HCl(aq) (25 equiv.) was added to the crude enol ether 301 
and the resulting mixture was stirred for 0.5 h. The solution was washed with DCM 5X, 
and the aqueous layer was concentrated in vacuo to give the piperidinone 315 as the 
hydrochloride salt. 
 
Cyclization procedure B (p-tosic acid in DCM) 
p-Toluene sulfonic acid (2 equiv.) was added to a stirred suspension of 4Å molecular 
sieves (0.3 g), and the crude enol ether 301 (1 equiv., 0.07M) in dry DCM under Ar. The 
solution was heated at 40 
oC for 17 h, cooled to RT and quenched with 1M HCl(aq) (2ml). 
The reaction mixture stirred for a further 0.5 h, basified with NaOH(aq), and the solution 
was extracted with DCM. The organic extract was washed with satd. NaCl (1), dried 
over Na2SO4, and concentrated in vacuo to give the crude piperidinone 302, which was 
purified by column chromatography. 
 
Cyclization procedure C (p-tosic acid in DME) 
p-Toluene sulfonic acid (2 equiv.) was added to a stirred solution of crude enol ether 301 
(1 equiv., 0.1 M) in dry DME, under Ar. The solution was stirred at RT for 17 h, and  
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concentrated in vacuo. The resultant residue was stirred in 1M HCl(aq) (10 equiv.) for 1 h. 
The solution was basified with NaOH(aq), and extracted with DCM (4). The organic 
extract was washed with satd. NaCl (1), dried over Na2SO4, and concentrated in vacuo 
to give the crude piperidinone 302, which was purified by column chromatography. 
 
Cyclization procedure D (triisobutylaluminium in DMSO) 
Triisobutylaluminium (1.0 M in Hexanes, 2 equiv.) was added to the crude enol ether 301 
(1 equiv., 0.03 M) in dry DMSO, under Ar. The solution stirred at 28 
oC for 17h, and was 
quenched  with  careful addition  of  1M HCl(aq)  (35  equiv.).  The  reaction  mixture was 
stirred a further 45 min, basified with NaOH(aq), and extracted with EtOAc. The organic 
extract was washed with NH4Cl(aq), dried over Na2SO4, and concentrated in vacuo to give 
the crude piperidinone 302, which was purified by column chromatography.  
 
(4S) 4-Methyl-5-oxo-2-phenyloxazolidine-3-tert-butylcarbonate  290 
 
N
O
O
O
O
 
 
1M NaOH (11.2 mL, 11.2 mmol, 1 equiv.) was added to L-alanine (1.000 g, 11.2 mmol, 
1 equiv.). After the amino acid had fully dissolved, water was removed in vacuo via a 
Kugelrohr  apparatus  to  leave  the  sodium  salt.  4  Å  molecular  sieves  (1.0  g),  and 
benzaldehyde (1.7 mL, 16.8 mmol, 1.5 equiv.) were added to a solution of the sodium 
salt in DCM (11.0 mL). The solution was then heated under Ar at reflux for 5 h. The 
solvent was removed in vacuo to leave the Schiff base. Chloroform (17 mL), followed by 
di-tert-butyldicarbonate  (4.409  g,  20.2  mmol,  1.8  equiv.)  were  added  to  the  flask 
containing the Schiff base, and the reaction was stirred under Ar at 55 
oC for 15 h. The 
turbid solution was washed with water (1), NaHCO3 (1), NaHSO3 (1), dried over 
MgSO4, filtered and concentrated in vacuo to give crude oxazolidinone as a yellow oily 
solid.  Recrystalyzation  from  Et2O,  in  hexane  gave  pure  (4S)  4-methyl-5-oxo-2-
phenyloxazolidine-3-tert-butylcarbonate 290 as a solid (0.653 g, 21%). IR (thin film): 
1778, 1685, 1399, 1365 cm
-1. H (d6 DMSO, 400 MHz, 80 
oC) 1.20 (9H, s, CH3C), 1.57 
(3H, d, J= 6.7, CH3CH), 4.65 (1H, q, J= 6.7, CHCH3), 6.51 (1H, s, CHC), 7.44 (5H, s, H 
arom.) C (d6 DMSO, 100 MHz, 80 
oC) 16.29 (CH3), 27.68 (CH3), 51.32 (C), 80.70  
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(CH), 88.98 (CH), 126.76 (CH), 128.44 (CH), 129.57 (CH), 137.80 (C), 150.69 (C), 
172.34 (C). HRMS: 277.1309 C15H19O4N, requires (M
+) 277.1314. 
 
(4S) 4-Methyl-5-methylene-2-phenyloxazolidine-3-tert-butylcarbonate  291 
 
N
O
O
O
 
 
A 1.30 M solution of Cp2TiMe2 (0.50 mL, 0.65 mmols, 1.5 equiv.) in toluene-THF (1:1 
by mass) was added to (4S) 4-methyl-5-oxo-2-phenyloxazolidine-3-tert-butylcarbonate 
290 (0.1204 g, 0.43 mmol, 1 equiv.), and sealed in a 10 mL microwave tube under argon. 
This  was  irradiated  under  100  W  maximum  microwave  power  using  a  CEM 
DISCOVERY synthesizer to raise the internal temperature to 65 
oC (ca. 7 min), and the 
temperature maintained with microwave irradiation a further 10 min, before cooling. The 
resultant black solution was concentrated in vacuo and hexane added to precipitate most 
titanium-containing impurities. The hexane extract was filtered and concentrated in vacuo 
to  yield  the  crude  enol  ether.  Column  chromatography  (SiO2,  Hexane-EtOAc-  NEt3 
96:6:1) gave (4S) 4-methyl-5-methylene-2-phenyloxazolidine-3-tert-butylcarbonate 291 
as an oil (77.6 mg, 65%). Rf (SiO2, Hexane-EtOAc-NEt3 93:6:1): 0.65. IR (thin film): 
1705, 1683, 1458 cm
-1. H (d6 DMSO, 400 MHz, 80 
oC) 1.17 (9H, s, CH3C), 1.47 (3H, d, 
J=  6.1,  CH3CH),  4.05  (1H,  dd,  J=  1.2,  2.2,  CH
AH
B=C),  4.24  (1H,  dd,  J=  1.5,  2.2, 
CH
AH
B=C), 4.67 (1H, tq, J= 1.3, 6.0, CHCH3), 6.18 (1H, s, CHC), 7.27-7.34  (2H, m, H 
arom.),  7.34-7.39 (3H, m, H arom.) C (d6 DMSO, 100 MHz, 80 
oC) 20.23 (CH3), 27.74 
(CH3), 53.83 (C), 79.91 (C), 80.52 (CH2), 90.64 (CH), 126.41 (CH), 128.15 (CH), 128.83 
(CH), 139.74 (C), 150.96 (C), 161.89 (C). m/z (EI): 275 (M
+, 15%), 219 (40), 202 (20), 
132 (75), 104 (90), 84 (100). HRMS: 275.1523 C16H21O3N, requires (M
+) 275.1521. 
  
Methyl (2S) 2-aminopropionoate hydrochloride salt  297 
 
H3N
OMe
Cl
Me
O  
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Using: thionyl chloride (1.63 ml, 22.5 mmol, 2 equiv.), L-alanine (1.000 g, 11.2 mmol, 1 
equiv.), in MeOH (20.0 mL), and following the general esterification procedure gave (2S) 
methyl 2-aminopropionoate hydrochloride salt 297 as a solid (1.404 g, 90%). IR (thin 
film): 1740 (C=O) cm
-1. H (CDCl3, 400 MHz) 1.72 (3H, d, J= 7.2, CH3CH), 3.80 (3H, s, 
OCH3), 4.23-4.33 (1H, m, CH) 8.68 (3H, broad s, NH3). m/z (CI): 104 (M
+, 100%). 
HRMS:  104.0713  C4H12O2N  requires  (M
+),  104.0712.  data  in  agreement  with  the 
literature.
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Methyl (2S, E) 2-(benzylidenamino)propionoate  298 
 
N
OMe
Me
O
 
 
Following general imine formation procedure A, triethylamine (1.00 ml, 7.2 mmol, 2 
equiv.), benzaldehyde (0.37 ml, 3.6 mmol, 1 equiv.), (2S) methyl 2-aminopropionoate 
hydrochloride salt 297 (0.500 g, 3.6 mmol, 1 equiv.), and Na2SO4 (0.305 g, 2.2 mmol, 0.6 
equiv.), in DCM (10 ml) gave (2S, E) methyl 2-(benzylideneamino)-propionoate 298 as 
an oil with no distillation necessary (542 mg, 79%). H (CDCl3, 400 MHz) 1.53 (3H, d, 
J= 6.8, CH3CH), 3.75 (3H, s, OCH3),  4.16 (1H, q, J= 6.8, CH),  7.38-7.47  (3H, m, H 
arom.),  7.75-7.80 (2H, m, H arom.),  8.32 (1H, s, N=CH). C (CDCl3, 100 MHz) 19.42 
(CH3), 52.16 (CH3) , 67.97 (CH), 128.45 (CH), 128.54 (CH), 131.07 (CH), 135.65 (C), 
162.93 (CH), 172.95 (C). Data in agreement with the literature.
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(3S, E) 2-Methoxy-3-(benzylidenamino)but-1-ene  299 
 
O
Me N
Me
 
 
Following methylenation procedure B, using a 1.30 M solution of Cp2TiMe2 (0.89 mL, 
1.16  mmol,  1.8  equiv.)  in  toluene-THF  (1:1  by  mass)  with  (2S,  E)  methyl  2-
(benzylideneamino)-propionoate  298  (123  mg,  0.64  mmol,  1  equiv.)  and  a  10  min 
reaction time at 65 °C (maximum pressure of 35 psi) gave crude enol ether. Distillation  
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gave pure (3S, E) 2-methoxy-3-(benzylideneamino)but-1-ene 299 (95 mg, 78%). Bp 140 
oC at 0.4 mm Hg. IR (thin film): 1644 (C=N), 1450, 1238 cm
-1. H (CDCl3, 400 MHz) 
1.43 (3H, d, J= 6.8, CH3CH), 3.59 (3H, s, OCH3),  3.94 (1H, q, J= 6.8, CHN), 3.93 (1H, 
d, J= 2.0, C=CH
AH
B), 4.12 (1H, d, J= 2.0, C=CH
AH
B), 7.28-7.37  (3H, m, H arom.),  
7.67-7.72 (2H, m, H arom.),  8.22 (1H, s, N=CH). C (CDCl3, 100 MHz) 20.68 (CH3), 
54.86 (CH3) , 68.08 (CH), 80.67 (CH2), 128.32 (CH), 128.47 (CH), 130.60 (CH), 136.28 
(C),  160.63  (CH),  165.16  (C).  m/z  (CI):  190  [(M+H)
+,  100%].  HRMS:  190.1230 
C12H16ON, requires (M+H
+) 190.1232. 
 
 
Methyl (3RS, E) 3-(benzylideneamino)butanoate  300a 
 
N OMe
O
 
 
Following general imine formation procedure A, triethylamine (0.45 ml, 3.3 mmol, 2 
equiv.), benzaldehyde (0.13 ml, 1.3 mmol, 0.8 equiv.), (3RS) methyl 3-aminobutanoate 
hydrochloride salt 306 (250 mg, 1.63 mmol, 1 equiv.), and Na2SO4 (281 mg, 1.96 mmol, 
1.2 equiv.), in DCM (4.5 ml) gave (3RS, E) methyl-3-(benzylidenamino)butanoate 300a 
as an oil with no distillation necessary (200 mg, 75%). IR (thin film): 1736 (C=O), 1644 
(C=N) cm
-1. H (CDCl3, 400 MHz) 1.30 (3H, d, J= 6.4, CH3CH),  2.60 (1H, dd, J= 5.3, 
15.5, CH
AH
B),  2.69 (1H, dd, J= 8.1, 15.5, CH
AH
B),  3.62 (3H, s, OCH3),  3.80-3.90 (1H, 
m, CHN),  7.38-7.44  (3H, m, H arom.),  7.69-7.74 (2H, m, H arom.),  8.34 (1H, s, 
N=CH). C (CDCl3, 100 MHz) 22.30 (CH3), 42.26 (CH2), 51.43 (CH3) , 62.68 (CH), 
128.19 (CH), 128.51 (CH), 130.61 (CH), 136.14 (C), 160.38 (CH), 172.20 (C). m/z (EI): 
205  (M
+,  15%),  132  (30),  82  (100).  HRMS:  205.1101.  C12H15O2N,  requires  (M
+) 
205.1103. 
 
 
 
 
 
  
138
Methyl (3RS, E) 3-(benzylidenamino)-3-phenylpropionate   300b 
 
 
N OMe
O
 
 
Following imine formation procedure A, triethylamine (0.33 ml, 2.3 mmol, 2 equiv.), 
benzaldehyde (0.13 ml, 1.3 mmol, 1.1 equiv.), (3RS) methyl 3-amino-3-phenylpropionate 
hydrochloride salt 307 (250 mg, 1.16 mmol, 1 equiv.), and Na2SO4 (199 mg, 1.40 mmol, 
1.2  equiv.),  in  DCM  (5.0  ml)  gave  (3RS,  E)  methyl  3-(benzylidenamino)-3-
phenylpropionate 300b as an oil (272 mg, 89%). Bp 200 
oC at 0.6 mm Hg. IR (thin film): 
1736  (C=O),  1644  (C=N)  cm
-1.  H  (CDCl3,  400  MHz)  2.90  (1H,  dd,  J=  4.4,  15.6, 
CH
AH
B),  3.05 (1H, dd, J= 9.2, 15.6, CH
AH
B),  3.61 (3H, s, OCH3),  4.86 (1H, dd, J= 9.2, 
4.4, CHN),  7.21-7.44  (8H, m, H arom.),  7.73-7.79 (2H, m, H arom.),  8.44 (1H, s, 
N=CH). C (CDCl3, 100 MHz) 43.09 (CH2), 51.56 (CH3), 70.85 (CH), 126.89 (CH), 
127.36 (CH), 128.39 (CH), 128.47 (CH), 128.59 (CH), 130.76 (CH), 136.10 (C), 142.74 
(CH), 161.48 (CH), 171.73 (C). m/z (EI): 267 (M
+, 80%), 208 (30%), 194 (100%), 121 
(95), 104 (70). HRMS: 267.1262. C17H17O2N, requires (M
+) 267.1259. 
 
 
Methyl (3RS, E) 3-(2’,4’-dimethoxybenzylidenamino)-3-phenylpropionate   300c 
 
 
N OMe
O
MeO OMe  
 
Following imine formation procedure A, triethylamine (0.91 ml, 6.5 mmol, 2 equiv.), 
(3RS) methyl 3-amino-3-phenylpropionate hydrochloride salt 307 (700 mg, 3.24 mmol, 1 
equiv.), 2,4-dimethoxybenzaldehyde (538 mg, 3.24 mmol, 1 equiv.), and Na2SO4 (0.55 g, 
3.9  mmol,  1.2  equiv.),  in  DCM  (10.0  ml),  gave  (3RS,  E)  methyl  3-(2’,4’- 
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dimethoxybenzylidenamino)-3-phenylpropionate 300c as a pale yellow solid (1.000 g, 
94%). Bp 215 
oC at 0.8 mm Hg. Mp 78-79 
oC. IR (thin film): 1730 (C=O), 1600 (C=N) 
cm
-1. H (CDCl3, 400 MHz) 2.90 (1H, dd, J= 5.1, 15.2, CH
AH
B),  3.00 (1H, dd, J= 9.0, 
15.3, CH
AH
B),  3.61 (3H, s, OCH3),  3.82 (3H, s, OCH3),  3.83 (3H, s, OCH3),  4.82 (1H, 
dd, J= 5.1, 8.9, CHN),  6.40 (1H, d, J= 2.2, H3’),  6.50 (1H, dd, J= 2.2, 8.6, H5’),  7.21-
7.28 (1H, m, H arom.),  7.29-7.36 (2H, m, H arom.),  7.42-7.46 (2H, m, H arom.),  7.96 
(1H, d, J= 8.6, H6’),  8.71 (1H, s, N=CH). C (CDCl3, 100 MHz) 43.41 (CH2), 51.46 
(CH3), 55.37 (CH3), 55.42 (CH3), 71.18 (CH), 97.85 (CH), 105.31 (CH), 117.94 (C), 
126.88 (CH), 127.11 (CH), 128.46 (CH),  128.79 (CH), 143.30 (C), 156.85 (CH), 160.20 
(C), 163.11 (C), 171.76 (C). m/z (EI): 327 (M
+, 20%), 254 (100), 164 (90), 149 (60), 121 
(65). HRMS: 327.1473 C19H21O4N, requires (M
+) 327.1471. 
 
Methyl (3RS, E) 3-(benzylidenamino)-4-phenylbutanoate  300d 
 
N OMe
O
 
 
Following imine formation procedure A, triethylamine (0.31 mL, 2.2 mmol, 2 equiv.), 
benzaldehyde (0.12 mL, 1.2 mmol, 1.1 equiv.), (3RS) methyl 3-amino-4-phenylbutanoate 
hydrochloride salt 308 (249 mg, 1.09 mmol, 1 equiv.), and Na2SO4 (186 mg, 1.31 mmol, 
1.2  equiv.),  in  DCM  (4.0  mL),  gave  (3RS,  E)  methyl  3-(benzylidenamino)-4-
phenylbutanoate 300d as a colorless oil with no distillation necessary (253 mg, 83%). IR 
(thin film): 1736 (C=O), 1602 (C=N) cm
-1. H (CDCl3, 400 MHz): 2.69 (1H, dd, J= 4.4, 
15.6, CH
AH
BCO), 2.76 (1H, dd, J= 8.4, 15.6, CH
AH
BCO), 2.93 (1H, dd, J= 7.6, 13.2, 
PhCH
CH
D), 2.98 (1H, dd, J= 6.0, 13.2, PhCH
CH
D), 3.61 (3H, s, OCH3), 3.86-3.94 (1H, 
m, CHN), 7.15-7.21 (3H, m, H arom.), 7.21-7.28 (2H, m, H arom.), 7.37-7.48 (3H, m, H 
arom.), 7.63-7.71 (2H, m, H arom.), 8.04 (1H, s, N=CH). C (CDCl3, 100 MHz): 40.23 
(CH2), 42.54 (CH2), 51.47 (CH3), 68.94 (CH), 126.30 (CH), 128.15 (CH), 128.23 (CH), 
128.45 (CH), 129.74 (CH), 130.58 (CH), 135.98 (C), 138.27 (C), 161.50 (CH), 172.18 
(C). m/z (EI): 281 (M
+, 10%), 250 (20), 190 (100), 158 (50), 130 (90), 117 (30), 91 (60), 
77 (20). HRMS: 281.1414 C18H19O2N requires (M
+), 281.1416.   
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Methyl (3RS, 1’E, 2’E) 3-[3’-(4”-methoxyphenyl)prop-2’-enylidenamino]butanoate 
300e 
 
N OMe
O
MeO  
 
Following imine formation procedure A, triethylamine (0.91 ml, 6.5 mmol, 2 equiv.), 
(3RS) methyl 3-amino-butanoate hydrochloride salt 306 (498 mg, 3.26 mmol, 1 equiv.), 
4-methoxycinnamaldehyde (423 mg, 2.60 mmol, 0.8 equiv.), and Na2SO4 (0.56 g, 4.00 
mmol), in DCM (10.0 ml), gave (3RS, 1’E, 2’E) methyl 3-[3’-(4”-methoxyphenyl)prop-
2-enylidenamino]butanoate 300e as a pale yellow oil (592 mg, 87%). Bp 190 
oC at 0.45 
mm Hg. IR (thin film): 1736 (C=O), 1635 (C=N) cm
-1. H (CDCl3, 400 MHz) 1.25 (3H, 
d, J= 6.4, CH3CH),  2.53 (1H, dd, J= 5.2, 15.5, CH
AH
B),  2.62 (1H, dd, J= 8.2, 15.5, 
CH
AH
B),  3.63 (3H, s, OCH3),  3.64-3.76 (1H, m, CHN),  3.81 (3H, s, OCH3),  6.73 (1H, 
dd, J= 8.8, 15.9, H2’),  6.85-6.91 (2H, m, H arom.),  6.90 (1H, d, J= 16, H3’),  7.40 (2H, 
d, J= 8.9, H arom.),  8.04 (1H, d, J =8.8, H1’). C (CDCl3, 100 MHz) 22.37 (CH3), 42.28 
(CH2), 51.41 (CH3) , 55.26 (CH3), 62.30 (CH), 114.20 (CH), 125.81 (CH), 128.43 (C), 
138.64  (CH),  141.73  (CH),  160.42  (C),  162.31  (CH),  172.14  (C).  m/z  (FAB):  262 
[(M+H)
+, 100%]. HRMS: 262.1446 C15H19O3N, requires (M+H)
+ 262.1443. 
 
 
Methyl (3RS, E) 3-(2’,4’-dimethoxybenzylidinamino)butanoate   300f 
 
N OMe
O
OMe MeO  
 
Following imine formation procedure A, triethylamine (0.51 mL, 3.7 mmol, 2 equiv.), 
(3RS) methyl 3-aminobutanoate hydrochloride salt 306 (278 mg, 1.81 mmol, 1 equiv.), 
2,4-dimethoxybenzaldehyde (309 mg, 1.86 mmol, 1 equiv.), and Na2SO4 (309 mg, 2.18 
mmol,  1.2  equiv.),  in  DCM  (6.0  ml),  gave  (3RS,  E)  methyl  3-(2’,4’- 
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dimethoxybenzylidinamino)butanoate 300f as an oil (291 mg, 61%). Bp 175 
oC at 0.2 
mm Hg. IR (thin film): 1737 (C=O), 1607 (C=N) cm
-1. H (CDCl3, 400 MHz): 1.28 (3H, 
d, J= 6.4, CH3CH), 2.56 (1H, dd, J= 5.8, 15.1, CH
AH
B), 2.64 (1H, dd, J= 7.8, 15.1, 
CH
AH
B), 3.63 (3H, s, OCH3), 3.78-3.86 (1H, m, CHN), 3.82 (3H, s, OCH3), 3.83 (3H, s, 
OCH3), 6.42 (1H, d, J= 2.3, H3’), 6.49 (1H, dd, J= 2.3, 8.6, H5’), 7.86 (1H, d, J= 8.6, 
H6’), 8.64 (1H, s,  CH=N).  C  (CDCl3, 100  MHz): 22.47  (CH3),  42.66  (CH2), 51.38 
(CH3), 55.41 (CH3), 55.46 (CH3), 62.86 (CH), 97.97 (CH), 105.27 (CH), 117.99 (C), 
128.59 (CH), 155.77 (CH), 160.06 (C), 162.99 (C), 172.35 (C). m/z (EI): 265 (M
+, 15%), 
234 (20), 192 (70), 164 (100), 149 (75), 121 (15). HRMS: 265.1313 C14H19O4N requires 
(M
+), 265.1314.   
 
Methyl (3RS, E) 3-(3’-bromobenzylidenamino)butanoate  300g 
 
N OMe
O
Br  
 
Following imine formation procedure A triethylamine (0.31 mL, 2.2 mmol, 2 equiv.), 3-
bromobenzaldehyde  (0.13  ml,  1.1  mmol,  1  equiv.),  (3RS)  methyl  3-aminobutanoate 
hydrochloride salt 306 (170 mg, 1.11 mmol, 1 equiv.), and Na2SO4 (309 mg, 2.18 mmol, 
1.2 equiv.), DCM (6.0 ml), gave a mixture of the desired imino-ester and un-reacted 3-
bromobenzaldehyde. Removal of the aldehyde by distillation (75 
oC, 0.5 mmHg) gave 
pure (3RS, E) methyl 3-(3’-bromobenzylidenamino)butanoate 300g as an oil (184 mg, 
58%). IR (thin film): 1736 (C=O), 1644 (C=N) cm
-1. H (CDCl3, 400 MHz): 1.29 (3H, d, 
J= 6.5, CH3CH), 2.59 (1H, dd, J= 5.1, 15.6, CH
AH
B), 2.68 (1H, dd, J= 8.3, 15.6, CH
AH
B), 
3.63 (3H, s, OCH3), 3.80-3.90 (1H, m, CHN), 7.27 (1H, t, J= 7.8, H5’), 7.53 (1H, ddd, J= 
1.0, 1.9, 8.0, H4’), 7.60 (1H, broad d, J= 7.7, H6’), 7.92 (1H, t, 1.6, H2’), 8.27 (1H, s, 
N=CH). C (CDCl3, 100 MHz): 22.25 (CH3), 42.09 (CH2), 51.48 (CH3), 62.58 (CH), 
122.87 (C), 127.09 (CH), 130.03 (CH), 130.70 (CH), 133.50 (CH), 138.16 (C), 158.81 
(CH), 172.08 (C). m/z (EI): 285 (M
+, 45%), 283 (M
+, 45%), 226 (45), 224 (45), 212 (90), 
210  (100),  130  (40),  104,  (65),  102  (85),  86 (70), 84  (100).  HRMS:  285.0181,  and 
283.0207, C12H14O2N
81Br requires (M
+), 285.0188, and C12H14O2N
79Br requires (M
+), 
283.0208;  
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Methyl (3RS, E) 3-(2’,2’-dimethylpropylidenamino)-3-phenylbutanoate  300h 
 
N OMe
O
 
 
Triethylamine (0.15 mL, 1.1  mmol, 1.1  equiv.)  was  added to  a  suspension of (3RS) 
methyl  3-amino-3-phenylpropionate  hydrochloride  salt  307  (217  mg,  1.01  mmol,  1 
equiv.), and Na2SO4 (170 mg, 1.20 mmol, 1.2 equiv.) in dry DCM (5.0 mL) under Ar. 
The suspension stirred 1 h and pivaldehyde (0.20 ml, 1.8 mmol, 1.8 equiv.) was added. 
The reaction mixture stirred a futher 30 min, was filtered, and concentrated in vacuo. The 
resultant  residue  was  extracted  with  dry  Et2O  (3).  The  extracts  were  filtered  and 
concentrated  in  vacuo  to  give  (3RS,  E)  methyl  3-(2’,2’-dimethylpropylidenamino)-3-
phenylbutanoate 300h as an oil (224 mg, 90 %). IR (thin film): 1740 (C=O), 1666 (C=N) 
cm
-1. H (CDCl3, 400 MHz): 1.05 (9H, s, CH3C), 2.77 (1H, dd, J= 4.5, 15.0, CH
AH
B), 
2.86 (1H, dd, J= 9.6, 15.0, CH
AH
B), 3.63 (3H, s, OCH3), 4.57 (1H, dd, J= 4.5, 9.6, CHN), 
7.21-7.27 (1H, m, H arom.), 7.29-7.35 (2H, m, H arom.), 7.35-7.40 (2H, m, H arom.), 
7.63 (1H, s, N=CH). C (CDCl3, 100 MHz): 26.85 (CH3), 36.14 (C), 43.59 (CH2), 51.36 
(CH3), 70.57 (CH), 126.64 (CH), 127.10 (CH), 128.44 (CH), 143.14 (C), 171.68 (C=N), 
172.64 (C=O). m/z (EI): 247 (M
+, 30%), 174 (40), 121 (100), 104 (50). HRMS: 247.1575 
C15H21O2N requires (M
+), 247.1572. 
 
Methyl (3RS, E) 3-(propylidenamino)-3-phenylpropionoate  300i 
 
N OMe
O
 
 
In the  same way  as for the preparation of imine 300h, triethylamine (0.26 mL, 1.83 
mmol, 2 equiv.), (3RS) methyl 3-amino-3-phenylpropionate hydrochloride salt 307 (197 
mg, 0.91 mmol, 1 equiv.), Na2SO4 (157 mg, 1.11 mmol, 1.2 equiv.), and propionaldehyde  
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(0.073 ml, 1.01 mmol, 1.1 equiv.), in DCM (5.0 ml) gave a mixture of (3RS, E) methyl 3-
(propylidenamino)-3-phenylpropionoate  300i,  the  starting  (3RS)  methyl  3-amino-3-
phenylpropionate 307, and propionaldehyde in a 80:13:7 ratio (183 mg, 86% imine 300i 
by mass, 79% yield). H (CDCl3, 400 MHz):  1.07 (3H, t, J=7.6, CH3CH2), 2.26 (2H, dq, 
J= 4.7, 7.5, CH2CH3), 2.79 (1H, dd, J= 4.7, 15.4, CH
AH
B), 2.94 (1H, dd, J= 9.4, 15.4, 
CH
AH
B), 3.64 (3H, s, OCH3), 4.59 (1H, dd, J= 4.7, 9.4, CHN), 7.23-7.28 (1H, m, H 
arom.), 7.29-7.38 (4H, m, H arom.),  (1H, t, J= 4.8, N=CH). 
 
Methyl (3RS, E) 3-(2’-fluorobenzylidenamino)butanoate  300j 
 
N OMe
O
F  
 
Following imine formation procedure A, triethylamine (0.68 mL, 4.9 mmol, 2 equiv.), 
(3RS) methyl 3-aminobutanoate hydrochloride salt 306 (376 mg, 2.45 mmol, 1 equiv.), 2-
fluorobenzaldehyde (0.31 ml, 2.9 mmol, 1.2 equiv.), and Na2SO4 (422 mg, 2.97 mmol, 
1.2  equiv.),  in  DCM  (10.0  ml),  gave  (3RS,  E) methyl  3-(2’-fluorobenzylidenamino)-
butanoate 300j as an oil (302 mg, 55%). Bp 125 
oC at 0.5 mm Hg. IR (thin film): 1739 
(C=O), 1640 (C=N) cm
-1. H (CDCl3, 400 MHz) 1.30 (3H, d, J= 6.4, CH3CH),  2.60 (1H, 
dd, J= 5.4, 15.4, CH
AH
B),  2.68 (1H, dd, J= 8.1, 15.4, CH
AH
B),  3.64 (3H, s, OCH3),  
3.84-3.94 (1H, m. CHN), 7.06 (1H, broad dd, J= 8.7, 10.2, H3’), 7.15 (1H, broad t, J= 
7.8,  H5’), 7.35-7.41 (1H, m,  H4’), 7.95 (1H,  dt,  J= 1.8, 7.5,  H6’), 8.63 (1H,  s). C 
(CDCl3, 100 MHz) 22.27 (CH3), 42.27 (CH2), 51.49 (CH3) , 62.94 (CH), 115.70 (CH, d, 
J= 21.2), 123.79 (C, d, J= 9.6), 124.28 (CH, d, J= 3.5), 127.85 (CH, d, J= 2.7), 132.21 
(CH, d, J= 8.7), 153.79 (CH, d, J= 4.8), 162.23 (C, d, J= 251.1), 172.06 (C). m/z (EI): 
223 (M
+, 50%), 164 (50), 150 (100), 123 (50), 102 (60). HRMS: 223.1011. C12H14O2NF, 
requires (M
+) 223.1009. 
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Methyl (3RS, E) 3-(2’-nitrobenzylidenamino)-3-phenylpropionoate  300k 
 
N OMe
O
NO2  
 
Following imine formation procedure A, triethylamine (0.85 mL, 6.1 mmol, 2 equiv.), 
(3RS) methyl 3-amino-3-phenylpropionoate hydrochloride salt 307 (0.709 g, 3.3 mmol, 1 
equiv.), 2-nitrobenzaldehyde (0.450 g, 3.0 mmol, 0.9 equiv.), and Na2SO4 (0.460 g, 3.3 
mmol, 1 equiv.), in DCM (10.0 ml), gave (3RS, E) methyl 3-(2’-nitrobenzylidenamino)-
3-phenylpropionoate 300k as a yellow oil with no distillation necessary (0.852 g, 92%). 
IR (thin film): 1736 (C=O), 1636 (C=N) cm
-1. H (CDCl3, 400 MHz) 2.93 (1H, dd, J= 
4.6, 15.5, CH
AH
B),  3.08 (1H, dd, J= 9.4, 15.5, CH
AH
B),  3.68 (3H, s, OCH3),  4.97 (1H, 
dd, J= 4.6, 9.4, CHN), 7.25-7.31 (1H, m, H arom.), 7.34-7.39 (2H, m, H arom.), 7.43-
7.47 (2H, m, H arom.), 7.55 (1H, dt, J= 1.5, 7.8, H5’), 7.65 (1H, broad t, J= 7.5, H4’), 
8.01 (1H, dd, J= 1.1, 8.1, H6’), 8.05 (1H, dd, J= 1.5, 7.7, H3’), 8.81 (1H, s, N=CH). C 
(CDCl3, 100 MHz) 42.93 (CH2), 51.77 (CH3) , 71.01 (CH), 124.27 (CH), 126.96 (CH), 
127.69 (CH), 128.78 (CH), 130.11 (CH), 130.82 (CH), 131.14 (C), 133.45 (CH), 141.86 
(C), 148.87 (C), 157.58 (CH), 171.29 (C). m/z (CI): 313 [(M+H)
+, 100%], 163 (30), 121 
(40). HRMS: 313.1190. C17H17O4N2, requires (M+H
+) 313.1188. 
 
Methyl (3RS, E) 3-phenyl-3-[(pyrid-3'-yl)methylidenamino]-propionoate  300l 
 
N
N OMe
O
 
 
Following imine formation procedure A, triethylamine (0.25 mL, 1.8 mmol, 2 equiv.), 
(3RS) methyl 3-amino-3-phenylpropionoate hydrochloride salt 307 (0.198 g, 0.9 mmol, 1 
equiv.), 3-pyridinecarboxaldehyde (0.10 mL, 1.0 mmol, 1.1 equiv.), and Na2SO4 (0.160 
g, 1.1 mmol, 1.2 equiv.), in DCM (4.0 ml), gave a mixture of the desired imino-ester and  
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un-reacted 3-pyridinecarboxaldehyde. Removal of the aldehyde by distillation (70 
oC, 0.5 
mm  Hg)  gave  pure  (3RS,  E)  methyl  3-phenyl-3-[(pyrid-3'-yl)methylidenamino]-
propionoate 300l as an oil (0.221 g, 90%). IR (thin film): 1736 (C=O), 1644 (C=N) cm
-1. 
H (CDCl3, 400 MHz) 2.90 (1H, dd, J= 4.4, 15.8, CH
AH
B),  3.06 (1H, dd, J= 9.4, 15.8, 
CH
AH
B),  3.62 (3H, s, OCH3),  4.89 (1H, dd, J= 4.4, 9.4, CHN), 7.25-7.39 (4H, m, H 
arom.), 7.42-7.47 (2H, m, H arom.), 8.14 (1H, td, J= 1.9, 7.9, H4’), 8.42 (1H, s, N=CH), 
8.64 (1H, dd, J= 1.7, 4.8, H6’), 8.88 (1H, d, J= 1.6, H2’). C (CDCl3, 100 MHz) 42.93 
(CH2), 51.64 (CH3), 71.06 (CH), 123.58 (CH), 126.90 (CH), 127.61 (CH), 128.73 (CH), 
131.64 (C), 134.86 (CH), 142.31 (C), 150.42 (CH), 151.63 (CH), 158.72 (CH), 171.59 
(C).  m/z  (EI):  268  (M
+, 80%),  195  (85),  121  (100).  HRMS:  268.1208.  C16H16O2N2, 
requires (M
+) 268.1212. 
 
Methyl (3RS, E) 3-(1’-phenylethylidenamino)butanoate  300m 
 
N
Me
OMe
O
 
    
Following imine formation procedure C with a reaction time of 17 h, triethylamine (0.41 
mL, 2.9  mmol, 2 equiv.),  acetophenone  (0.21 mL,  1.8  mmol, 1.2  equiv.),  and (3RS) 
methyl  3-aminobutanoate  hydrochloride  salt  306  (223  mg,  1.45  mmol,  1  equiv.),  in 
toluene  (6.0  mL),  gave  a  93:7  mixture  of  (3RS,  E),  and  (3RS,  Z)  methyl  3-(1’-
phenylethylidenamino)butanoate 300m as an oil (235 mg, 74%). Bp 150 
oC at 0.6 mm 
Hg. IR (thin film): 1737 (C=O), 1635 (C=N) cm
-1. H (CDCl3, 400 MHz) 1.22 (3H, d, J= 
6.4, CH3CH), 2.29 (3H, s, CH3C), 2.60 (1H, dd, J= 5.5, 15.3, CH
AH
B),  2.71 (1H, dd, J= 
7.8, 15.2, CH
AH
B),  3.65 (3H, s, OCH3),  4.16-4.26 (1H, m, CHN),  7.35-7.38  (3H, m, H 
arom.),  7.69-7.74 (2H, m, H arom.). C (CDCl3, 100 MHz) 15.49 (CH3), 21.00 (CH3), 
42.83 (CH2), 51.40 (CH3), 53.34 (CH), 126.70 (CH), 128.17 (CH), 129.34 (CH), 141.55 
(C), 164.14 (C), 172.69 (C). m/z (EI): 219 (M
+, 10%), 204 (15), 188 (15), 160 (20), 146, 
(100),  145  (90),  105  (60),  84  (85).  HRMS:  219.1262.  C13H17O2N,  requires  (M
+) 
219.1259. 
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Methyl (3RS) 3-(cyclohexylidenamino)-3-phenylbutanoate  300n 
 
N OMe
O
 
    
Following imine formation procedure C with a reaction time of 48 h, triethylamine (0.61 
ml, 4.39 mmol, 2 equiv.), (3RS) methyl 3-amino-3-phenylpropionate hydrochloride salt 
307 (472 mg, 2.19 mmol, 1 equiv.), cyclohexanone (0.34 mL, 3.3 mmol, 1.5 equiv.), in 
toluene (6.0 mL), gave (3RS) methyl 3-(cyclohexylidenamino)-3-phenylbutanoate 300n 
as an oil (416 mg, 73%). Bp 190 
oC at 0.4 mm Hg. IR (thin film): 1736 (C=O), 1655 
(C=N) cm
-1. H (CDCl3, 400 MHz) 1.40-1.72 (6H, m), 2.18-2.32 (3H, m), 2.39-2.48 (1H, 
m), 2.81 (1H, dd, J= 5.0, 15.2, CH
AH
B),  2.97 (1H, dd, J= 9.0, 15.2, CH
AH
B),  3.63 (3H, 
s, OCH3),  5.09 (1H, dd, J= 5.0, 9.0, CHN),  7.19-7.24  (1H, m, H arom.),  7.27-7.36 (4H, 
m, H arom.). C (CDCl3, 100 MHz) 25.95 (CH2), 26.93 (CH2), 27.85 (CH2), 30.02 (CH2), 
40.14 (CH2), 43.86 (CH2), 51.44 (CH3), 59.40 (CH) 126.10 (CH), 126.81 (CH), 128.46 
(CH), 143.54 (C), 172.19 (C=N), 174.36 (C=O). m/z (EI): 259 (M
+, 30%), 200 (15), 186 
(40),  121  (50),  106  (40),  84  (100).  HRMS:  259.1575.  C16H21O2N,  requires  (M
+) 
259.1572. 
 
(4RS, E) 4-(Benzylidenamino)-2-methoxypent-1-ene  301a  
 
N
Ph
Me
OMe
 
 
Following methylenation procedure B, using a 1.30 M solution of Cp2TiMe2 (1.28 mL, 
1.66  mmol,  1.9  equiv.)  in  toluene-THF  (1:1  by  mass)  with  (3RS,  E)  methyl  3-
(benzylidenamino)butanoate 300a (179 mg, 0.87 mmol, 1 equiv.) and a 10 min reaction 
time at 65 °C (maximum pressure of 45 psi) gave crude enol ether 301a (202 mg). H 
(CDCl3, 400 MHz) 1.28 (3H, d, J= 6.4, CH3CH), 2.32-2.37 (2H, m, CHCH2), 3.48 (3H,  
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s, OCH3),  3.55-3.63 (1H, m, CHN), 3.96-3.99 (2H, m, C=CH2), 7.37-7.42 (3H, m, H 
arom.),  7.69-7.74 (2H, m, H arom.),  8.23 (1H, s, N=CH).  
 
(4RS, E) 4-(Benzylidenamino)-2-methoxy-4-phenylbut-1-ene  301b  
 
N
Ph
Ph
OMe
 
 
Following methylenation procedure B, a 1.30 M solution of Cp2TiMe2 (0.63 mL, 0.82 
mmol,  2.1  equiv.)  in  toluene-THF  (1:1  by  mass)  with  (3RS,  E)  methyl  3-
(benzylidenamino)-3-phenylpropionate 300b (104.8 mg, 0.39 mmol, 1 equiv.) and a 10 
min reaction time at 65 °C (maximum pressure of 25 psi) gave crude enol ether 301b 
(142.7 mg). H (CDCl3, 400 MHz) 2.71 (2H, d, J = 7.0, CHCH2), 3.53 (3H, s, OCH3), 
3.81 (1H, d, J = 2.0, C=CH
AH
B), 3.88 (1H, d, J = 2.0, C=CH
AH
B), 4.59 (1H, t, J= 7.0, 
CHN),  7.21-7.49  (8H, m, H arom.),  7.74-7.78 (2H, m, H arom.),  8.26 (1H, s, N=CH). 
 
(4RS, E) 4-(2’,4’-dimethoxybenzylidenamino)-2-Methoxy-4-phenylbut-1-ene  301c  
 
N
Ph
OMe
OMe MeO  
 
Following methylenation procedure B, a 1.30 M solution of Cp2TiMe2 (0.40 mL, 0.51 
mmol,  1.8  equiv.)  in  toluene-THF  (1:1  by  mass)  with  (3RS,  E)  methyl  3-(2’,4’-
dimethoxybenzylidenamino)-3-phenylpropionate 300c (92.3 mg, 0.28 mmol, 1 equiv.) 
and a 3.5 min reaction time at 65 °C (maximum pressure of 24 psi) gave crude enol ether 
301c (128.9 mg). H (CDCl3, 400 MHz) 2.59-2.70 (2H, m, CHCH2), 3.51 (3H, s, OCH3),  
3.78-3.87 (8H, m, 2  OCH3, C=CH2), 4.53-4.60 (1H, m, CHN),  6.41-6.43 (1H, m, H3’),  
6.50-6.54 (1H, m, H5’),  7.22-7.29 (1H, m, H arom.),  7.30-7.37 (2H, m, H arom.),  7.41-
7.45 (2H, m, H arom.),  7.98-8.01 (1H, m, H6’), 8.57 (1H, s, N=CH). 
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(4RS, E) 4-(Benzylidenamino)-2-methoxy-5-phenylpent-1-ene  301d  
 
N
Ph
OMe
Ph
 
 
Following methylenation procedure B, a 1.30 M solution of Cp2TiMe2 (92 mL, 1.20 
mmol,  1.8  equiv.)  in  toluene-THF  (1:1  by  mass)  with  (3RS,  E)  methyl  3-
(benzylidenamino)-4-phenylbutanoate 300d (186.4 mg, 0.66 mmol, 1 equiv.) and a 10 
min reaction time at 65 °C (maximum pressure of 44 psi) gave crude enol ether 301d 
(128.9 mg). H (CDCl3, 400 MHz): 2.45 (1H, dd, J= 8.0, 13.6, CH
AH
BC=), 2.52 (1H, dd, 
J= 6.0, 13.6, CH
AH
BC=), 2.91 (1H, dd, J= 8.4, 13.2, PhCH
CH
D), 2.99 (1H, dd, J= 4.8, 
13.2, PhCH
CH
D), 3.48 (3H, s, OCH3), 3.58-3.65 (1H, m, CHN), 3.89 (2H, s, C=CH2),  
7.10-7.14 (3H, m, H arom.), 7.18-7.23 (2H, m, H arom.), 7.35-7.47 (3H, m, H arom.), 
7.62-7.71 (2H, m, H arom.), 7.84 (1H, s, N=CH).  
 
(4RS, 1’E, 2’E) 2-Methoxy-4-[3’-(4”-methoxyphenyl)prop-2’-enylidenamino]pent-1-
ene  301e  
 
N
Me
OMe
MeO  
 
Following methylenation procedure B, a 1.30 M solution of Cp2TiMe2 (0.54 mL, 0.70 
mmol, 2.0 equiv.) in toluene-THF (1:1 by mass) with (3RS, 1’E, 2’E) methyl 3-[3’-(4”-
Methoxyphenyl)prop-2’-enylidenamino]butanoate 300e (91.9 mg, 0.35 mmol, 1 equiv.), 
and a 3 min reaction time at 65 °C (maximum pressure of 29 psi) gave crude enol ether 
301e (101.3 mg). H (CDCl3, 400 MHz) 1.15 (3H, d, J= 6.4, CH3CH),  2.24 (2H, d, J= 
6.4, CHCH2), 3.35-3.46 (1H, m, CHN), 3.43 (3H, s, OCH3),  3.75 (3H, s, OCH3), 3.80 
(1H, d, J = 2.0, C=CH
AH
B), 3.82 (1H, d, J = 2.0, C=CH
AH
B), 6.67-6.88 (4H, m, H2’, H3’, 
H arom.),  7.33 (2H, d, J= 8.6, H arom.),  7.85 (1H, d, J =8.2, H1’). 
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(4RS, E) 4-(2’,4’-Dimethoxybenzylidenamino)-2-methoxypent-1-ene  301f 
 
N
Me
OMe
OMe MeO  
 
Following methylenation procedure B, a 1.30 M solution of Cp2TiMe2 (0.93 mL, 1.21 
mmol,  1.8  equiv.)  in  toluene-THF  (1:1  by  mass)  with  (3RS,  E)  methyl  3-(2’,4’-
dimethoxybenzylidenamino)butanoate 300f (178.9 mg, 0.68 mmol, 1 equiv.) and a 2.5 
min reaction time at 65 °C (maximum pressure of 48 psi) gave crude enol ether 301f 
(198.0 mg). H (CDCl3, 400 MHz): 1.18 (3H, d, J= 6.4, CH3CH), 2.31 (1H, dd, J= 6.8, 
14.0, CHCH
AH
B), 2.36 (1H, dd, J= 7.2, 14.0, CHCH
AH
B), 3.46 (3H, s, OCH3), 3.61-3.68 
(1H,  m,  CHN),  3.61  (3H,  s,  OCH3),  3.62  (3H,  s,  OCH3),  3.85  (1H,  d,  J  =  2.0, 
C=CH
AH
B), 3.86 (1H, d, J = 2.0, C=CH
AH
B), 6.40 (1H, d, J= 2.3, H3’), 6.48 (1H, dd, J= 
2.3, 8.6, H5’), 7.86 (1H, d, J= 8.6, H6’), 8.52 (1H, s, CH=N).  
 
(4RS, E) 4-(3’-Bromobenzylidenamino)-2-methoxypent-1-ene   301g 
 
N
Me
OMe
Br  
 
Following methylenation procedure B, a 1.30 M solution of Cp2TiMe2 (0.63 mL, 0.82 
mmol,  1.8  equiv.)  in  toluene-THF  (1:1  by  mass)  with  (3RS,  E)  methyl  3-(3’-
bromobenzylidenamino)butanoate 300g (129.6 mg, 0.46 mmol, 1 equiv.) and a 10 min 
reaction time at 65 °C (maximum pressure of 33 psi) gave crude enol ether 301g (151.4 
mg). H (CDCl3, 400 MHz): 1.22 (3H, d, J= 6.6, CH3CH), 2.31 (2H, d, J = 7.2, CHCH2), 
3.44 (3H, s, OCH3), 3.68-3.75 (1H, m, CHN), 3.81 (1H, d, J= 2.0, C=CH
AH
B), 3.83 (1H, 
d, J= 2.0, C=CH
AH
B), 7.23-7.32 (1H, m, H5’), 7.50-7.54 (1H, m, H4’), 7.58-7.61 (1H, m, 
H6’), 7.90-7.93 (1H, m, H2’), 8.1 (1H, s, N=CH).  
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(4RS, E) 4-(2’,2’-Dimethylpropylidenamino)-2-methoxy-4-phenylbut-1-ene   301h 
 
N
Ph
OMe
 
 
Following methylenation procedure B, a 1.30 M solution of Cp2TiMe2 (0.70 mL, 0.91 
mmol,  1.8  equiv.)  in  toluene-THF  (1:1  by  mass)  with  (3RS,  E)  methyl  3-(2’,2’-
dimethylpropylidenamino)-3-phenylbutanoate 300h (125.0 mg, 0.51 mmol, 1 equiv.) and 
a 10 min reaction time at 65 °C (maximum pressure of 33 psi) gave crude enol ether 301h 
(158.6 mg). H (CDCl3, 400 MHz): 1.07 (9H, s, CH3C), 2.50 (1H, dd, J= 9.2, 13.6, 
CHCH
AH
B), 2.58 (1H, dd, J= 4.4, 13.6, CHCH
AH
B), 3.52 (3H, s, OCH3), 3.80 (1H, d, J= 
2.0, C=CH
AH
B), 3.87 (1H, d, J= 2.0, C=CH
AH
B), 4.29 (1H, dd, J= 4.4, 9.2, CHN), 7.21-
7.24 (1H, m, H arom.), 7.30-7.35 (2H, m, H arom.), 7.40-7.43 (2H, m, H arom.), 7.47 
(1H, s, N=CH). 
 
(4RS, E) 2-Methoxy-4-phenyl-4-(propylidenamino)but-1-ene  301i 
 
N
Ph
OMe
 
 
Following methylenation procedure B, a 1.30 M solution of Cp2TiMe2 (0.72 mL, 0.94 
mmol,  2.1  equiv.)  in  toluene-THF  (1:1  by  mass)  with  (3RS,  E)  methyl  3-
(propylidenamino)-3-phenylbutanoate 300i (114.5 mg, 86% pure by mass, 0.45 mmol, 1 
equiv.) and a 2.5 min reaction time at 65 °C (maximum pressure of 34 psi) gave crude 
enol ether 301i (151.1 mg). No characterization was performed due to instability of the 
aliphatic imine. 
 
(4RS, E) 4-(2’-Fluorobenzylidenamino)-2-methoxypent-1-ene   301j 
 
N
Me
OMe
F   
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Following methylenation procedure B, a 1.30 M solution of Cp2TiMe2 (0.52 mL, 0.68 
mmol,  2.0  equiv.)  in  toluene-THF  (1:1  by  mass)  with  (3RS,  E)  methyl  3-(2’-
fluorobenzylidenamino)-butanoate 300j (75.1 mg, 0.34 mmol, 1 equiv.), and a 10 min 
reaction time at 65 °C (maximum pressure of 23 psi) gave crude enol ether 301j (100.9 
mg). H (CDCl3, 400 MHz) 1.34 (3H, d, J= 6.4, CH3CH),  2.40 (2H, d, J= 6.4, CHCH2),  
3.51 (3H, s, OCH3),  3.62-3.66 (1H, m. CHN), 3.84 (1H, d, J= 2.0, C=CH
AH
B), 3.87 (1H, 
d, J= 2.0, C=CH
AH
B), 6.93-7.00 (1H, m, H3’), 7.04-7.07 (1H, m, H5’), 7.23-7.29 (1H, m, 
H4’), 7.80-7.86 (1H, m, H6’), 8.38 (1H, s, N=CH). 
  
(4RS, E) 2-Methoxy-4-(1’-phenylethylidenamino)pent-1-ene   301m  
 
N
Ph
Me
OMe
Me  
    
Following methylenation procedure B, a 1.30 M solution of Cp2TiMe2 (0.94 mL, 1.22 
mmol,  1.9  equiv.)  in  toluene-THF  (1:1  by  mass)  with  (3RS,  E)  methyl  3-(1’-
phenylethylidenamino)butanoate 300m (140.6 mg, 0.64 mmol, 1 equiv.), and a 10 min 
reaction time at 65 °C (maximum pressure of 42 psi) gave crude enol ether 301m (155.7 
mg). H (CDCl3, 400 MHz) 1.20 (3H, d, J= 6.2, CH3CH), 2.21 (3H, s, CH3C), 2.35 (1H, 
dd,  J=  6.4,  13.6,  CHCH
AH
B),  2.41  (1H,  dd,  J=  7.6,  13.6,  CHCH
AH
B),  3.52 (3H,  s, 
OCH3),  3.86 (1H, d, J = 2.0, C=CH
AH
B), 3.88 (1H, d, J = 2.0, C=CH
AH
B), 3.92-4.01 
(1H, m, CHN),  7.33-7.36  (3H, m, H arom.), 7.68-7.73 (2H, m, H arom.).  
 
 
(4RS, E) 4-(cyclohexylidenamino)-2-methoxy-4-phenylbut-1-ene  301n 
 
N
Ph
OMe
 
    
Following methylenation procedure B, a 1.30 M solution of Cp2TiMe2 (0.90 mL, 1.17 
mmol,  2.0  equiv.)  in  toluene-THF  (1:1  by  mass)  with  (3RS)  methyl  3-
(cyclohexylidenamino)-3-phenylbutanoate 300n (75.1 mg, 0.34 mmol, 1 equiv.), and a 10  
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min reaction time at 65 °C (maximum pressure of 42 psi) gave crude enol ether 301n 
(153.5 mg). H (CDCl3, 400 MHz) 1.40-1.75 (6H, m), 2.18-2.45 (4H, m), 2.55-2.66 (2H, 
m, CHCH2), 3.53 (3H, s, OCH3), 3.82 (1H, d, J= 2.0, C=CH
AH
B), 3.85 (1H, d, J= 2.0, 
C=CH
AH
B), 4.86 (1H, dd, J= 5.2, 8.0, CHN),  7.19-7.45  (5H, m, H arom.). 
 
(2RS, 6RS) 2-Methyl-6-phenylpiperidin-4-one  302a 
 
N
H
O
H H
 
 
Following methylenation procedure B, a 1.30 M solution of Cp2TiMe2 (1.28 mL, 1.66 
mmol,  1.9  equiv.)  in  toluene-THF  (1:1  by  mass)  with  (3RS,  E)  methyl  3-
(benzylidenamino)-butanoate 300a (179 mg, 0.87 mmol, 1 equiv.) and a 10 min reaction 
time  at 65  °C (maximum  pressure of  45 psi) gave crude enol  ether 301a (202  mg). 
Following cyclization procedure D, triisobutylaluminium (0.62 ml, 0.62 mmol, 1.0 M in 
hexanes, 2 equiv.), and a portion of the crude enol ether 301a (71.1 mg), in DMSO (10.0 
ml) yielded the crude piperidinone. Column chromatography [SiO2, DCM-MeOH (50:1)] 
gave (2RS, 6RS) 2-methyl-6-phenylpiperidin-4-one 302a as a solid (39.4 mg, 68%). Rf 
[SiO2, DCM-MeOH (20:1)]: 0.44. Mp 81-82 
oC. Lit:
130 mp 65-67 
oC. H (CDCl3, 400 
MHz) 1.26 (3H, d, J= 6.2, CH3CH), 2.23 (1H, dd, J= 11.6, 14.0, H3
ax),  2.41 (1H, broad 
dd, J= 2.8, 14.0, H3
eq),  2.48-2.52 (2H, m, H5),  3.12  (1H, dqd, J= 2.9, 6.1, 12.0, H2),  
3.96 (1H, m, H6),  7.27-7.41 (5H, m, H arom.). C (CDCl3, 100 MHz) 22.61 (CH3), 49.76 
(CH2), 49.89 (CH2), 52.32 (CH), 61.02 (CH), 126.51 (CH), 127.85 (CH), 128.75 (CH) 
142.58 (C), 208.93 (C). 
1H NMR data in agreement with the literature.
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(2RS, 6SR) 2,6-Diphenylpiperidin-4-one  302b 
  
N
H
O
H H
 
 
Following methylenation procedure B, a 1.30 M solution of Cp2TiMe2 (0.63 mL, 0.82 
mmol,  2.1  equiv.)  in  toluene-THF  (1:1  by  mass)  with  (3RS,  E)  methyl  3- 
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(benzylidenamino)-3-phenylpropionate 300b (105 mg, 0.39 mmol, 1 equiv.) and a 10 min 
reaction time at 65 °C (maximum pressure of 25 psi) gave crude enol ether 301b (143 
mg). Following cyclization procedure D, triisobutylaluminium (0.78 ml, 0.78 mmol, 1.0 
M in hexanes, 2 equiv.), and crude enol ether 301b (143 mg), in DMSO (13.0 ml) yielded 
the crude piperidinone. Column chromatography [SiO2, DCM-MeOH (100:1)] gave (2RS, 
6SR)  2,6-diphenylpiperidin-4-one  302b  as  a  solid  (68.9  mg,  70%).  Rf  [SiO2,  DCM-
MeOH (40/1)]: 0.31. Mp 99-100 
oC. H (CDCl3, 400 MHz) 2.48-2.62 (4H, m, H3 & H5), 
4.01 (2H, dd, J= 3.6, 10.8, H2 & H6), 7.16-7.41 (10H, m, H arom.). C (CDCl3, 100 
MHz) 50.38 (CH2), 61.16 (CH), 126.54 (CH), 127.93 (CH), 128.76 (CH) 142.68 (C), 
208.24 (C). 
1H NMR data in agreement with the literature.
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(2RS, 6SR) 2-(2’,4’-Dimethoxyphenyl)-6-phenylpiperidin-4-one  302c 
 
N
H
O
H H
OMe
MeO  
 
Following methylenation procedure B, a 1.30 M solution of Cp2TiMe2 (0.40 mL, 0.51 
mmol,  1.8  equiv.)  in  toluene-THF  (1:1  by  mass)  with  (3RS,  E)  methyl  3-(2’,4’-
dimethoxybenzylidenamino)-3-phenylpropionate 300c (92.3 mg, 0.28 mmol, 1 equiv.) 
and a 3.5 min reaction time at 65 °C (maximum pressure of 24 psi) gave crude enol ether 
301c (128.9 mg). Following cyclization procedure D, triisobutylaluminium (0.56 ml, 0.56 
mmol, 1.0 M in hexanes, 2 equiv.), and crude enol ether 301c (128.9 mg), in DMSO 
(10.0 ml) yielded the crude piperidinone. Column chromatography [SiO2, DCM-MeOH 
(50:1)] gave (2RS, 6SR) 2-(2’,4’-dimethoxyphenyl)-6-phenylpiperidin-4-one 302c as an 
oil (57.9 mg, 66%). Rf [SiO2, DCM-MeOH (20:1)]: 0.70. IR (thin film): 1730 (C=O) cm
-
1. H (CDCl3, 400 MHz) 2.51-2.66 (4H, m, H3 & H5),  3.80 (3H, s, OCH3),  3.81 (3H, s, 
OCH3),  4.10 (1H, dd, J= 5.6, 9.2, H6),  4.41 (1H, dd, J= 3.3, 11.5, H2),  6.46 (1H, d, J= 
2.4, H3’),  6.52 (1H, dd, J= 2.4, 8.5, H5’),  7.26-7.39 (3H, m, H arom.),  7.44-7.50 (3H, 
m, H arom.). C (CDCl3, 100 MHz) 47.30 (CH2), 49.32 (CH2), 52.86 (CH), 54.28 (CH3), 
54.33 (CH3), 60.13 (CH), 97.37 (CH), 103.35 (CH), 122.19 (C), 125.56 (CH), 125.90 
(CH), 126.73 (CH), 127.68 (CH), 141.99 (C), 156.37 (C), 159.14 (C), 207.94 (C). m/z 
(EI):  311  (M
+,  75%),  192  (100),  164  (90),  149  (60),  121  (40).  HRMS:  311.1523 
C19H21O3N, requires (M
+) 311.1521.  
154
 
(2RS, 6RS) 2-Benzyl-6-phenylpiperidin-4-one  302d 
 
N
H
O
H H
 
 
Following methylenation procedure B, a 1.30 M solution of Cp2TiMe2 (92 mL, 1.20 
mmol,  1.8  equiv.)  in  toluene-THF  (1:1  by  mass)  with  (3RS,  3E)  methyl  3-
(benzylidenamino)-4-phenylbutanoate 300d (186.4 mg, 0.66 mmol, 1 equiv.) and a 10 
min reaction time at 65 °C (maximum pressure of 44 psi) gave crude enol ether 301d 
(128.9 mg). Following cyclization procedure B, p-toluene sulfonic acid (73 mg, 0.43 
mmol, 2 equiv.), and crude enol ether 301d (64.0 mg), in DCM (5.0 ml) yielded the crude 
piperidinone. Column chromatography [SiO2, DCM-MeOH (50:1)] gave (2RS, 6RS) 2-
benzyl-6-phenylpiperin-4-one 302d as a colorless oil (34.5 mg, 61%). Rf [SiO2, DCM-
MeOH (20/1)]: 0.50. IR (thin film): 1714 (C=O) cm
-1. H (CDCl3, 400 MHz): 2.25 (1H, 
dd, J= 11.6, 14.0, H3
ax), 2.38 (1H, dd, J= 2.5, 14.5, H3
eq), 2.39-2.44 (2H, m, H5), 2.73 
(1H, dd, J= 8.2, 13.5, CHAHBCH), 2.81 (1H, dd, J= 5.0, 13.5, CHAHBCH), 3.15 (1H, 
dddd, J= 2.9, 5.2, 8.1, 11.3, H2), 3.74-3.82 (1H, m, H6), 7.12-7.33 (10H, m, H arom.). C 
(CDCl3, 100 MHz): 43.34 (CH2), 48.09 (CH2), 50.54 (CH2), 57.82 (CH), 60.79 (CH), 
126.41  (CH),  126.70  (CH),  127.78  (CH),  128.72  (CH),  128.97  (CH),  129.14  (CH), 
137.63 (C), 142.64 (C), 208.46 (C). m/z (CI): 266 [(M+H)
+, 100%], 174.2 (15). HRMS: 
266.1544 C18H20ON requires (M+H
+), 266.1545.   
 
 
(2RS, 6RS, E) 2-[2’-(4”-Methoxyphenyl)vinyl]-6-methylpiperidin-4-one  302e 
 
N
H
O
H H
MeO  
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Following methylenation procedure B, a 1.30 M solution of Cp2TiMe2 (0.54 mL, 0.70 
mmol, 2.0 equiv.) in toluene-THF (1:1 by mass) with (3RS, 1’E, 2’E) methyl 3-[3’-(4”-
methoxyphenyl)prop-2’-enylidenamino]butanoate 300e (91.9 mg, 0.35 mmol, 1 equiv.), 
and a 3 min reaction time at 65 °C (maximum pressure of 29 psi) gave crude enol ether 
301e (101.3 mg). Following cyclization procedure D, triisobutylaluminium (0.70 ml, 0.70 
mmol, 1.0 M in hexanes, 2 equiv.), and the crude enol ether 301e (101.3 mg), in DMSO 
(10.0  ml)  gave  the  crude  piperidinone.  Column  chromatography  [SiO2,  DCM/MeOH 
(50/1)]  gave  (2RS,  6RS,  E)  2-[2’-(4”-methoxyphenyl)vinyl]-6-methylpiperidin-4-one 
302e as an oil (44.0 mg, 51%). Rf [SiO2, DCM/MeOH (20/1)] 0.23. IR (thin film): 1703 
(C=O), 1604 (C=C) cm
-1. H (CDCl3, 400 MHz) 1.24 (3H, d, J= 6.2, CH3CH),  2.15 (1H, 
broad ddd, J= 1.1, 11.7, 14.0, H5
ax),  2.33 (1H, ddd, J= 1.1, 11.4, 14.1, H3
ax),  2.34-2.37 
(1H, m, H5
eq), 2.36 (1H, ddd, J= 2.1, 3.3, 14.0, H3
eq), 3.07 (1H, dqd, J= 3.0, 6.1, 11.7, 
H6),  3.59 (1H, dddd, J= 1.0, 3.4, 7.3, 11.7, H2),  3.81 (3H, s, OCH3),  6.06 (1H, dd, J= 
7.2, 15.8, H1’),  6.52 (1H, broad d, J= 15.8, H2’),  6.83-6.88 (2H, d, J= 8.8, H3’’ & 
H5’’), 7.28-7.33 (2H, d, J= 8.4, H2’’ & H6’’). C (CDCl3, 100 MHz) 22.64 (CH3), 48.00 
(CH2), 49.77 (CH2), 51.88 (CH), 55.27 (CH3), 58.98 (CH), 114.04 (CH), 127.61 (CH), 
128.29  (CH),  129.11  (C),  130.45  (CH),  159.42  (C),  208.53 (C).  m/z  (EI):  245  (M
+, 
100%), 160 (70), 121 (75). HRMS: 245.1415 C15H19O2N, requires (M
+) 245.1416. 
 
(2RS, 6RS) 2-(2’, 4’-Dimethoxyphenyl)-6-methylpiperidin-4-one  302f 
 
N
H
O
H H
OMe
MeO  
 
Following methylenation procedure B, a 1.30 M solution of Cp2TiMe2 (0.93 mL, 1.21 
mmol,  1.8  equiv.)  in  toluene-THF  (1:1  by  mass)  with  (3RS,  E)  methyl  3-(2’,4’-
dimethoxybenzylidenamino)butanoate 300f (178.9 mg, 0.68 mmol, 1 equiv.) and a 2.5 
min reaction time at 65 °C (maximum pressure of 48 psi) gave crude enol ether 301f 
(198.0 mg). Following cyclization procedure C, p-toluene sulfonic acid (106 mg, 0.62 
mmol, 2 equiv.), and a portion of the crude enol ether 301f (90.9 mg), in DME (3.0 ml) 
yielded  the  crude  piperidinone.  Column  chromatography  [SiO2,  DCM-MeOH  (50:1)] 
gave (2RS, 6RS) 2-(2’, 4’-dimethoxyphenyl)-6-methylpiperidin-4-one 302f as an oil (44.4 
mg, 58%).  Rf [SiO2, DCM-MeOH (20:1)]: 0.24. IR (thin film): 1713 (C=O) cm
-1. H  
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(CDCl3, 400 MHz): 1.22 (3H, d, J= 6.2, CH3CH), 2.17 (1H, dd, J= 11.8, 13.9, H5
ax), 2.40 
(1H, ddd, J= 1.8, 2.7, 14.0, H5
eq), 2.43-2.54 (2H, m, H3), 3.11 (1H, dqd, J= 2.9, 6.1, 
12.0, H6), 3.797 (3H, s, OCH3), 3.800 (3H, s, OCH3), 4.22 (1H, dd, J= 4.1, 10.8, H2), 
6.45 (1H, d, J= 2.4, H3’), 6.49 (1H, dd, J= 2.4, 8.4, H5’), 7.32 (1H, d, J= 8.4, H6’). C 
(CDCl3, 100 MHz): 22.72 (CH3), 47.94 (CH2), 49.99 (CH2), 52.32 (CH), 54.43 (CH), 
55.26 (CH3), 55.35 (CH3), 98.53 (CH), 104.19 (CH), 122.88 (C), 127.25 (CH), 157.45 
(C), 160.09 (C), 209.73 (C). m/z (EI+): 249 ((M)
+, 100%), 206 (65), 192 (90), 164 (100), 
149 (75), 121 (45). HRMS: 249.1362 C14H19O3N requires (M
+), 249.1365.   
 
 
(2RS, 6RS) 2-(3’-Bromophenyl)-6-methylpiperidin-4-one  302g 
 
N
H
O
H H
Br  
 
Following methylenation procedure B, a 1.30 M solution of Cp2TiMe2 (0.63 mL, 0.82 
mmol,  1.8  equiv.)  in  toluene-THF  (1:1  by  mass)  with  (3RS,  E)  methyl  3-(3’-
bromobenzylidenamino)butanoate 300g (129.6 mg, 0.46 mmol, 1 equiv.) and a 10 min 
reaction time at 65 °C (maximum pressure of 33 psi) gave crude enol ether 301g (151.4 
mg). Following cyclization procedure C, p-toluene sulfonic acid (157 mg, 0.91 mmol, 2 
equiv.),  and  crude  enol  ether  301g  (151.4  mg),  in  DME  (5.0  ml)  yielded  the  crude 
piperidinone. Column chromatography [SiO2, DCM-MeOH (100:3)] gave (2RS, 6RS) 2-
(3’-bromophenyl)-6-methylpiperidin-4-one 302g as an oil (58.6 mg, 48%).  Rf [SiO2, 
DCM-MeOH (100:3)]: 0.51. IR (thin film): 1714 (C=O) cm
-1. H (CDCl3, 400 MHz): 
1.26 (3H, d, J= 6.2, CH3CH), 2.21 (1H, ddd, J= 0.7, 11.7, 13.9, H5
ax), 2.37-2.44 (2H, m, 
H5
eq, H3
ax), 2.48 (1H, ddd, J= 2.0, 3.7, 14.0, H3
eq), 3.10 (1H, dqd, J= 3.0, 6.2, 11.6, H6), 
3.92 (1H, dd, J= 3.7, 11.2, H2), 7.21 (1H, t, J= 7.8, H5’), 7.30 (1H, broad d, J= 7.7, H6’), 
7.42 (1H, ddd, J= 1.2, 1.9, 7.9, H4’), 7.59 (1H, t, 1.8, H2’). C (CDCl3, 100 MHz): 22.58 
(CH3), 49.64 (CH2), 49.78 (CH2), 52.20 (CH), 60.39 (CH), 122.81 (C), 125.24 (CH), 
129.59 (CH), 130.28 (CH), 130.93 (CH), 144.95 (C), 208.13 (C). m/z (EI): 269 (M
+, 
15%). 267 (M
+, 15%), 212 (10), 210 (10), 184 (15), 182 (15), 85 (60), 83 (100). HRMS: 
269.0239, and 267.0258, C12H14ON
81Br requires (M
+), 269.0239, C12H14ON
79Br requires 
(M
+), 267.0259.  
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(2RS, 6SR) 2-(1’, 1’-Dimethylethyl)-6-phenylpiperidin-4-one  302h 
 
N
H
O
H H
 
 
Following methylenation procedure B, a 1.30 M solution of Cp2TiMe2 (0.70 mL, 0.91 
mmol,  1.8  equiv.)  in  toluene-THF  (1:1  by  mass)  with  (3RS,  E)  methyl  3-(2’,2’-
dimethylpropylidenamino)-3-phenylbutanoate 300h (125.0 mg, 0.51 mmol, 1 equiv.) and 
a 10 min reaction time at 65 °C (maximum pressure of 33 psi) gave crude enol ether 301h 
(158.6 mg). Following cyclization procedure C, p-toluene sulfonic acid (89 mg, 0.52 
mmol, 2 equiv.), and a portion of the crude enol ether 301h (80.2 mg), in DME (4.0 ml) 
yielded  the  crude  piperidinone.  Column  chromatography  [SiO2,  DCM-MeOH  (50:1)] 
gave (2RS, 6SR) 2-(1’, 1’-dimethylethyl)-6-phenylpiperidin-4-one 302h as an oil (34.5 
mg, 58 %).  Rf [SiO2, DCM-MeOH (20:1)]: 0.30. IR (thin film): 1714 (C=O) cm
-1. H 
(CDCl3, 400 MHz): 0.98 (9H, s, CH3C), 2.27 (1H, broad t, J= 12.6, H3
ax), 2.40-2.47 (2H, 
m, H3
eq & H5
ax), 2.50 (1H, ddd, 2.0, 3.7, 13.7, H5
eq), 2.69 (1H, dd, J= 2.8, 11.8, H2), 
3.89 (1H, dd, J= 3.7, 11.2, H6), 7.27-7.33 (1H, m, H arom.), 7.34-7.39 (2H, m, H arom.), 
7.41-7.45 (2H, m, H arom.). C (CDCl3, 100 MHz): 26.18 (CH3), 33.64 (C), 43.37 (CH2), 
50.57 (CH2), 60.95 (CH), 65.64 (CH), 126.53 (CH), 127.73 (CH), 128.68 (CH), 143.27 
(C), 210.14 (C). m/z (CI+): 232 [(M+H)
+, 100%], 174 (20). HRMS: 232. 1703 C15H22ON 
requires (M+H)
+, 232.1701. 
 
(2SR, 6SR) 2-Ethyl-6-phenylpiperidin-4-one  302i 
 
N
H
O
H H
 
 
Following methylenation procedure B, a 1.30 M solution of Cp2TiMe2 (0.72 mL, 0.94 
mmol,  2.1  equiv.)  in  toluene-THF  (1:1  by  mass)  with  (3RS,  3E)  methyl  3-
(propylidenamino)-3-phenylbutanoate 300i (114.5 mg, 86% pure by mass, 0.45 mmol, 1 
equiv.) and a 2.5 min reaction time at 65 °C (maximum pressure of 34 psi) gave crude  
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enol ether 301i (151.1 mg). Following cyclization procedure C, p-toluene sulfonic acid 
(180 mg, 1.05 mmol, 2.3 equiv.), and the crude enol ether 301i (151.1 mg), in DME (5.0 
ml)  yielded  the  crude  piperidinone.  Column  chromatography  [SiO2,  DCM-MeOH 
(100:3)] gave (2SR, 6SR) 2-ethyl-6-phenylpiperidin-4-one 302i as an oil (32.4 mg, 35%).  
Rf [SiO2, DCM-MeOH (20:1)]: 0.48. IR (thin film): 1714 (C=O) cm
-1. H (CDCl3, 400 
MHz): 0.97 (3H, t, J= 7.5, CH3CH2), 1.54-1.65 (2H, m, CH3CH2), 2.21 (1H, dd, J= 11.8, 
13.7, H3
ax), 2.45 (1H, ddd, J= 1.4, 2.7, 13.9, H3
eq), 2.48-2.54 (2H, m, H5), 2.90 (1H, dtd, 
J= 2.8, 6.3, 11.9, H2), 3.89-3.97 (1H, m, H6), 7.27-7.32 (1H, m, H arom.), 7.32-7.43 (4H, 
m,  H  arom.). C (CDCl3,  100  MHz):  10.06  (CH3), 29.74  (CH2),  47.77  (CH2), 50.42 
(CH2), 58.26 (CH), 61.03 (CH), 126.53 (CH), 127.82 (CH), 128.73 (CH), 142.76 (C), 
208.98 (C). m/z (EI): 203 (M
+, 15%), 174 (20), 149 (20), 131 (20), 104 (20), 84 (100). 
HRMS: 203.1313 C13H17ON requires (M
+), 203.1310. 
 
(2RS, 6RS) 2-(2’-Fluorophenyl)-6-methylpiperidin-4-one  302j 
 
N
H
Me
O
F
H H
 
 
Following methylenation procedure B, a 1.30 M solution of Cp2TiMe2 (0.52 mL, 0.68 
mmol,  2.0  equiv.)  in  toluene-THF  (1:1  by  mass)  with  (3RS,  E)  methyl  3-(2’-
fluorobenzylidenamino)-butanoate 300j (75.1 mg, 0.34 mmol, 1 equiv.), and a 10 min 
reaction time at 65 °C (maximum pressure of 23 psi) gave crude enol ether 301j (100.9 
mg). Following cyclization procedure D, triisobutylaluminium (0.67 ml, 0.67 mmol, 1.0 
M in hexanes, 2 equiv.), and the crude enol ether 301j (100.9 mg), in DMSO (10.0 ml) 
gave the crude piperidinone. Column chromatography [SiO2, DCM-MeOH (50:1)] gave 
(2RS, 6RS) 2-(2’-fluorophenyl)-6-methylpiperidin-4-one 302j as a solid (44.8 mg, 64%). 
Rf (SiO2, DCM/MeOH 50/1): 0.50. Mp 84-85 
oC. IR (thin film): 1716 (C=O) cm
-1. H 
(CDCl3, 400 MHz) 1.27 (3H, d, J= 6.2, CH3CH), 2.21 (1H, ddd, J= 0.7, 11.7, 14.1, 
H5
ax), 2.43 (1H, ddd, J= 2.1, 2.8, 14.1, H5
eq),  2.47 (1H, ddd, J= 0.7, 11.6, 13.9, H3
ax), 
2.55 (1H, ddd, J= 2.0, 3.5, 14.0, H3
eq), 3.15  (1H, dqd, J= 2.9, 6.2, 11.7, H6),  4.31 (1H, 
dd, J= 3.4, 11.5, H2),  7.05 (1H, ddd, J= 1.1, 8.2, 10.6, H3’), 7.17 (1H, dt, J=1.1, 7.6, 
H5’), 7.28 (1H, dddd, J= 1.8, 5.3, 7.6, 8.2. H4’), 7.54 (1H, dt, 1.7, 7.5, H6’).  C (CDCl3, 
100 MHz) 22.65 (CH3), 48.12 (CH2), 49.82 (CH2) , 52.30 (CH), 53.77 (CH, d, J= 2.9),  
159
115.62 (CH, d, J= 22.3), 124.63 (CH, d, J= 4.0), 127.52 (CH, d. J= 3.8), 129.16 (CH, d, 
J= 7.9), 129.31 (C, d, J= 13.5), 160.06 (C, d, J= 244.2), 208.36 (C). m/z (EI): 207 (M
+, 
20%), 164 (15%), 149 (20%), 122 (25), 84 (100). HRMS: 207.1057 C12H14ONF, requires 
(M
+) 207.1059. 
 
(2RS, 6RS) 2,6-Dimethyl-2-phenylpiperidin-4-one  302m  
  
N
H
Me
O
R
R' H  
A) R=Ph, R’=Me 
B) R=Me, R’=Ph 
A:B = 89:11 
 
Following methylenation procedure  B, a 1.30 M solution of Cp2TiMe2 (0.94 mL, 1.22 
mmol,  1.9  equiv.)  in  toluene-THF  (1:1  by  mass)  with  (3RS,  E)  methyl  3-(1’-
phenylethylidenamino)butanoate 300m (140.6 mg, 0.64 mmol, 1 equiv.), and a 10 min 
reaction time at 65 °C (maximum pressure of 42 psi) gave crude enol ether 301m (155.7 
mg). Following cyclization procedure D, triisobutylaluminium (0.64 mL, 0.64 mmol, 1.0 
M in hexanes, 2 equiv.), and a portion of the crude enol ether 301m (78.1 mg), in DMSO 
(11.0  ml)  gave  an  89:11  ratio  of  the  2,6-syn,  and  the  2.6-anti  2,6-dimethyl-2-
phenylpiperidin-4-one  302m  as  an  oil  (44.8  mg,  68%)  after  column  chromatography 
[SiO2,  DCM-MeOH  (40:1)].  Repeated  chromatography  allowed  samples  of  each 
diastereomer to be isolated pure. 2,6-syn 302m: Rf [SiO2, DCM-MeOH (40/1)]: 0.25. IR 
(thin film): 1715 (C=O) cm
-1. H (CDCl3, 400 MHz) 1.28 (3H, d, J= 6.2, CH3CH), 1.43 
(3H, s, CH3C), 2.08 (1H, ddd, J= 0.9, 11.4, 13.6, H5
ax), 2.44 (1H, ddd, J= 1.8, 3.2, 13.6, 
H5
eq), 2.56 (1H, broad d, J= 13.2, H3
ax), 2.63 (1H, dd, J= 1.8, 13.2, H3
eq), 3.42 (1H, dqd, 
J= 3.3, 6.2, 11.3. H6), 7.26-7.30 (1H, m, H arom.), 7.32-7.39 (2H, m, H arom.), 7.54-7.59 
(2H, m, H arom.). C (CDCl3, 100 MHz) 23.12 (CH3), 25.67 (CH3), 47.27 (CH), 50.19 
(CH2), 54.08 (CH2), 58.95 (CH), 124.65 (CH), 127.03 (CH), 128.43 (CH), 148.17 (C), 
209.63 (C=O). m/z (EI): 203 (M
+, 10%), 188 (10%), 160 (5%), 149 (10%), 146 (10), 84 
(100). HRMS: 203.1313 C13H17ON, requires (M
+) 203.1310. 2,6-anti 302m: Rf [SiO2, 
DCM-MeOH (40:1)]: 0.21. IR (thin film): 1714 (C=O) cm
-1. H (CDCl3, 400 MHz) 1.14 
(3H, d, J= 6.2, CH3CH), 1.48 (3H, s, CH3C), 2.01 (1H, broad dd, J= 12.2, 13.7, H5
ax), 
2.23 (1H, ddd, J= 1.9, 2.9, 14.3, H5
eq), 2.43 (1H, broad d, J= 14.0, H3
ax), 2.67-2.77 (1H,  
160
m, H6), 3.17 (1H, dd, J= 1.8, 14.4, H3
eq), 7.18-7.40 (5H, m, H arom.). C (CDCl3, 100 
MHz) 25.54 (CH3), 34.11 (CH3), 47.15 (CH), 49.65 (CH2), 51.67 (CH2), 59.65 (CH), 
125.90 (CH), 126.81 (CH), 128.68 (CH), 145.02 (C), 209.24 (C). m/z (CI): 204 [(M+H)
+, 
100%]. HRMS: 204.1389 C13H18ON, requires (M+H
+), 204.1388. 
 
(2RS) 2-Phenyl-1-aza-spiro-5,5-undecan-4-one  302n  
 
N
H
O
 
 
Following methylenation procedure B, a 1.30 M solution of Cp2TiMe2 (0.90 mL, 1.17 
mmol,  2.0  equiv.)  in  toluene-THF  (1:1  by  mass)  with  (3RS)  methyl  3-
(cyclohexylidenamino)-3-phenylbutanoate 300n (75.1 mg, 0.34 mmol, 1 equiv.), and a 10 
min reaction time at 65 °C (maximum pressure of 42 psi) gave crude enol ether 301n 
(153.5 mg). Following  cyclization procedure  D, triisobutylaluminium  (0.48  mL, 0.48 
mmol, 1.0 M in hexanes, 2 equiv.), and a portion of the crude enol ether 301n (63.7 mg), 
in DMSO (8.0 ml) gave the crude piperidinone. Column chromatography [SiO2, DCM-
MeOH (40:1)] gave (2RS) 2-phenyl-1-aza-spiro-5,5-undecan-4-one 302n as an oil (30.6 
mg, 52%). Rf [SiO2, DCM-MeOH (40:1)]: 0.25. IR (thin film): 1711 (C=O) cm
-1. H 
(CDCl3, 400 MHz) 1.31-1.78 (10H, m, CH2), 2.31-2.54 (4H, m H3 & H5), 4.16 (1H, dd, 
J= 4.7, 10.2, H2), 7.27-7.33 (1H, m, H arom.), 7.34-7.39 (2H, m, H arom.), 7.41-7.45 
(2H, m. H arom.). C (CDCl3, 100 MHz) 21.50 (CH2), 21.73 (CH2), 25.56 (CH2), 32.50 
(CH2), 40.32 (CH2), 50.03 (CH2), 53.08 (CH2), 54.65 (CH), 55.42 (C), 126.68 (CH), 
127.76 (CH), 128.70 (CH), 143.10 (C), 209.80 (C). m/z (EI): 243 (M
+, 60%), 200 (100), 
187  (55),  131  (50),  104  (45),  83  (25).  HRMS:  243.1624  C16H19ON,  requires  (M
+) 
243.1623. 
 
(3RS) Methyl 3-aminobutanoate, hydrochloride salt  306 
 
H3N OMe
O
Cl  
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Using: thionyl chloride (2.80 ml , 38.6 mmol, 2 equiv.), (3RS) 3-aminobutyric acid 303 
(1.98  g,  19.2  mmol,  1  equiv.),  in  MeOH  (33.0  mL),  and  following  the  general 
esterification procedure gave (3RS) methyl 3-aminobutanoate hydrochloride salt 306 as 
an oil (2.90 g, 98%). IR (thin film): 1731 (C=O) cm
-1. H (CDCl3, 400 MHz) 1.50 (3H, d, 
J= 6.5, CH3CH),  2.75 (1H, dd, J= 5.7, 17.0, CH
AH
B),  2.97 (1H, dd, J= 6.7, 17.0, 
CH
AH
B),  3.73 (3H, s, OCH3),  3.76-3.87 (1H, broad m, CHN),  8.35  (3H, broad s, NH3). 
C (CDCl3, 100 MHz) 18.52 (CH3), 37.99 (CH2), 45.08 (CH) , 52.34 (CH3), 171.10 (C). 
m/z (CI): 118 (M
+, 100%). HRMS: 118.0867 C5H12O2N requires (M
+), 118.0868. 
1H and 
13C NMR consistent but different with the literature NMR spectra, which used D2O as the 
solvent.
132 
 
 
(3RS) Methyl 3-amino-3-phenylpropionate, hydrochloride salt  307 
 
H3N OMe
O
Cl  
 
Using:  thionyl  chloride  (3.22  ml,  44.4  mmol,  2  equiv.),  (3RS)  3-amino-3-
phenylpropionoic acid 304 (3.663 g, 22.2 mmol, 1 equiv.), in MeOH (40.0 mL) and 
following  the  general  esterification  procedure  gave  (3RS)  Methyl  3-amino-3-
phenylpropionate hydrochloride salt 307 as a solid (4.660 g, 98%). Mp 145-147 
oC. IR 
(thin film): 1734 (C=O) cm
-1. H (CDCl3, 400 MHz) 3.02 (1H, dd, J= 7.2, 16.8, CH
AH
B),  
3.29 (1H, dd, J= 6.8, 16.8, CH
AH
B),  3.60 (3H, s, OCH3),  4.65-4.78 (1H, broad m, 
CHN),  7.30-7.39 (3H, m, H arom.),  7.49-7.56 (2H, m, H arom.),  8.75  (3H, broad s, 
NH3).  C  (CDCl3,  100  MHz)  38.37  (CH2),  52.23 (CH)  ,  52.28 (CH3), 127.55 (CH), 
129.14 (CH), 129.34 (CH), 135.24 (C), 170.06 (C). m/z (CI): 180 (M
+, 100%), 163 (33), 
106 (20).  HRMS:  180.1024 C10H14O2N requires (M
+), 180.1025.  Consistent with but 
different from data for the free base.
133 
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(3RS) Methyl 3-amino-4-phenylbutanoate, hydrochloride salt  308 
 
H3N OMe
O
Cl  
 
Using: thionyl chloride (0.41 mL, 5.6 mmol, 2 equiv.), (3RS) 3-amino-4-phenylbutyric 
acid 305 (500 mg, 2.8 mmol, 1 equiv.), in MeOH (5.0 mL) and following the general 
esterification procedure gave (3RS) methyl 3-amino-4-phenylbutyrate hydrochloride salt 
308 as a solid (640 mg, quantitative). Mp 133-135 
oC. IR (thin film): 1716 (C=O) cm
-1. 
H (DMSO, 400 MHz): 2.56 (1H, dd, J= 5.8, 16.7, CH
AH
B), 2.71 (1H, dd, J= 6.9, 16.7, 
CH
AH
B), 2.82 (1H, dd, J= 8.6, 13.6, CH
CH
D), 3.10 (1H, dd, J= 5.5, 13.6, CH
CH
D), 3.53 
(3H, s, OCH3), 3.62-3.72 (1H, m, CHN), 7.23-7.28 (3H, m, H arom.), 7.30-7.37 (2H, m, 
H arom.), 8.40 (3H, s, NH3). C (CDCl3, 100 MHz): 35.79 (CH2), 37.94 (CH2), 48.80 
(CH), 51.71 (CH3), 126.96 (CH), 128.59 (CH), 129.40 (CH), 135.92 (C), 170.10 (C=O). 
m/z  (CI):  194  (M
+,  100%),  102  (20).  HRMS:  194.1184  C11H16N1O2  requires  (M
+), 
194.1181.
134 
 
Methyl 2-aminobenzoate  310 
 
NH2
OMe
O
 
 
Using: thionyl chloride (2.12 mL, 29.2 mmol, 2 equiv.), 2-aminobenzoic acid 309 (2.001 
g,  14.6 mmol,  1 equiv.),  in  MeOH (25  mL) and  following  the  general  esterification 
procedure, but using a reaction time of 39 h instead of 3 h, gave the hydrochloride salt as 
a solid. The salt is taken up in water which is basified with 1M NaOH, and extracted with 
DCM. The organic layer is dried over Na2SO4 filtered and concentrated in vacuo to give 
methyl 2-aminobenzoate 310 as an oil (1.733 g, 78%). IR (thin film): 1694 (C=O) cm
-1. 
H (CDCl3, 400 MHz): 3.86 (1H, s, OCH3), 5.71 (2H, broad s, NH2), 6.61-6.67 (2H, m, H 
arom.), 7.26 (1H, dt, J= 1.6, 7.7, H4), 7.85 (1H, dd, J= 1.6, 8.0, H6). C (CDCl3, 100 
MHz): 51.50 (CH3), 110.70 (C), 116.26 (CH), 116.65 (CH), 131.17 (CH), 134.06 (CH),  
163
150.33  (C),  168.54  (C).  m/z  (EI):  151  (M
+,  80%),  119  (100).  HRMS:  151.0636 
C8H9N1O2 requires (M
+), 151.0633. 
 
Methyl 2-(benzylidenamino)benzoate  311 
 
OMe
O
N
 
    
Following imine formation procedure C with a 48 h reaction time, triethylamine (0.60 
mL, 4.3 mmol, 2 equiv.), benzaldehyde (0.26 mL, 2.6 mmol, 1.2 equiv.), and methyl 2-
aminobenzoate hydrochloride salt 310 (399 mg, 2.1 mmol, 1 equiv.), in toluene (9.0 mL), 
gave methyl 2-(benzylideneamino)benzoate 311 as an oil (141 mg, 28 %). Bp 180 
oC at 
0.6 mm Hg. IR (thin film): 1689, 1578 cm
-1. H (CDCl3, 400 MHz) 3.84 (3H, s, OCH3), 
6.95 (1H, dd, J= 0.9, 7.9, H3), 7.23 (1H, dt, J= 1.0, 7.6, H5), 7.45-7.53 (4H, m, H arom.). 
7.88-7.93 (3H, m, H arom.), 8.29 (1H, s, N=CH). C (CDCl3, 100 MHz) 52.04 (CH3), 
120.21 (CH), 123.12 (C), 124.68 (CH), 128.77 (CH), 128.90 (CH), 130.72 (CH), 131.51 
(CH), 132.93 (CH), 136.07 (C), 153.39 (C), 160.62 (CH), 167.14 (C). m/z (EI): 239 (M
+, 
30%),  224  (100),  151  (30),  119  (35).  HRMS:  239.0948.  C15H13O2N,  requires  (M
+) 
239.0946. 
 
 
(2RS, 6RS) 2-Methyl-6-phenylpiperidin-4-one, hydrochloride salt  315a 
 
N
H2
O
Cl
H H
 
 
Following methylenation procedure A, a 0.96 M solution of Cp2TiMe2 (0.71 mL, 0.68 
mmol,  2.1  equiv.)  in  toluene-THF  (1:1  by  mass)  and  (3RS,  E)  methyl  3-
(benzylidenamino)butanoate 300a (65.4 mg, 0.32 mmol, 1 equiv.), gave crude enol ether 
301a (44.9 mg). Following cyclization procedure A, 7M HCl(aq) (3 ml), and a portion of  
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the crude enol ether 301a (21.2 mg), gave (2RS, 6RS) 2-methyl-6-phenylpiperidin-4-one, 
hydrochloride salt 315a as a brown solid (21.2 mg, 62%). Mp 191-192 
oC IR (thin film): 
1721 (C=O) cm
-1. H (CDCl3, 400 MHz) 1.46 (3H, d, J= 6.4, CH3),  2.53-2.58 (1H, m, 
H3
eq),  2.58-2.62 (1H, m, H5
eq),  2.98 (1H, dd, J= 12.8, 15.6, H3
ax),  3.21 (1H, dd, J= 
13.6, 15.4, H5
ax),  3.72-3.85  (1H, broad m, H2),  4.73-4.82 (1H, broad m, H6),  7.42-
7.52 (3H, m, H arom.),  7.75 (2H, d, J= 7.6, H arom.),  9.59-9.68 (1H, broad m, NH
AH
B),  
10.41-10.56 (1H, broad m, NH
AH
B). C (CDCl3, 100 MHz) 18.21 (CH3), 44.28 (CH2), 
44.42 (CH2), 51.93 (CH), 57.98 (CH), 127.92 (CH), 128.86 (CH), 129.20 (CH) 135.95 
(C), 202.60 (C). m/z (CI): 190 (M
+, 100%). HRMS: 190.1231 C12H16ON requires (M
+), 
190.1232. 
 
(2RS, 6SR) 2,6-Diphenylpiperidin-4-one hydrochloride salt  315b 
 
N
H2
O
H
Cl
H
 
 
Following methylenation procedure A, a 0.96 M solution of Cp2TiMe2 (0.79 mL, 0.76 
mmol,  1.8  equiv.)  in  toluene-THF  (1:1  by  mass)  with  (3RS,  E)  methyl  3-
(benzylidenamino)-3-phenylpropionate 300b (112.4 mg, 0.42 mmol, 1 equiv.) gave crude 
enol ether 301b (110.4 mg). Following cyclization procedure A, 7M HCl(aq) (10 ml), and 
the  crude  enol  ether  301b  (110.4  mg)  gave  (2RS,  6SR)  2,6-diphenylpiperidin-4-one 
hydrochloride salt 315b as a beige solid (75.4 mg, 62%). Mp 215-216 
oC.  IR (thin film): 
1725 (C=O) cm
-1. H (CDCl3, 400 MHz) 2.63-2.73 (2H, broad m, H3
eq & 5
eq),  3.45-3.58 
(2H, broad m, H3
ax & 5
ax),  4.92-5.01 (2H, broad m, H2 & H6),  7.38-7.48 (6H, m, H 
arom.),  7.80 (4H, d, J= 6.8, H arom.),  9.95-10.06 (1H, broad m, NH
AH
B),  10.71-10.84 
(1H, broad m, NH
AH
B). C (CDCl3, 100 MHz) 44.33 (CH2), 59.12 (CH), 128.35 (CH), 
128.65 (CH), 129.23 (CH) 135.54 (C), 202.20 (C). m/z (CI): 252 (M
+, 100%). HRMS: 
252.1389 C17H18ON requires (M
+), 252.1388. 
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Methyl 4-aminobutanoate, hydrochloride salt  326 
 
H3N
OMe
O Cl  
 
Using: thionyl chloride (3.45 mL, 47.5 mmol, 2 equiv.), 4-aminobutyric acid 325 (2.451 
g,  23.8 mmol,  1 equiv.),  in  MeOH (45  mL) and  following  the  general  esterification 
procedure  gave methyl 4-aminobutanoate hydrochloride salt  326  as  a  solid  (3.567  g, 
98%). IR (thin film): 1726 (C=O) cm
-1. H (DMSO, 400 MHz): 2.13 (2H, quin., J= 7.3, 
CH2CH2CH2), 2.53 (2H, t, J= 7.2, CH2C), 3.07-3.19 (2H, m, CH2N), 3.68 (3H, s, OCH3), 
8.19 (3H, s, NH3). C (CDCl3, 100 MHz): 22.60 (CH2), 30.94 (CH2), 39.37 (CH2), 51.95 
(CH3), 173.32 (C). m/z (CI): 118 (M
+, 100%). HRMS: 118.0867 C5H12N1O2 requires 
(M
+), 118.0868. 
 
 
(E) Methyl 4-(benzylidenamino)butanoate  327 
 
OMe
N
O
 
 
Following Imine formation procedure A, triethylamine (0.46 ml, 3.3 mmol, 2 equiv.), 
benzaldehyde (0.21 ml, 2.0 mmol, 1.2 equiv.), methyl 4-aminobutanoate hydrochloride 
salt 326 (0.254 g, 1.7 mmol, 1 equiv.), and Na2SO4 (0.288 g, 2.0 mmol, 1.2 equiv.), in 
DCM (5.0 ml) gave (E) methyl 4-(benzylidenamino)butanoate 327 as an oil (0.2721 g, 
80%).  Bp 150 
oC  at 0.6 mm Hg. IR  (thin  film):  1736 (C=O), 1645 (C=N)  cm
-1. H 
(CDCl3, 400 MHz) 2.06 (2H, quin., J= 7.0, CH2CH2CH2), 2.42 (2H, t, J= 7.2, CH2C),  
3.62 (2H, t, J= 6.8, CH2N),  3.66 (3H, s, OCH3), 7.37-7.42 (3H, m, H arom.),  7.70-7.74 
(2H, m, H arom.),  8.28 (1H, s, N=CH). C (CDCl3, 100 MHz) 26.05 (CH2), 31.69 (CH2), 
51.49 (CH3) , 60.39 (CH2), 128.04 (CH), 128.55 (CH), 130.61 (CH), 136.09 (C), 161.50 
(CH), 173.89 (C). m/z (EI): 205 (M
+, 30%), 174 (85), 132 (100). HRMS: 205.1101. 
C16H16O2N2, requires (M
+) 205.1103. 
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(E) 2-Methoxy-5-(benzylidenamino)pent-1-ene  328 
 
N
OMe
 
 
Following methylenation procedure B, a 0.96 M solution of Cp2TiMe2 (0.88 mL, 0.84 
mmol,  1.8  equiv.),  in  toluene-THF  (1:1  by  mass)  with  (E)  methyl  4-
(benzylidenamino)butanoate 327 (96.1 mg, 0.47 mmol, 1 equiv.), and a 10 min reaction 
time at 65 
oC gave crude enol ether (E) 2-methoxy-5-(benzylidenamino)pent-1-ene 328 
(84.1 mg). H (CDCl3, 400 MHz) 1.91 (2H, quin., J= 7.2, CH2CH2CH2), 2.18 (2H, t, J= 
7.4, CH2C),  3.53 (3H, s, OCH3), 3.62 (2H, dt, J= 1.2, 7.2, CH2N),  3.89 (2H, s, C=CH2), 
7.38-7.43 (3H, m, H arom.),  7.70-7.74 (2H, m, H arom.),  8.28 (1H, t, J= 1.2, N=CH). C 
(CDCl3, 100 MHz) 28.34 (CH2), 32.55 (CH2), 54.74 (CH3) , 60.90 (CH2), 80.60 (CH2), 
128.06 (CH), 128.60 (CH), 130.53 (CH), 136.30 (C), 161.24 (CH), 163.69 (C). 
 
(2SR, 3SR) 1-(2’-Phenylpyrrolidin-3’-yl)ethanone, hydrochloride salt  329 
 
N
H2
O
H
H Cl
 
 
Following methylenation procedure A, Cp2TiMe2 (0.88 mL, 0.84 mmol, 1.8 equiv.), and 
(E) methyl 4-(benzylidenamino)-butanoate 327 (96.1 mg, 0.47 mmol, 1 equiv.), gave 
crude enol ether 328 (84.1 mg). Using non-oven-dried glassware, conc. HCl(aq) (3 ml) 
was added to the crude enol ether and the resulting mixture was stirred for 0.5 h. The 
solution was washed with DCM (5X), and the aqueous layer was concentrated in vacuo 
to give (2SR, 3SR) 1-(2-phenylpyrrolidin-3-yl)ethanone hydrochloride salt 329 as a solid 
(25.7 mg, 62%). For characterization purposes the salt was dissolved in water, basified 
with NaOH(aq), extracted with DCM, dried over Na2SO4, and concentrated in vacuo to 
give the free base. IR (thin film): 1708 (C=O) cm
-1. H (CDCl3, 400 MHz) 1.92-2.05 (1H, 
m, CHCH
AH
B), 2.02 (3H, s, CH3), 2.06-2.19 (1H, m, CHCH
AH
B), 2.97-3.08 (2H, m, 
CH2N), 3.16 (1H, ddd, J= 4.9, 7.5, 10.0, CHCO),  4.25 (1H, d, J= 7.2, CHN), 7.13-7.31  
(5H, m, H arom.). C (CDCl3, 100 MHz) 30.00 (CH3), 30.23 (CH2), 46.77 (CH2), 60.07  
167
(CH), 65.09 (CH), 126.68 (CH), 127.35 (CH), 128.59 (CH) 143.14 (C), 209.36 (C). m/z 
(CI+): 190 [(M+H)
+, 100%]. HRMS: 190.1231. C12H16ON requires (M+H)
+, 190.1232.  
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